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A.ABSTRACT 
THE EFFICACY AND OUTCOME OF SCREENING FOR TUBERCULOSIS. 
Introduction 
Tuberculosis (TB) is a disease of public health importance due to the associated 
morbidity and mortality as well as the potential for transmission of infection to 
uninfected contacts. Tuberculosis can be prevented by screening of high risk groups and 
targeted prophylaxis with isoniazid (INH). Screening programs with structured 
guidelines exist for the screening of many groups at risk for TB, including refugees, 
contacts, health workers and prisoners, with some run by health authorities and others 
by employers. 
Screening programs for TB may focus on case finding, prevention or a combination of 
both, and may differ in their aims, guidelines, practice and resources. The outcomes and 
effectiveness of such programs may also differ, and may be influenced by a number of 
factors. These include the nature of screening guidelines and whether such guidelines 
are evidence based, the consistency between policy and practice of screening by health 
professionals, and external factors such as structural or political change and financial 
restrictions. The null hypothesis is that TB screening programs operate under evidence-
based guidelines, have good implementation of guidelines and have optimal outcomes. 
Aims 
To examine screening programs for contacts, refugees and prisoners in selected 
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programs in Australia and the USA. Because of the differences in screening methods 
and policy outlined above, I aimed to examine the rationale of screening policies and 
their scientific basis, the efficacy of screening practice, whether screening guidelines are 
properly implemented by medical and nursing staff, what intrinsic and extrinsic 
problems may have hindered the implementation of guidelines, and the outcomes of 
screening programs as measured by the incidence of active TB and skin test conversion, 
and the prevention of active TB. 
Methods 
I undertook a series of separate studies in order to address the aims above. The studies 
are outlined below. The first chapter presents background and a general literature 
review, but more specific literature reviews are contained in the subsequent chapters. 
1) The first study retrospectively estimates missed opportunities for prevention of TB in 
notified cases of active TB in Victoria, Australia. All notified cases of active TB in 
1991 in Victoria (n=231) were reviewed for any past screening for TB. If such 
screening or indications for screening were documented, each case was evaluated as to 
whether appropriate preventive action was taken. Missed opportunities for prevention of 
TB were quantified for each case. 
2) The next chapter is a retrospective cohort study of 1,142 contacts of tuberculosis 
screened in 1991. This cohort was screened by health authorities in Victoria, Australia, 
and had two years of follow up for the development of active disease. The study 
describes the two-year incidence of TB in recent contacts. Skin test reaction sizes were 
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correlated with risk of developing active disease in order to provide data to select 
appropriate criteria for the interpretation of the test. Preventability of incident cases of 
TB was quantified retrospectively. 
3) The third study is a detailed analysis of each step of screening and prevention in the 
1, 142 recent contacts described in item (2) above. This study compares recommended 
guidelines with actual practice. 
4) The cost effectiveness of contact screening per case prevented and per case found was 
estimated for three different models. The first model describes cost effectiveness of 
contact screening as it was conducted in 1991; the second model describes cost 
effectiveness of contact screening had the 1991 guidelines been followed closely; and 
the final model describes the cost effectiveness of contact screening practised according 
to hypothetical, evidence-based guidelines. 
5) This study is a retrospective cohort study of 1,101 Indo-Chinese refugees screened 
between 1989-1990 in Victoria, Australia. The study included five years of follow up 
for the development of active disease. Skin test reaction sizes were correlated with risk 
of developing active disease in order to provide data to select appropriate criteria for the 
interpretation of the test. Preventability of incident cases was assessed retrospectively. 
6) This study is a detailed analysis of each step of screening and prevention in the 1, 101 
refugees, comparing recommended guidelines with actual practice. 
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7) This study is a comparison of tuberculin skin test distributions in a number of 
Victorian populations of varying degree of risk for TB. The skin test distributions are 
used to assess the sensitivity and specificity of the cut-off points used in Victoria at the 
time for defining a positive reaction. 
8) This is a study to determine the incidence of skin test conversion during annual 
screening of inmates of Maryland prisons, with an analysis of the impact of TB control 
measures and risk factors on the incidence of skin test conversion. 
9) A study of the skin test converters identified in (8) above was then conducted to 
determine exposure to undetected TB within the correctional system. The movements 
within the correctional system of skin test converters were matched with those of 
inmates with documented infectious TB. This was supplemented by a linkage study 
with the State TB registry to identify cases of active TB which may have been missed 
within the prison system. 
10) In the same group, I studied implementation of screening guidelines by prison 
medical and nursing staff and the utilisation of INH prophylaxis. 
Results 
The study of all notified cases of active TB in 1991 identified that nearly half of all 
notified cases of TB have been screened for TB in the past, and yet this screening had 
failed to prevent the development of active TB. Over 70% of those screened were found 
to be at risk for TB, but rates of preventive therapy were low. Nearly 30% of cases may 
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have been prevented. 
There was evidence that the guidelines for screening and prevention used in Victoria for 
refugees and contacts required updating. These guidelines emphasise case finding rather 
than identification of asymptomatic infection and prevention, and rely more on chest 
radiograph (CXR) screening than skin testing. In addition, the guidelines were poorly 
implemented . This was partly explained by devolution of TB screening programs in the 
1970s and 1980s and lack of resources. 
In nearly 60% of contacts, the presence or absence of infection could not be determined 
because a skin test was not done, and a CXR, if done, was clear. The rate of preventive 
therapy for eligible contacts and refugees was low. The two year incidence of active 
pulmonary TB was 531/100,000 per year for contacts, and 110/100,000 per year for 
refugees. Of the incident cases, many were considered "not infected" at the time of 
screening because of they had received BCG vaccine in the past and had a skin test 
reaction of 10-19mm. In logistic regression models testing various skin test cut-off 
points, a reading of 15mm or more was the strongest predictor of the development of 
active TB for contacts. The use of a 20mm cut-off excludes most individuals who are at 
risk. The incidence of active TB increased with increasing skin test reaction size. 
The direct cost of contact screening as it was actually performed in 1991 was 
A$331,610 per case prevented, A$248,708 per case found and A$871 per contact 
traced. If the guidelines had been followed closely, the respective costs would have 
been A$81,892 per case prevented, A$286,621 per case found and A$ l ,004 per contact 
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traced. In an alternative model which I propose, the costs would be A$47,358 per case 
prevented, A$319 ,670 per case found and A$793 per contact traced. 
The guidelines used in Maryland prisons, in contrast, are well supported by the 
literature. However, I found a poor implementation of guidelines by prison medical and 
nursing staff, and a low rate of preventive therapy for eligible inmates. Skin test 
conversions occurred at a rate of 6.3/100 person-years, and the rate of preventive 
therapy was lowest for this high risk group. Reasons for not giving, or prematurely 
ceasing INH were largely unfounded. The rate of true side effects was low. There was a 
wide variation in skin test conversion rates and in rates of giving INH, between different 
prisons and prison types. The highest risk of conversion was in the intake institution. A 
strong positive correlation existed between prison crowding and skin test conversion, 
and a strong negative correlation with rates of INH use and skin test conversion. 
Exposure to TB was only found for 30% of skin test converters. Linkage with the State 
TB registry identified cases of TB that occurred in inmates but were undiagnosed during 
incarceration. 
Discussion 
The lack of adherence to screening guidelines and the inadequate use of preventive 
therapy were problems common to all screening programs. Although under-use of 
preventive therapy in different settings has been reported in the literature, this is a poorly 
studied area. The low rates of preventive therapy and the low threshold for 
discontinuing it once started, suggest that confusion and fear about the use of INH may 
be prevalent, and that there is a need for education of providers. 
23 
The guidelines used for contact and refugee screening in Victoria are not well supported 
by scientific rationale and exclude a large proportion of individuals who are at high risk. 
This was confirmed by the high incidence of active TB at follow up, and by examining 
the features of each incident case. It was further confirmed by finding the high rate of 
preventability of notified cases of active TB. I found a lack of cost effectiveness of the 
contact screening program, largely because intervention in the form of prevention was 
an unlikely outcome at the end of a sequence of screening tests. The findings also 
emphasise that in a low prevalence setting, case finding is an expensive exercise and 
should not be the main focus of screening. In the Maryland prisons, whilst the 
guidelines used were well founded, a wide variation was found in adherence to 
guidelines and in rates of preventive therapy. Evidence was also found that significant 
transmission of TB may go undetected in prisons, due to high population turnover. 
For the Victorian contact and refugee programs, the recommendation that more sensitive 
skin test criteria be adopted, that age should not be considered for contacts of TB when 
skin testing or offering preventive therapy, that CXR screening needs to be rationalised, 
and that contacts of non-infectious TB need not be screened en masse, have been 
accepted and adopted. These data contributed to significant revision of the screening 
guidelines in 1994. It would be prudent to conduct a follow up study of the application 
and impact of these changes. In Maryland prisons, it was recommended that efforts be 
made to standardise preventive efforts across different prisons, and to prioritize TB 
control measures according to the level of risk of the prison. Crowding is not a risk 
factor which is readily amenable to change, but maximal use of preventive therapy can 
diminish that risk. 
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Guidelines used by screening programs are variable. In the case of Victoria, there was 
no convincing evidence or data for the use of their screening guidelines. This study 
provided sound data for decision making and had a favourable impact on the revision of 
guidelines. This in itself is a public health exercise which proves that long standing 
policies should be questioned for validity, and if those policies are not supported by 
evidence, the collection of required evidence for change is indicated. The major 
problem faced by the screening programs studied, however, is not a lack of policies, but 
a failure to apply structured guidelines in the practice of prevention. In the case of 
Victoria, this is partly explained by factors extrinsic to the TB program, such the 
devolution of TB services in the 1970s and 1980s, and lack of adequate resources and 
support for TB program staff. There is, nonetheless, considerable opportunity to 
i~prove the outcome of screening, which should not be carried out unless there is a 
commitment to intervention that makes a positive public health impact. Screening 
without an end point of change in outcome is not good practice. In the case of TB, 
intervention in the form of INH preventive therapy is available, and as such, should be 
used. 
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B. BACKGROUND AND GENERAL LITERATURE REVIEW 
An introduction to tuberculosis 
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis 
complex (MTB). There are many other non-tuberculous mycobacteria, some of which 
have common antigens with MTB. Mycobacteria are distinguished bacteriologically by 
the fact that they are resistant to decolourisation by acid alcohol when stained with basic 
fuschin. This "acid fastness" is related to the waxy component of the bacterial cell wall. 
MTB is a slow growing, strict aero be and thrives in the lungs because of the relatively 
high oxygen tension in that organ. In Victoria, Australia 60-70% of cases of active TB 
are pulmonary .1 TB, however, can occur in most other organs, including the kidneys, 
bones, lymph nodes or meninges, and may be disseminated. TB is transmitted from 
person to person through the respiratory route, primarily by coughing. It may then 
spread by the haematogenous or lymphatic routes to other organs or lymph nodes. 
In Australia and other developed countries, certain groups are at higher risk for TB. 
These include migrants, especially those from developing countries, Australian 
Aboriginal people, health professionals, alcoholics, older people, institutionalised 
persons including prisoners, and persons living in sub-standard, overcrowded 
conditions. 1-4 
In an individual, the risk of clinical TB is related to the risk of acquiring infection and 
the risk of infection progressing to disease. The risk of acquiring infection depends 
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mainly on the following three factors: 
1. The characteristics of the index case: Pulmonary and laryngeal TB are infectious, 
whereas extra pulmonary TB (such as lymph node, genitourinary, bone or meningeal 
TB) carry negligible risk of transmission. In addition, the level of infectivity of a case of 
pulmonary TB is determined by whether the sputum is culture positive, whether the 
sputum is smear positive, the degree of smear positivity (indicating bacterial load) and 
whether a cavity is present on CXR. Smear positive, culture positive, cavitating 
pulmonary disease is highly infectious.5 
2. The degree of contact with the case: People in casual contact with infectious patients 
are at low risk - continuous, close contact (such as living in the same household) is 
associated with high risk. 6• 7 
3. Environmental factors such as ventilation, although this is not thought to be as 
important as proximity of contact.8•10 
The risk of progression of TB from asymptomatic infection to clinical disease depends 
on factors relating to immunity and predisposition: persons with diabetes, silicosis, 
those with HIV infection and persons with immunosuppression from other causes (such 
as long-term corticosteroid therapy) are at increased risk.11 Of all these groups, the 
highest risk of active TB is in patients with HIV infection. 11-13 
MTB also infects animals, particularly cattle, and can be transmitted during the 
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slaughtering process, or through unpasteurised milk. The organism in cattle is usually 
Mycobacterium bovis (M bovis). M bovis disease, however, is rare in humans in 
developed countries today. 
A .person who is infected with MTB carries a 10% lifetime risk of developing active TB. 
Half of these cases occur within the first two years after infection. If active TB is left 
untreated, it results in 50% mortality in two years. Of the remainder, 25% achieve 
spontaneous cure and 25% develop chronic TB.14 
Understanding the cycle of TB transmission and propagation is important for effective 
TB control. Figure 1.1 shows the cycle of transmission of TB, and points where the 
cycle can be broken. It shows the relationship between the asymptomatic infection stage 
and progression to active disease, and indicates that the cycle of transmission can be 
interrupted at several different points, by several different methods. 
Prevention of cases can be achieved by: 
1. Reducing the risk of new infection. 
Transmission of TB from a person with pulmonary disease to a non-infected person can 
be reduced by BCG vaccine,15 by prompt diagnosis and treatment16-19 and by good 
hospital infection control measures.20• 21 Environmental factors such as ventilation and 
ultra-violet light may also play a role. 
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Figure 1.1 The cycle of TB transmission and points 
at which the cycle can be broken. 
Active pulmonary TB 
*BCG vaccination 
*Infection control --
*Early diagnosis 
and treatment 
.....i1• *Screening and 
prophylaxis 
(isoniazid) 
Asymptomatic TB infection 
2. Prevention of disease in those already infected 
Development of disease in persons with asymptomatic infection can be reduced by 
screening and identifying persons at risk and giving them preventive therapy with INH. 
Effective treatment of co-morbid conditions such as diabetes or HIV infection may also 
reduce the risk of reactivation. 
Worldwide trends in tuberculosis 
Tuberculosis remains, in the developing world, the commonest cause of mortality as a 
single infectious agent, accounting for 26% of avoidable adult deaths, and 6. 7% of all 
deaths.22 It is estimated that one-third of the world's population is infected with MTB.23 
Worldwide there are an estimated 8 million new cases of tuberculosis and 3 million 
deaths from tuberculosis per year, with the largest number of new cases occurring in 
young adults.23·24 In sub-Saharan Africa the case fatality of tuberculosis is 41-48%, a 
figure which hardly differs from that of the pre-chemotherapy era of 50% mortality in 2 
years.14, 24 
In countries where both tuberculosis and HIV are highly prevalent, such as Uganda and 
Zambia, there is a strong association between the diseases, with HIV seropositivity rates 
in tuberculosis patients of up to 62%. 13• 25 World Health Organization (WHO) estimates 
suggest that 4 million persons had both HIV and tuberculosis infection in 1992.26 HIV 
seroprevalence rates in tuberculosis clinics in the USA range from 0-46%, depending on 
the State, with a median of 3%.27 The WHO also estimates that in the year 2000, the 
largest burden of HIV /TB co infection will be shared equally between South East (SE) 
Asia and Africa. 
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Tuberculosis is also a threat in the developed world. In the US the annual incidence of 
tuberculosis rose by 20% between 1985 and 1992, and has since declined by 8.7%.11•28 
There have been a number of outbreaks of multi-drug resistant tuberculosis within 
hospitals, prisons and other institutions, largely affecting HIV infected persons.20• 29• 30 
Multi-drug resistant tuberculosis is associated with high mortality rates and low survival 
time, particularly in HIV-infected persons.20•31 •32 
The resurgence of tuberculosis as a major public health problem in the USA has not 
been seen in Australia.4 However, the expected decline of TB in the past decade has not 
occurred. The factors contributing to the rise in TB in the USA, such as the HIV 
epidemic, lack of available health care, poverty and homelessness, are not present to the 
same extent in Australia. However, European countries have seen increases in TB 
incidence of up to 33% over the past 5 years, attributed largely to changing migration 
pattems.33 In Victoria around 80% of new cases of TB are seen in migrants.1•34 This is 
in contrast to the USA, where around 32% of new cases in 1994 were migrants.28• 35 
Tuberculosis in Victoria and Australia 
In Victoria (and in Australia, overall) the incidence of TB in the general population is 
low by world standards at around 6/100,000/year.1•4 The 1945 Tuberculosis Act 
encouraged States to co-operate, using Commonwealth funds, in a campaign for 
tuberculosis control. 36 In 1946 tuberculosis was responsible for 28% of all deaths in the 
age group 20-39 years in Victoria. During that year, overall, it was responsible for twice 
as many deaths as cancer and exceeded by 50% the number of ischaemic heart disease 
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deaths.36 The tuberculosis campaign was discontinued in 1976. It was at this time, 
ironically, that Australia began to receive refugees from countries of high tuberculosis 
prevalence. 
The incidence of tuberculosis in Victoria has declined from 46.8/100,000 in 1953 to 
5.8/100,000 in 1991.1 However, after a long period of steady decline from 1964 to 
1976, there was a plateau of incidence from 1985-1992, rather than the expected 
continued decline. The majority (70-80%) of cases seen in Victoria and Australia now 
are foreign born. 1' 4 
The history of the Victorian TB program 
The 1945 Tuberculosis Act, which resulted in a national campaign for tuberculosis 
control continued in Australia until 1976. During those 31 years the Commonwealth 
government provided States with funding for TB control.36 The Victorian tuberculosis 
campaign continued until 1976, after which there was a gradual devolution of the 
program, corresponding with the declining incidence of TB. Reduced funding for TB 
control activities in the 1970s and 1980s resulted in a gradual reduction in the number of 
the State-run chest clinics which were a dedicated TB service, along with a reduction in 
their medical and nursing staff. The refugee screening program was established in 1978 
at Heatherton hospital, and was moved to Fairfield Hospital in 1979.37 
By 1991, the TB program ran its own TB clinics and screening programs, but its 
medical staffing and capacity were gradually reduced, leaving nurses to shoulder the 
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majority of the responsibility by the early 1990s. During the preceding decade, we saw 
a change in patient mix, from a predominantly Australian-born patient population in the 
1970s to a predominantly foreign-born patient population by 1992.1 Despite the 
changing epidemiology of TB in Australia, the TB nurses were left with outdated 
guidelines in use since the 1960s, written for a different patient mix and with an 
emphasis on mass CXR screening and case finding. 
In 1991, the TB program consisted of a nurse manager, eight TB nurses, two secretarial 
staff and one full time medical officer, with an external specialist advisor providing 
additional support and supervision. The program provided supervision of treatment for 
cases of TB, contact tracing and screening, refugee screening, migrant screening, 
outbreak investigation and follow up of immigrants on tuberculosis health undertakings. 
The period under study in this thesis was one of flux, uncertainty and difficulty for the 
TB program, so that the subsequent chapters relating to the Victorian TB program 
should be considered in this context. 
In 1994 there was a further decentralisation of the TB program, with services tendered 
out to Fairfield Infectious Diseases Hospital, Victoria.38 By 1995, with the closure of 
this hospital, TB services were again centralised to the Department of Human Services, 
with some components of the service tendered out to other providers. 
The role of the private sector 
Some patients with TB are treated in the private sector. Private physicians are required 
to notify cases of TB, and once notified, the TB program initiates contact tracing. It is 
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unlikely that TB is under-notified in the public or the private sector.39 The procurement 
of free anti-tuberculous drugs requires notification, making under-notification less 
likely. The private sector works closely with the public sector in TB control, with the 
TB program having close links and good communication with most private physicians 
who treat TB patients. 
Principles of surveillance and screening 
A surveillance system examines patterns of disease within a temporal, geographic, 
demographic and clinical context, and detects changes in these patterns. Any changes 
detected provide a scientific and reasoned basis for targeted intervention. Surveillance 
may also function as a warning system for early detection of disease outbreaks. An 
example is surveillance for influenza, the results of which influence the choice of 
influenza vaccine manufactured each year. Other forms of surveillance include the use 
of sentinel chickens in Australia to detect Murray Valley Encephalitis (MVE) before 
humans are affected. These chickens are bled periodically and tested for serological 
evidence of MVE. If MVE is detected, mosquito control measures are promoted in the 
population. These examples illustrate the practical value of surveillance. 
The most important form of surveillance for TB is surveillance of active disease 
(clinical TB). All State and Territory health departments conduct surveillance for active 
TB by statutory notification. Surveillance of active TB allows comparison of trends in 
disease incidence over time, as well as epidemiological linking of cases by molecular 
typing.40 This information provides a basis for future TB control measures and 
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prioritising of resources. 
Screening of risk groups for asymptomatic infection with TB is also a form of 
surveillance, and in fact is one of the most important components of TB surveillance 
because it has the potential for prevention. In the case of tuberculosis, intervention in 
the form of prevention with INH is possible, and therefore screening and surveillance 
are of practical value. 
Screening is done to detect a disease or disease risk factor in selected populations, and is 
reserved for conditions of sufficient public health importance where some form of 
intervention and change in outcome is possible. In addition, screening programs should 
be evidence based and proven to be of net benefit to the population.41 
Screening and surveillance for disease or disease risk factors are common public health 
practice, and often require significant resources. The first principle of good screening 
practice is that the disease or condition being screened is of public health 
importance.42• 43 The condition should also be of high enough prevalence in the 
population so as to make screening cost-effective. Once these conditions are met, 
screening should be carried out only if intervention is possible and probable, and that 
intervention results in a change in outcome with public health benefits. For example, 
conducting screening for a rare disease for which there is no possible intervention, or for 
a disease that does not have serious health outcomes, would not be a good use of 
resources. On the other hand, screening for early detection of common cancers such as 
cervical cancer in women is good public health practice and has been proven to reduce 
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the mortality from that disease.44 Some rare diseases are suitable for screening. An 
example is phenylketonuria, which has serious, irreversible long term consequences, but 
which is preventable and can be detected by a cheap, simple screening test. 
Implicit in the concept of screening is that early detection of disease and appropriate 
preventive treatment during the detectable, pre-clinical phase of the illness, will alter the 
clinical outcome. This assumption may not hold true in all cases - for example, 
screening for asymptomatic lung cancer using CXR would probably not improve 
survival. Even for a screening program with potential health benefits, the risks and costs 
of screening need to be weighed up against those benefits.43 
Once a screening program is deemed suitable and of net benefit to the community, there 
must also be a commitment to ensuring that the screening is conducted systematically, 
and that there is appropriate intervention for persons with positive screening results. 
Studies have shown that physicians can fail to follow recommended guidelines for TB 
screening, and thereby miss opportunities for prevention.45• 46 One study of an 
established TB screening program for high risk students found that screening was 
conducted, but was not cost effective because of low rates of preventive therapy .47 
Screening programs, once established, should be evaluated periodically in order to 
identify problems, determine cost effectiveness and improve system performance.48-50 
These basic principles should be adhered to if screening resources are to be used 
optimally. 
The most desirable characteristics of a screening test in the context of TB are high 
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sensitivity and positive predictive value, because finding positive reactors and treating 
those at risk is the goal of screening. Since positive predictive value increases with 
increasing prevalence of disease, screening for TB is more effective in populations at 
high risk. 
Few screening tests are perfect, and the TST is no exception. The TST is a function of 
the organism, the host, the population and the test, with these four factors affecting each 
other. Finding a suitable definition of infection involves a trade off between sensitivity 
and specificity, with one increasing as the other decreases. The choice of definition 
should take into consideration host, organism, test and population factors. For example, 
in HIV positive populations, where reduced immunity may affect the delayed cutaneous 
hypersensitivity reaction, a lower cut-off point should be used. In a population with a 
high prevalence of TB, such as a refugee camp, a sensitive definition should be used, 
since the positive predictive value of the test will be high. 
Screening tools 
A. The tuberculin skin test (TST) 
The TST is an intradermal injection of purified protein derivative (PPD) called 
tuberculin, to which the delayed cutaneous hypersensitivity response is measured 72 
hours later. The diameter of induration (rather than erythema) is measured, and 
positivity is defined according to a selected cut off point of the reaction size. 
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In a population without significant exposure to non-tuberculous mycobacteria, a 
bimodal distribution curve ofTST reactivity is expected.51 The first part of the curve 
represents un-infected persons, while the second part represents infected persons. There 
may be a "grey" area between the two curves where false positives and false negatives 
occur. The chosen cut-off point for defining infection should lie in this grey area, and 
will be highly sensitive, but of lower specificity if shifted to the left; and highly specific 
but of lower sensitivity of shifted to the right. 
It is not possible to calculate the true sensitivity and specificity of the test without an 
autopsy study (as was done in cattle), since infection with TB is asymptomatic, and 
there is no definite way to determine if a positive test is due to TB. Normally, 
sensitivity and specificity are considered constant characteristics of a screening test. In 
the case of the TST, however, sensitivity and specificity of the test depend on the chosen 
cut-off point for defining "infection", and on host factors such as immune and 
nutritional status. 
The TST is reported to be a highly sensitive test,52 so that most people who are infected 
with TB should have a positive test; however, about 10% of the normal population are 
anergic and would not display a cutaneous reaction, even if they were infected. Other 
reasons for a false negative reaction include test failure, which one would assume would 
be rare when the test is carried out by experienced investigators, and 
immunosuppression such as that caused by HIV infection. Normally, about 20% of 
close, recent contacts of a case of TB would be expected to be infected;53 therefore of 
the 20% who were infected, 10% would not display a cutaneous reaction due to anergy. 
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In a population of 100 close contacts you would therefore expect 2 false negative 
reactions due to anergy. The TST is at least 85% sensitive52 but sensitivity depends on 
the cut-off selected - for example, if Smm is selected the value indicating infection, the 
sensitivity is higher than if 20mm is selected. 
The question of the specificity of the TST is more complicated,52 and varies depending 
on the prevalence of exposure to non-tuberculous mycobacteria. Exposure to non-
tuberculous mycobacteria and BCG vaccination also may result in a positive test. The 
TST in humans is not a highly specific test, and false positive reactions are common. In 
a population with high rates of BCG vaccination, but low rates of true TB infection, a 
large number of false positives would be expected and the specificity would be low. 
However, autopsy studies in cattle have shown a specificity as high as 89% percent for 
the TST.52 
The positive predictive value of the TST is also variable, and depends on the prevalence 
of TB infection in the population being studied. In a population where TB infection is 
highly prevalent, the positive predictive value of the test is higher and may approach 
99%. 52• 54 In a population where TB infection is of low prevalence, the positive 
predictive value is lower, and screening would be of less value. 
The general Australian population has a low prevalence of TB infection, so that 
interpretation of a positive TST reaction can be difficult, especially because of high rates 
ofBCG vaccination or exposure to non-tuberculous mycobacteria in some States. In the 
US, selected sections of the population have a higher prevalence of TB, but the general 
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population prevalence is low.28 In addition, BCG vaccination has not been used widely 
in the US, so that its role in the interpretation of skin testing is less important than in 
Australia. The prevalence of non-tuberculous mycobacteria varies geographically in the 
US, 55 so that interpretation of a positive skin test needs to take account of this variation. 
Recent contacts of cases of active TB are a special risk group with a high prevalence of 
TB infection, making the positive predictive value of the test, when applied to this 
group, higher. Refugees and prison inmates are also at higher risk than the general 
population, so that the positive predictive value of the test is greater in these 
populations. 
B. The chest radiograph (CXR) 
CXR is used in screening for two purposes - firstly, to identify active TB and secondly, 
to identify asymptomatic, inactive TB. As a screening tool for the latter it has a very 
low sensitivity and a high specificity. It is valuable as an investigation for symptomatic 
patients to diagnose pulmonary disease. The chance of detecting a case of active TB by 
CXR screening, even in high risk populations is low in asymptomatic subjects.56-59 The 
World Health Organization ceased to recommend mass CXR screening in 1975, even in 
high prevalence countries, concluding that CXR was not a cost effective means of case 
finding.60 
The Centers for Disease Control (CDC) recommends the use of CXR screening "when 
the objective is to identijj; persons who have current pulmonary TB and when preventive 
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therapy for infected persons is not the primary goal (eg. in high turnover jails or 
homeless shelters). In these screening programs, patients who have signs and/or 
symptoms suggesting pulmonary or pleural TB ... should have a standard anterior-
posterior chest radiograph, regardless of the skin test result."61 
As shown in Table 1.2, the 1991 Victorian contact screening guidelines recommended 
that all contacts aged over 35 years receive a CXR as the sole screening test. 
Preventive therapy for TB 
INH is effective in preventive the development of TB in infected individuals.62-65 The 
ideal duration of therapy is 12 months for individuals with CXR evidence of inactive 
TB, but six months may also be effective, particularly in persons with a clear CXR and a 
positive TST. The benefits ofINH prophylaxis extend to HIV infected individuals with 
a positive TST, who have a higher risk of developing TB.66-69 The benefits of preventive 
therapy outweigh any potential risks in persons who are at high risk for TB and are aged 
under 35 years.10•73 
Decision analyses weighing the risks and benefits of the drug have shown low rates of 
hepatitis, and clear benefits in life expectancy except in the very elderly (>80 years of 
age).74 One decision analysis found clear benefits for all CDC recommended low risk 
groups under the age of 35 years.75 INH associated hepatitis is a known risk factor in 
persons aged over 35 years however studies have shown that when recent exposure to 
TB is documented, even in this age group, the benefits of INH may outweigh any 
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potential risks.72• 73• 76-79 Furthermore, a review of deaths previously attributed to INH 
revealed no definite relationship between INH and fatal hepatitis. 80 Recent reports of 
fatal INH hepatitis indicate that deaths occurred in patients who continued taking INH 
for weeks despite the onset of symptoms suggestive of hepatitis.77 If selection of 
candidates for INH is based on recommended CDC criteria61 and close monitoring of 
treatment, such adverse effects would be rare. A comprehensive meta-analysis of 
published studies of over 20,000 patients given INH according to CDC 
recommendations showed no deaths from hepatitis.81 A review of unpublished data 
showed 2/202,497 hepatitis deaths, or a rate of0.001%.81 
TB screening and surveillance in Victoria 
Surveillance by notification 
In Victoria, doctors and laboratories have a statutory obligation to notify cases of 
tuberculosis to the Victorian Department of Human Services (DHS). Similar legal 
obligations exist in other States and territories. 
The Tuberculosis Unit of the DHS receives notifications of new and reactivated cases 
from medical practitioners and laboratories. Accepted cases are those which are 
confirmed as belonging to Mycobacterium tuberculosis complex by culture or 
microscopy, or diagnosed as active tuberculosis on clinical grounds. Tuberculosis is 
less likely than other notifiable diseases to be under-notified.39 A mean of 80% of 
notified cases in Victoria are bacteriologically confirmed.1 These notification data 
provide the basis for surveillance in Victoria. 
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Notification data have been collected in varied forms over the years. From the 1960s 
until 1986, data are available in published annual reports, but there is no ready means of 
examining longitudinal trends. From 1986 until 1990, data were collected in a 
computerised database. This contained extensive information on notified cases, 
however, fields of entry varied from year to year, making longitudinal analysis difficult. 
In 1987 variables included: demographic data, country of birth, date of arrival in 
Australia (migrants), site of disease, bacteriology and drug sensitivities. In 1988 this was 
expanded to include information about contact tracing and prophylaxis of contacts. In 
1989, further variables were added, including length of treatment, tuberculin skin test 
(TST) results and CXR results. The expanded database contained most of the 
information needed for good surveillance, but this was ceased at the end of 1990. From 
1991 until 1996 TB notifications have been stored in a computerised database, which 
for the purpose of tuberculosis surveillance, contains very limited data. The variables 
collected are identification number, date received, diagnosis code, type, patient name, 
address, date of onset, age, reporting doctor, suburb of doctor, laboratory code, date of 
specimen and laboratory name and telephone number. Except for basic demographic 
data, this does not allow much useful analysis. Prior to the recent addition of a 
supplementary form containing basic medical information, notifications were 
incompletely entered due to incomplete recording on the notification forms. Once a 
case of TB is notified, a medical summary is sought from the treating doctor or hospital, 
and contact screening is initiated. 
Laboratory surveillance 
Victoria has one Mycobacterium Reference Laboratory, which is a part of the Victorian 
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Infectious Diseases Reference Laboratory (VIDRL), which provides additional 
surveillance information. This is the only Victorian laboratory which tests for drug 
sensitivity. The majority of positive TB cultures in Victoria are sent here for 
confirmation and sensitivity testing. VIDRL keeps a computerised database containing 
extensive information on bacteriologically proven cases, including demographic data, 
HIV status, treating hospital, occupation, country of birth, date of arrival in Australia 
(for migrants), interval from arrival in Australia to diagnosis of TB, site of disease and 
drug sensitivities. Data were collected from 1981 until the present time, and have been 
updated. Complete records are available from 1986 onward. 
Contact tracing 
Contact tracing is carried out by the nurses of the TB Program. When a notification of 
TB (whether infectious or non infectious) is received, a medical history is sought from 
the notifying doctor or hospital, and close contacts are followed. Until 1994, close 
contacts aged 35 years or under received a tuberculin skin test (TST) by the Mantoux 
method, with a follow up test in three months if the first test was negative. In the 1991 
Victorian guidelines infection was defined as a TST reaction greater than 20mm, or 
greater than Smm without a history of BCG vaccination, or documented conversion 
from a negative to a positive reaction. Infected contacts were recommended for a CXR, 
and referred to a TB specialist or specialist hospital clinic, with a letter. The consulting 
doctor then made a decision regarding administration ofINH prophylaxis. The TB 
Program attempted to follow the outcome among these contacts, but this was difficult 
due to constraints on staffing, and to the wide network of referrals. 
44 
Contacts aged over 35 in 1991 policy were screened with a CXR only, and received 
repeat CXRs at regular intervals (three, six and twelve months and then annually ifhigh 
risk). Detailed individual records are kept in the TB Program for all contacts, but 
information about prophylaxis and long term follow up are not always available. 
Migrant and refugee screening 
Refugees entering Australia undergo screening for TB in their countries of origin 
according to standards set by the Australian Government, which are implemented by 
The International Organization for migration (IOM). They then undergo screening again 
at State level once they enter Australia. Migrants are also screened in their country of 
origin prior to arrival in Australia. If they are found to have active TB, they require 
treatment and proof of sputum smear negative status before being allowed admission 
into Australia. If treated for TB, or if evidence of old, inactive TB or asymptomatic 
infection with TB is found, they are required to sign a health undertaking, known 
colloquially as a "tuberculosis health undertaking" or "TBU", in which they declare that 
they will present to State health authorities for follow up after arrival in Australia. A 
TBU is not legally enforceable.82 The State health authorities, therefore, provide post-
migration screening for all refugees and selected migrants who enter the country on a 
TBU. 
Until 1992, migrants entering Australia on a TBU and all refugees were screened at 
Fairfield Infectious Diseases Hospital in a State program. This program continued to 
screen all Indo-Chinese migrants on TB Us and refugees. Screening of all other migrants 
on TBUs and refugees was taken over by the Commonwealth (national) program in 
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1992. 
Preventive therapy with INH was recommended for refugees or migrants aged <35 years 
with a skin test reaction of20mm or more post-BCG, or 15mm or more without BCG, 
or with CXR evidence of inactive TB. The State program provided preventive therapy 
and follow up of at risk refugees and migrants. 
TB surveillance and screening in the United States. 
The CDC has identified three key strategies for TB control.83 They are, in order of 
priority: 
1. Case finding, together with ensuring completion of treatment for all cases of active 
TB. 
2. Contact investigation, with the aims of both case finding and identification of 
asymptomatic infection. The latter should be followed by preventive therapy. 
3. Screening of high risk populations in order to identify asymptomatic infection and 
prevent the development of active disease. Case finding is a secondary aim. Defined 
high risk populations (other than close recent contacts) include: 
*persons infected with HIV; 
*illicit drug users or substance abusers; 
*persons with medical risk factors for TB; 
*residents and employees of high risk congregate settings (such as prisons, nursing 
homes and homeless shelters); 
* health care workers who serve high-risk clients; 
*foreign-born persons, especially recent arrivals, from countries of high TB 
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prevalence; 
*some medically underserved, low income populations; 
*high risk racial or ethnic minorities; 
*infants, children and adolescents exposed to adults in high risk categories. 83 
The CDC also states that "tuberculin skin testing programs that identify infected 
persons without current disease should be undertaken only if the diagnostic evaluation 
and a course of prescribed therapy can be initiated and completed. "83 
The CDC defines the tuberculin skin test as the standard for identifying persons with 
infected with TB, and recommends that it be conducted by the Mantoux method using 5 
Tuberculin Units (TU) of purified protein derivative. CXR is recommended as a 
screening method for identifying active pulmonary TB in patients with symptoms or 
signs suggestive of disease.83 
The cut-off points recommended by CDC for interpretation of the TST vary according to 
the population being screened,61 as shown in Table 1.1, which also compares the cut-off 
points used in Victoria for various levels of population risk. Table 1.2 compares the 
1991 guidelines used in Victoria with the CDC guidelines for contact screening, and 
shows differences in the dose of tuberculin used as well as the interpretation of the test 
results. 
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Table 1.1: Comparison of CDC61 and Victorian criteria for interpretation of 
tuberculin skin test. 
Category Skin test criteria Skin test criteria 
CDC 1990-95 Victoria, 1991 
Recent close contacts >=5mm >=20mm post BCG, 
or >5mm (no history of 
BCG) 
HIV -infected persons >=5mm Not mentioned 
Other risk factors for TB >=lOmm >=20mm post BCG or 
(HIV negative IV drug users, medical risk factors, >=15mm, no BCG 
residents of high risk institutions, foreign born, 
medically underserved populations, high risk ethnic 
minorities, infants, children or adolescents exposed 
to adults in risk groups) 
No risk factors for TB >=15mm >=20mm post BCG or 
>=15mm, no BCG 
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Table 1.2: Comparison of contact screening between Victoria, Australia and USA 
Parameter CDC guidelines 1991 Victorian 
(1990, 1995) guidelines 
Skin test method Mantoux Mantoux 
Dose of tuberculin 5TU lOTU 
Indication for TST in All recent contacts Recent contacts aged 
contact screening <35 years only 
BCG history considered in No Yes 
interpretation of skin test 
Use of CXR in contact For symptomatic contacts For all recent contacts 
screenmg suspected of having active aged >=35 years 
TB. 
Preventive therapy for For all infected contacts For infected contacts 
contacts aged <35 years 
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The recommendations of the CDC are carried out at State level by State health 
authorities. The CDC guidelines for screening of inmates of correctional institutions 
recommend as a general principle that baseline skin testing of inmates and employees 
should be done, and that repeat annual testing should be carried out if there is a 
significant risk of ongoing exposure to TB.61 Two-step testing is recommended ifthe 
risk of boosting is thought to be significant, based on the demographic characteristics of 
the population. The CDC also recommends that screening by interview for symptoms 
suggestive of active TB should be a priority for new admissions to correctional 
institutions, due to the high risk of TB at intake.61 , 84 
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C. HYPOTHESIS AND RESEARCH QUESTIONS 
The null hypothesis tested in this thesis is that health services, policy and practice 
achieve maximal prevention and control of tuberculosis, in the most cost-effective 
manner. Within this null hypothesis, several sub-hypotheses are tested. 
Firstly, I hypothesised that the limited resources for control of tuberculosis are not 
maximally utilised in Victoria, that current activities may not be cost-effective, but a 
cost-effective program is achievable. 
Secondly, I hypothesised that preventive therapy for tuberculosis is underutilised in 
many settings, including Victoria, Australia and Maryland, USA. Although this is not a 
well studied area, there are some studies which suggest that preventive therapy with 
INH is underutilised in many settings, and that its popularity has fluctuated over the 
decades. 85-88 
Screening guidelines should be evidence based and have sound scientific rationale. 
Guidelines are usually updated as new evidence comes to light. I hypothesised that 
some aspects of screening guidelines used in Victoria were not evidence-based. For 
example, that the current cut-off points for defining infection with TB (in Victoria) are 
too specific and have low sensitivity; and that the use of mass CXR screening of 
contacts is costly and has a low yield. 
Another area which is not well studied is the discrepancy between policy and practice. 
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Even the most scientific and evidence-based screening guidelines are of no use unless 
they are implemented properly. Reasons for non-implementation of recommended 
guidelines include a lag between evidence and practice, entrenched practices and lack of 
faith in the guidelines. I hypothesised that recommended guidelines for TB control are 
not implemented in a systematic fashion. 
If one or all the hypotheses above are correct, then it follows that a significant 
proportion of cases of active TB which occur may have been preventable. For example, 
if guidelines are not evidence-based, patients at risk of TB may not be selected for 
screening; if guidelines are not followed systematically (such as withholding INH from 
persons who have an indication), cases of TB may fail to be prevented. 
These hypotheses lead to a series of specific research questions including whether 
screening guidelines for TB are rational and scientific, and if so, whether they are 
implemented fully. I also questioned whether screening is effective, as measured by the 
ability of screening programs to identify at-risk persons and prevent TB; and whether 
screening is cost-effective. I also sought to determine if screening can be improved in a 
cost effective manner. 
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D. OUTLINE OF THESIS STRUCTURE 
The first chapter presents the background of this thesis, with a general literature review. 
More specific literature reviews are contained in the subsequent chapters, which consist 
of ten separate but related studies, all linked by the common theme of screening for and 
prevention of TB. The aims, methods and results of each study are described separately. 
The first seven studies are set in Victoria, the second most populated State in Australia, 
and examine the Victorian State TB screening programs. The final three studies are set 
in the State of Maryland, USA, and examine aspects of TB screening in prisons. 
The first study describes missed opportunities for prevention of TB in Victoria by 
retrospective examination of all notifications of TB to the State Registry in 1991. The 
subsequent studies examine the contact and refugee screening programs, first measuring 
the incidence of TB during longitudinal follow up in screened contacts and refugees, and 
then examining the rationale of screening policy. The discrepancies between policy and 
practice in contact and refugee screening are then examined. The lack of evidence-
based guidelines and the lack of systematic practice provide an explanation for the 
missed opportunities described initially, and define areas for improvement for both 
programs. 
The next chapter determines the cost-effectiveness of contact screening as practised in 
1991, and compares it with how contact screening should have been practised if the 
guidelines of the time had been followed, to a proposed alternative method of contact 
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screening using hypothetical, evidence-based guidelines. 
One of the major issues of screening for TB in Victoria, the interpretation of the 
tuberculin skin test, which is discussed in the preceding chapters in relation to contact 
and refugee screening, is examined in chapter eight. This chapter compares tuberculin 
screening data for local populations, including recent contacts, refugees and school 
children. The appropriateness of the Victorian guidelines for defining a positive TST 
are examined against real TST distributions. 
The final three chapters are set in the Maryland Division of Correction, USA. The first 
of these studies describes a prison annual TB screening program and measures risk 
factors for skin test conversion in inmates of Maryland prisons. The second chapter 
determines exposure to TB retrospectively in captive inmates with skin test conversion, 
and addresses the question of whether these skin test conversions represent boosting or 
undetected exposure to TB. The final chapter examines the use ofINH preventive 
therapy in Maryland prisons, comparing policy with practice. 
The thesis concludes by summing up common issues for TB screening and prevention 
which are relevant to all types of TB screening programs, and by addressing each 
hypothesis stated in the introduction. 
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CHAPTER2 
MISSED OPPORTUNITIES FOR PREVENTION OF 
TUBERCULOSIS IN VICTORIA, AUSTRALIA - IDENTIFYING A 
PROBLEM. 
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Abstract 
Aims: To ascertain missed opportunities for prevention in all persons notified in 1991 to 
the State registry with active tuberculosis (TB) in Victoria, Australia, and to examine 
aspects of case management relevant to prevention. 
Methods: A descriptive study. Records were reviewed for 231/236 cases of TB notified 
in the State of Victoria in 1991. Documentation of past screening for TB, preventive 
therapy, treatment of active disease and follow up was sought for all cases. Past 
screening was defined as past contact screening, migrant screening, refugee screening 
and health undertakings for TB. 
Results: Of the cases, 13/231 were not confirmed to have TB. Of the remaining 218 
cases, 78% were foreign-born, and of these, nearly half were diagnosed within 3 years of 
arriving in Australia. Nearly half of all cases (97 /218) had some form of past screening 
for TB. The most common type of screening was refugee and migrant screening 
(45/218, 21 %) followed by tuberculosis health undertakings (25/218, 12%) and contact 
screening (15/218, 7%). Of those with past screening, 70% (68/97) had a positive 
screening result at the time. Among these, the first screening episode resulted in the 
diagnosis of active TB in 5/68, and TB infection in 63/68. In the latter group only 5% 
(3/63) received preventive therapy. 
Conclusion: There are significant missed opportunities for prevention in Victoria, 
particularly in the foreign-born cases who receive screening on entry into the country. 
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For screening to be a meaningful exercise, preventive therapy must be used where 
medically indicated. 
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Introduction 
The primary aim of a tuberculosis program is control of the disease. The most 
important strategy in controlling the disease is prevention. Prevention of cases can be 
achieved by two strategies: firstly, reducing the risk of new infection or secondly by 
prevention of disease in those already infected. Reducing the risk of new infection can 
be achieved by early diagnosis of infectious tuberculosis (TB) and prompt treatment 
(thereby reducing the period of infectivity and the risk of transmission to others), as well 
as by improved infection control procedures. In addition, BCG vaccine is up to 50% 
effective in preventing TB in susceptible persons.15 In the Australian population, 
where the incidence of tuberculosis is relatively low, mass BCG vaccination is not a 
cost-effective measure. 
Screening and surveillance should be carried out only if intervention is possible and 
probable, and that intervention results in public health benefits.42 This is a basic 
principle of public health practice, and should be adhered to if screening resources are 
to be used optimally. In the case of tuberculosis, intervention in the form of 
prevention is possible, and therefore screening and surveillance are of practical value. 
In those instances where TB infection is identified by screening, treatment is available 
to prevent the development of active disease. There is general consensus that the 
benefits of preventive therapy outweigh any potential risks in persons aged under 35 
years. INH associated hepatitis is a known risk factor in persons aged over 35 
years,76 however, studies have shown that even in this age group where exposure to 
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TB is known, the benefits of INH may outweigh any potential risks.79 Furthermore, a 
review of deaths previously attributed to INH revealed no definite relationship 
between INH and fatal hepatitis.80 Despite this, there still remain doubts about the 
safety of INH in many practitioners' minds, a factor which may be important in 
under-use of the drug in preventive therapy. 
In Australia the best strategy is to identify those who are known to be at high risk and 
use preventive therapy for infected individuals. Each State in Australia runs its own 
TB control program and has its own guidelines for screening. There are also national 
guidelines, which may differ somewhat from State guidelines. In Victoria, the second 
most populated State in Australia, the incidence of TB in the general population is 
6.2/100,000, a figure similar to the national rate.1 Nearly 80% of new cases of 
tuberculosis (TB) occur in foreign-born persons.1 The largest group among these are 
South-East Asian born persons, who have a case rate of over 100/100,000 
population. 1 The interventions used by the Victorian program are preventive therapy 
or long term follow up with CXR, but only preventive therapy is of proven value. 61 • 89 
The major screening programs in Victoria are for three groups - contacts of active TB, 
migrants and refugees. These screening programs identify infected individuals and 
aim to prevent the development of TB in these individuals. If these programs are 
successful, a lower incidence of active TB in those at-risk individuals who have 
undergone screening could be expected. 
Screening provides an opportunity to prevent TB, and as such, the utilisation of this 
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opportunity should be evaluated. Despite a low general prevalence of TB in 
Australia, we can benefit from critical evaluation and improvement of our TB control 
programs. 
Aims 
To assess missed opportunities for the prevention of notified cases of active 
tuberculosis by identifying past screening efforts for TB in patients notified with 
active TB. 
To examine patterns of treatment of active disease in the same group and assess the 
importance of these patterns in prevention of TB transmission. 
Methods 
I undertook a descriptive study of all cases of TB notified to the Victorian Department 
of Health in 1991, in order to determine missed opportunities for prevention. The 
Victorian Department of Health receives notifications of active tuberculosis and runs 
contact screening programs and post-migration screening of refugees and selected 
migrants. Doctors and laboratories have a statutory obligation to notify cases of 
tuberculosis to the Victorian Health Department. Accepted cases of TB are those 
which are confirmed as belonging to Mycobacterium tuberculosis complex by culture 
or microscopy, or diagnosed as active tuberculosis on clinical grounds. Once 
notifications are received, a clinical case record is compiled and stored at the 
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Department of Health. Cases are also recorded in a computerised database. Clinical 
records for all cases of active TB notified in 1991 were sought and studied. These 
records contain documentation of all past screening carried out in the State of 
Victoria, such as contact screening and post-migration refugee and migrant screening. 
In 1991, 236 cases of TB were notified. The records were found for 2311236 (98%) 
of the notifications - the 5 remaining records were located in rural centres and could 
not be accessed. Records were reviewed for 2311236 cases. The diagnosis of TB was 
mistaken in 5.6% (13/231) of notified cases, which were subsequently de-notified, so 
that the denominator population available for the study was 218 cases. These records 
contained case information and information on past contact, refugee or migrant 
screening of that case in Victoria. Past screening in other States, or pre-migration 
screening were not consistently documented, and was not considered in this study. 
Information was sought from Department of Health medical records on past screening 
for tuberculosis and past follow up by the Department of Health. Past screening was 
defined as which occurred in Victoria prior to the development of active TB. Such 
screening includes contact screening following notification of a case of TB, post-
migration migrant screening, post-migration refugee screening and tuberculosis health 
undertakings, all of which are carried out by the Department of Health. My results do 
not include screening which occurred overseas. Migrants and refugees entering the 
country are screened by CXR in their country of origin. Those with active TB are 
treated prior to arrival and cannot enter the country until rendered non-infectious. 
Treated persons, and those with inactive pulmonary TB on pre-migration screening, 
61 
enter Australia with a health undertaking known as a Tuberculosis Undertaking 
(TBU), which requires them to present to their State health department for follow up. 
A TBU is not enforceable by law. All refugees received additional post-migration 
screening from the Department of Health. The populations screened in refugee 
screening are mainly Indo Chinese (Vietnam, Cambodia and Laos), and have an 
average age of 33 years. 37 
BCG vaccination is considered in interpreting Tuberculin skin tests (TSTs) because 
universal BCG vaccination for school leavers was in practice in Victoria until 1985. 
In Australia, 10 Tuberculin units (TU) of purified protein derivative (PPD) are used 
for tuberculin testing by the Mantoux method. There is no reliable means of 
distinguishing a positive TST reaction due to TB from one due to BCG vaccination or 
exposure to non-tuberculous mycobacteria. It is, however, accepted in the USA that 
infection with TB is likely if the TST reaction is 15mm or more (regardless of 
previous BCG) in a low risk population or lOmm or more in a high risk population. 61 
In the USA, however, TSTs are performed using five TU .61 
I defined infection with TB according to the Victorian guidelines of the time, since 
preventive therapy was administered according to these criteria. In 1991, the 
Victorian contact screening guidelines recommended skin testing only for contacts 
aged under 35 years, and referral to a treating facility for contacts with a TST reaction 
of 20mm or more, regardless of previous BCG vaccination; or a reaction of 5mm or 
more in the absence of previous BCG vaccination.9() The Victorian guidelines 
recommend that refugees and migrants aged 35 years and under be screened with a 
62 
TST, and those over 10 years with a CXR. Only persons with a TST reaction of 
20mm or more, or 15mm or more without BCG, or those with an abnormal CXR, 
were recalled for further evaluation, chest clinic follow up and/or preventive therapy 
or treatment. In the Victorian recommendations, prophylaxis with INH for contacts, 
migrants and refugees is only mentioned in relation to neonates of a culture-positive 
mother, and is not otherwise explicitly defined. 
A potentially preventable case of TB was defined as one who received past screening 
for TB, was found to be infected by radiographic or skin test criteria, but did not 
receive preventive therapy; or one who was indicated for a skin test at the time of 
screening but did not receive one. 
I also examined patterns of treatment, compliance and follow up of active TB in this 
group of patients, since these patterns influence the cycle of transmission of TB, and 
are, therefore, relevant to prevention. Non-compliance was ascertained by 
documentation by the supervising TB nurse in the medical record. 
The Australian guidelines for the treatment of active TB recommend standard six 
month therapy with four drugs or nine month therapy with three drugs, and directly 
observed intermittent therapy for specific patients or groups with suspected non-
compliance. 91 The World Health Organization recommends that intermittent therapy 
should always be directly observed, and that daily therapy should be fully supervised 
in areas with well developed primary health care services.92 
63 
Data were analysed using Epi Info version 5 .93 Data were de-linked from unique 
identifiers during analysis. 
Results 
I studied 218/223 records of cases of TB notified in 1991. The mean age of cases was 
47 years, with a median of 44 years and a range of 2-91 years. There were 105/218 
(48%) females and 113/218 (52%) males. The majority of cases (78.4% or 171/218) 
were foreign-born, 18.4% (40/218) were Australian-born, and in 3.2% (7/218) the 
country of birth was not documented. Figure 2.1 shows the cumulative percentage of 
foreign-born cases diagnosed with TB over the first 10 years of residence in 
Australia. Only 27% were diagnosed after 10 years. Nearly half were diagnosed 
within the first three years after arrival - 24 % within the first year, 40 % within the 
first two years, 49% within the first three years and 59% within the first five years. 
Past screening for TB 
Of the notified cases in 1991, 97 /218 ( 45 % ) had some form of past screening for TB, 
100/218 (46%) had no past screening, and details were unknown for 21/218 (10%). 
Over 21 % (45/218) of all the notified cases in 1991 had post-migration refugee or 
migrant screening, 7% (15/218) had past contact screening, 11.5% (25/218) had 
signed a TBU and 5.5% (12/218) had other screening for tuberculosis. All these 
forms of screening had been carried out in Victoria. In total, 52 % (89/171) of foreign-
born cases, and 17 .5 % (7 /40) Australian-born cases had past screening for TB in 
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Victoria. The likelihood of past screening for foreign-born cases was much greater 
(OR 5.12, 95% CI 2.02-13.48). Over 66% (811122) of Asian-born cases had past 
screening. 
Results of past screening 
Of those who had past screening, 68/97 (70%) had a positive result (either CXR or 
Mantoux), indicating infection with MTb or active TB (see Figure 2.2). Only 15/97 
(15.5%) had a negative result, and in 14/97 (14.5%) the results of screening were 
unknown. Of those with a positive result, 69% (47/68) had an abnormality on CXR 
and 63% (43/68) had a positive TST. This included 22/68 (32%) who had both a 
positive CXR and TST. Nearly half (22/47) of the cases with an abnormal CXR had 
come into the country having signed a TBU. Of those with a negative screening result 
only 8/15 had a Mantoux, and of these 4/8 had reactions of 11-13mm with a past 
history of BCG. The remaining 7/15 were screened only with a CXR and represent 
potentially preventable cases had they had a TST - 217 were aged < 35 years at the 
time of screening. 
Intervention at the time of past screening 
Figure 2.2 describes the sequelae of positive screening results, whether preventive 
therapy was given, and the features of persons who did not receive prevention. Of the 
cases who had past contact screening, 14/15 were aged under 35 years at the time. In 
this group only 8/14 received a TST, and only 5/8 had the results recorded, all of 
which were > 1 Omm. Only two received preventive therapy. 
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Interval between screening and diagnosis of active TB 
The majority (71 % , 69/97) of cases who had past screening presented with active TB 
unrelated to any screening or follow up by the TB Program. The remaining 28/97 
cases were diagnosed during screening or follow up by the Department of Health. All 
28 had positive screening results. This represents 13 % (28/218) of all notifications in 
1991. Of these cases, 20/28 were culture-positive, five were culture negative and in 
three cases culture results were unknown. Only 5/28 were diagnosed with active TB at 
the initial screening episode, and 23/28 were found to be infected on initial screening 
and diagnosed with active TB during subsequent follow up. The exact date of past 
screening was documented for 92/97 cases. Figure 2.3 shows that 60% of cases who 
received past screening were diagnosed within three years of initial screening. 
Treatment of active cases 
The majority (2111218) of cases received treatment, treatment details were unknown 
in 4/218, and 3/218 did not receive treatment - of these, two were culture-positive and 
one had a culture negative pleural effusion. One of the culture-positive cases died 
before the diagnosis was made. It was unclear in the records why the other two were 
not treated. Duration of treatment was documented in 66% (144/218) of cases. Fifty 
eight percent (84/144) received treatment for six to nine months. There were 111144 
cases (8%) treated for less than six months, of which 3/11 had extra pulmonary TB. 
Treatment longer than nine months was twice as likely to be given for cases of extra 
pulmonary TB (OR 2.45, 1.07 <0R<5.64, p<0.05), but nearly half (23/50) of cases 
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Figure 2.3 Time from screening to diagnosis of TB 
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treated for longer than nine months had pulmonary TB. Only 5/23 of the pulmonary 
cases treated for over nine months had an obvious indication for prolonged therapy. 
Indications included immunosuppressive conditions, concurrent TB abscess and 
relapse of disease. Details of completion of treatment were available for 56% 
(122/218) of cases. Of these, 84% (103/122) completed treatment, and 16% (19/122) 
did not. 
Perceived level of compliance was documented in 68% (149/218) of cases. Among 
these, frank non-compliance was documented in 17.5% (26/149). Only 2.3 % (5/218) 
of all cases received directly observed treatment (DOT). Incompletely treated or 
untreated past TB was documented in 8% (18/218) of cases. The number of drugs 
used to treat patients was documented in 95% (207/218) of cases. Almost equal 
proportions of patients were treated with three (45%, 94/207) and four (51 %, 
106/207) drugs. Three percent (7/207) of cases were treated with one or two drugs. 
Of these only 1/7 had culture negative disease. 
Loss to follow up and death 
Over 15% (33/218) of cases were lost to follow up from the TB program. Death was 
recorded in 16/218 (7%) of all cases. TB was the only diagnosis and the sole cause of 
death in 2/16 cases - in one of these cases the diagnosis was made post-mortem, and in 
the other it was made two days before death. In 12/16 cases there were other illnesses 
contributing to or responsible for death, and in 2/16 cases the cause of death was 
unclear from the records. 
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Discussion 
Nearly half the notified cases of tuberculosis in 1991 had been screened specifically 
for tuberculosis in the past - this screening and follow up was instrumental in 
identifying some of these cases of active TB, but appears to have failed to prevent 
them. Furthermore, 70% of those screened in the past had a positive screening result 
at the time. These represent potentially preventable cases, yet only 5% received 
prophylactic or full treatment after screening. Surprisingly, 70% of those who did not 
receive treatment were aged under 35 years. This indicates significant missed 
opportunities for prevention at the time of screening. In addition, a further 8 % 
(18/218) of cases had previously untreated or inadequately treated TB, representing 
further missed opportunities. 
The Victorian guidelines of the time lacked emphasis on preventive therapy, and 
focused mainly on screening procedures. The Australian National Health and Medical 
Research Council (NH&MRC) guidelines are slightly different from the Victorian 
guidelines in that they recommend as a general principle that only TST reactors under 
the age of 35 be offered preventive therapy, and that those over the age of 35 be 
examined by CXR initially and at six and 12 months.91 Yet the majority of positive 
reactors aged under 35 years were not treated, showing a failure to adhere to current 
guidelines. The potential for prevention is further hindered by the likelihood that the 
guidelines are too specific, and exclude a large proportion of infected, at-risk 
individuals. The CDC defines recent contacts as being at high risk, and recommends 
a TST for all contacts, regardless of age, as well as using a lower cut-off point to 
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determine infection. 61 Furthermore, these guidelines recommend preventive treatment 
for all infected contacts, regardless of age.61 
If opportunities for prevention are to be maximised, then the guidelines for preventive 
therapy need to be re-assessed, and measures should be taken to ensure they are 
followed whenever possible. It is unlikely that all 60/63 infected individuals (identified 
at past screening) were not given prophylaxis due to genuine medical contraindications. 
A proportion of these individuals may not have been treated because they were aged 
over 35 years, but the majority (42/60) were aged under 35 years at the time, and 
contraindications are even less likely in this younger age group. If guidelines were 
followed, these 42 cases may have been prevented, representing 19% of all the notified 
cases in 1992. If the additional 8% of cases who had past untreated or inadequately 
treated TB were also included this figure would be 27%. Even more cases may have 
been prevented if all those screened had received a TST, and prophylaxis were 
recommended for older contacts. There is evidence, however, that missed opportunities 
are not a problem unique to Australia. McAnulty et al described missed opportunities 
for prevention in 59% of 153 cases of active TB in Oregon, USA, but used a broader 
definition of missed opportunity than my study.88 Sorresso et al reported in Tennessee, 
USA, that only 30 % of infected contacts deserving INH preventive therapy actually 
received it. 85 Another study found significant missed opportunities for TB screening 
by private physicians in New York.46 
The proportion of notified cases of TB which are foreign-born has increased steadily 
over the past two decades, 1 such that the majority of new cases in Victoria now occur 
in foreign-born persons. This group is an important target for TB control measures, 
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particularly in light of the fact that new cases are nearly seven times more likely to 
have had past post-migration screening for TB than Australian-born cases. As such, 
the screening process should be seen as an important point of intervention, and 
opportunities for prevention should be seized. Furthermore, the largest proportion of 
cases of TB in foreign-born persons appears to be within the first three years after 
arrival in Australia, with 24% diagnosed in the first year of arrival. This again 
emphasises the opportunity for prevention at the time of screening, both pre- and post-
migration, particularly for those on a TBU. A study of the follow up of migrants 
entering Australia on TBUs found that only 58 % of these persons complied with the 
health undertaking, but that 89 % of those who made contact with health authorities 
complied with the TBU. 82 This indicates that further improvement in prevention of 
TB can be made by improving compliance with TBUs. 
The reasons why the system appears to be failing to prevent cases of TB in those who 
have previously been screened, cannot be answered by this study. However, 
contributing factors may include unclear or outdated guidelines for screening and 
prevention; problems with follow up (indicated by the fact that 15 % of active cases of 
TB were lost to follow up); problems of following up TBUs, which are not legally 
enforceable; and continuing hesitancy to use prophylactic INH on the part of 
clinicians. These issues need to be studied in more detail if screening efforts are to be 
improved. 
Patterns of drug treatment of active TB can influence the cycle of transmission of TB, 
and are therefore relevant aspects of prevention. This study shows some 
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haphazardness in drug treatment of active TB, with seven culture-positive cases 
treated with only one or two drugs, and a further seven cases having a single drug 
added to continuing therapy. Both these treatment options are known to increase the 
risk of drug resistance.94 In addition, in 15% of cases, frank non-compliance was 
documented in the case notes, a figure which probably underestimates the true 
prevalence of non-compliance, since only the extreme end of the spectrum of non-
compliant behaviour is likely to be recorded. Non-compliance and poor drug 
regimens (particularly monotherapy or addition of a single drug to a failing regimen) 
are the most important predictors of drug resistance.94• 95 Multi-drug resistance is an 
emerging problem in the USA and other developing countries,20• 95 but has yet to be a 
major threat in Australia. The prevalence of multi-drug resistant strains was less than 
3% in Victoria in 1991,1 but this is no reason for complacency. An important 
preventive strategy advocated by many is the use of DOT,94 which only 2.6% of cases 
received. 
My study is subject to certain limitations. I may not have ascertained all cases of TB; 
however, the statutory notification system is likely to include the majority of cases of 
TB which occur in Victoria. Tuberculosis is less likely than other notifiable diseases 
to be under-notified, particularly since notification is necessary in order to obtain anti-
tuberculous drugs for treatment in the public sector.39 Missing screening data (such as 
for screening carried out in other States or in the private sector) may have led to an 
underestimate of preventable cases. 
This study indicates that tuberculosis control measures can be improved in Victoria by 
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maximising opportunities for prevention at the time of screening. The Victorian 
Tuberculosis program, as a result of this review, changed their screening guidelines 
by adopting a more sensitive screening cut-off point. In addition, other aspects of the 
screening programs are being reviewed, and efforts have been made at a national level 
to improve physician education in this area. This study resulted in data driven 
revision of the Victorian contact screening guidelines in 1994. The revised 
recommendations in 1994 suggest that a reaction of 1 Omm or more in the absence of 
BCG, or 15mm or more regardless of BCG, or documented conversion from negative 
to positive or of 1 Omm or more within the test period is sufficient to indicate 
infection. In conclusion, even in developed countries such as Australia, with low 
rates of TB, there are substantial opportunities to improve TB control. 
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CHAPTER3 
PREVENTABILITY OF INCIDENT CASES OF TUBERCULOSIS 
IN RECENTLY EXPOSED CONTACTS. 
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Abstract 
Introduction: Contacts of infectious tuberculosis are known to be at high risk for 
acquiring infection and developing disease. If contact screening and resultant 
intervention are effective in preventing TB, we would expect a reduced incidence of 
active TB in contacts who have been screened. 
Aims: To assess the outcomes of contact screening in Victoria, and whether prevention 
is successful as measured by the incidence of active TB in contacts during two years of 
follow up. 
Methods: A retrospective cohort study of 1, 142 contacts followed for 2 years from the 
time of contact with TB, for the development of active TB. Of the cohort, 783 were 
exposed to infectious TB. The cohort represented contacts screened from 231 cases of 
active TB (infectious and non-infectious) notified in 1991 to the State Registry in 
Victoria. These 1, 142 contacts were matched with new case notifications to the State 
TB registry in the following two years. 
Results: There were eight incident cases of TB in two years of follow up, a rate of 
511/100,000 contacts of infectious TB screened per year. The rate of disease for those 
contacts defined as infected was 1,460/100,000/year. Four cases were diagnosed at first 
screening. The risk of active TB increased with increasing skin test size and the risk 
was nearly nine times higher for contacts with reactions of 15mm or more. In stepwise 
Poisson regression the only significant variable predicting disease was skin test reaction 
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size. Age, region of birth, type of contact, BCG status and past prophylaxis did not 
predict risk. It was estimated that five of the eight incident cases were potentially 
preventable, with a lowest achievable incidence rate of 192/100,000/year. 
Discussion: This study has shown that contacts who have undergone screening for TB 
through a State screening program have a high incidence of active TB during 2 year 
follow up. The incidence of 511/100,000 among all contacts compares with published 
rates of between 425/100,000 and 670/100,000 in untreated contacts in outbreak 
situations. These data imply that the screening and preventive program has been 
successful at case finding, but had minimal impact on the natural history of the disease 
cycle. The apparent failure of the program to adequately prevent TB needs to be 
addressed at many levels both internal and external to the program structure. 
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Introduction 
Contacts of infectious tuberculosis are known to be at high risk for acquiring infection 
and developing disease.96 The risk of acquiring tuberculous infection increases with 
increasing closeness of contact and with increasing infectivity of the index case as 
measured by sputum smear.5-7 
The aim of tuberculosis (TB) screening programs is to change the natural history of the 
TB disease cycle by identifying infected individuals and preventing the development of 
disease in these individuals. The contact screening guidelines of the time state that the 
aims of the Victorian TB program in 1991 were case finding and identification of 
asymptomatic infection. In practice, however, more importance was placed on case 
finding. Regardless of the aim, such screening programs utilize significant resources. 
Screening and surveillance should only be carried out if the disease under surveillance is 
of sufficient public health importance, and some intervention and change of outcome is 
possible and probable.42 Quality control and evaluation of program effectiveness is 
therefore an important aspect of screening. One possible means of estimating the 
effectiveness of a screening program is to measure the degree of prevention achieved as 
reflected by the incidence of disease in the screened population. I had the opportunity to 
study this in a cohort of contacts screened in Victoria, the second most populous State in 
Australia. 
Aims 
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To calculate the incidence in the first two years after exposure to tuberculosis (TB) in 
contacts of notified cases of TB, to determine if preventive measures were successful, 
and to determine predictors of disease. 
Methods 
TB is a notifiable disease in Victoria, with doctors and laboratories having a statutory 
obligation to notify cases of active disease to the Department of Human Services (DHS). 
Once a case is notified to DHS, nurses from a dedicated TB program within DHS 
initiate contact tracing and screening. 
Identified contacts of all cases notified in 1991 were studied in a retrospective cohort 
analysis with 2 years of follow up from the time of contact with TB, for the 
development of active TB. The year 1991 was chosen because the highest incidence of 
active TB within contacts is in the first two years after exposure, and this allowed for 
analysis within two recent years (1992 and 1993). Records for contacts were available 
from both the index case notes, and from individual contact records, both of which 
contain contact demographic details, investigations, results of investigations, 
intervention and follow up details. 
The contact database was then matched with notifications of active TB for the years 
1991 - 1993, for 24 months following the notification of each case, and incident cases 
were identified. 
Univariate analysis was performed in Epilnfo 6,93 and multivariate analysis in Egret.97 
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Poisson regression was used to test likelihood for development of TB in contacts. The 
data in the regression models included all contacts identified, regardless of the results of 
screening, and regardless of whether or not they were infected. 
Universal BCG vaccination of school leavers was practised in Victoria until 1985, so 
that the majority of the adult population have received BCG vaccine. In Victoria skin 
tests utilise 10 TU of purified protein derivative, and are done by the Mantoux method. 
I defined infection as a skin test reaction of 1 Omm or more in the absence of past BCG 
vaccination, or 15mm or more with past BCG vaccination; or conversion from a 
negative to a positive skin test within three months, of at least 1 Omm; or CXR evidence 
of inactive TB. These criteria are based on international standards, and were 
incorporated into the Victorian guidelines in 1994 as a result of the early work in this 
thesis. In 1991, however (and until 1994, the year this thesis was commenced), the 
Victorian screening guidelines defined infection as a skin test reaction of 5mm or 
greater in the absence of previous BCG vaccination, or 20mm or more with a history of 
past BCG.90 The guidelines also recommended skin test screening and INH prophylaxis 
only for contacts aged under 35 years. Contacts aged over 35 years were recommended 
for a chest radiograph (CXR) only.90 The rationale for this was that interpretation of the 
skin test in the face of a largely BCG vaccinated adult population was thought to be too 
difficult. The guidelines also recommended screening for contacts of all notified cases 
of TB, including non-infectious (extra-pulmonary) TB. Infectious TB was defined as 
pulmonary or laryngeal TB, and non-infectious TB as all other (extra-pulmonary) forms 
of TB. 
I estimated the preventability of each case as assessed by a number of factors listed 
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below. 
1. Time from notification of the index case to initiation of contact tracing - if this was 
significantly delayed (more than four weeks), the case was assessed as potentially 
preventable had contact tracing been timely. 
2. Whether a skin test was done. If not, the case may have been preventable. 
3. Skin test reaction size. If the reaction was lOmm or greater, I considered the case 
potentially preventable, had the guidelines of the time considered this an appropriate 
level to define infection in recent contacts. 
4. Whether a CXR was done. If not, the case may have been preventable (for example, 
if a CXR had shown inactive TB and the case could have been given preventive therapy 
on that basis). 
5. Whether the diagnosis of TB was made at the time of first screening. If so, the case 
was considered not preventable (unless there was a significant delay in initiating 
screening). 
6. Whether preventive therapy was given. If given, the case was considered 
unpreventable, unless non-compliance was a factor, and suitable measures such as DOT 
were not instituted. 
Results 
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There were 231 cases of TB notified in 1991, resulting in 1, 142 contacts being identified 
that year. Of the 1,142 contacts screened, 68% (783/1,142) were exposed to an 
infectious case, 28% (315/1142) to a non-infectious case and 4% ( 44/1, 142) to a case of 
unknown infectivity. The majority of contacts (62%, 710/1,142) were aged 35 years or 
under; 32% (365/1,142) were over 35 years and in 6% (67/1,142) age was not 
documented. Forty-five percent (517/1,142) of contacts were born in Asia, 
29%(325/1,142) in Australia, 5% (53/1,142) in Europe and 4% (46/1,142) in other 
regions. In 17% (201/1,142) the region of birth was unknown. The majority (55%, 
626/1,142) were household contacts, 36% (407/1,142) were social contacts, 6% 
(63/1,142) were school contacts and 4% (42/1,142) were work contacts. The type of 
contact was not documented for 4/1, 142. 
In 42% ( 484/1, 142) of contacts, presence or absence of infection could be determined 
after screening. Of these, 42% (206/484) were infected as determined by skin test 
and/or CXR criteria. 
During two year follow up of contacts there were eight incident cases of TB. All eight 
of the incident cases were exposed to an infectious index case. The incidence of active 
TB for contacts of an infectious index case was 511/100,000/year for the first two years. 
There was no association with age group - the incidence of active disease was not 
significantly different in the age groups <20 years (361/100,000/year) and >=20 years 
(403/100,000/year) p=0.8, or <35 years (423/100,000/year) and >=35 years 
(274/100,000/year) p=0.5. Six of the eight cases were Asian-born. The incidence of 
active disease for Asian-born contacts was 561/100,000/year, and non-Asian born 
contacts, 167 /100,000/year, but this difference was not statistically significant in . 
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univariate analysis (RR 3.4, 95% CI 0.62-24.3, p=0.2). 
The incidence of disease among infected contacts only was 1,460/100,000 per year. 
Table 3 .1 describes the preventability of each case as assessed by a number of factors 
such as time from notification of the index case to initiation of contact tracing, whether 
a skin test and CXR were done, whether the diagnosis of TB was made at the time of 
first screening, and whether preventive therapy was given. It considers hypothetical 
maximum preventability, for example, if the screening guidelines had been different. It 
shows that three cases were not preventable- the remaining five were potentially 
preventable. Case number three, by my definition, may have theoretically been 
preventable, since contact tracing was delayed by five weeks. However, this case was 
diagnosed at the first episode of screening, so may not have been preventable, even if 
screening had been done earlier. If five cases had been prevented, the lowest possible 
incidence rate that could have been achieved is 192/100,000/year for contacts of 
infectious cases. If six cases were prevented, the lowest achievable incidence would 
have been 128/100,000. 
Skin test reaction size and risk of TB 
The risk of TB developing increased with increasing size of the reaction as shown in 
Table 3.2. The relative risk of disease ifthe reaction size was 15mm or more was 8.9 
(95% CI 1. 7-45). The largest increase in risk of disease was between the categories 10-
14mm and 15-19mm, from 1.4% to 4.2% of contacts respectively. No cases developed 
in contacts with reactions of 0-4mm. Age, region of birth, type of contact, BCG status, 
past prophylaxis and three different skin test reaction size categories (greater than or 
equal to 10, 15 and 20mm) were tested in stepwise regression as predictors of 
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developing active TB for all contacts. Only skin test reaction size of 15mm or more was 
significant. Table 3.3 shows the best Poisson regression model for predictors of 
development of TB. The relative risk of infectivity of the index case was incalculable, 
due to the zero incidence of disease in contacts exposed to a non-infectious index case. 
Discussion 
The incidence of disease in the first two years was 5111100,000/year for contacts of 
pulmonary TB, which compares to a rate of about 6/100,000 in the general Victorian 
population and 100/100,000 in Asian-born Victorians.1 The first two years after 
exposure to TB are associated with the highest incidence of disease in infected contacts. 
There are some data in the literature which suggest expected rates of disease in untreated 
contacts. Exposure to a case of pulmonary TB in a US school resulted in six secondary 
cases in 900 untreated contacts, a rate of 667 /100,000/year in the first year.98 An 
outbreak in the United Kingdom describes one case of TB resulting in 16 secondary 
cases in 3674 exposed, untreated children, a rate of 435/100,000/year in the first year.99 
Another study compared various durations ofINH prophylaxis with placebo in persons 
with inactive TB on CXR.100 Subjects in this study, being picked at unequal times from 
the onset of infection, and being for five years, are not directly comparable with recent 
contacts, and would be expected to have a lower rate of disease. However, the study 
found a rate of286/100,000/year in the placebo group during five-year follow up,100 a 
figure much lower than the 1,460/100,000/year rate described in my study in infected 
contacts in the first two years after contact. These and the other data in the literature 
suggest that the rate of disease in the Victorian contacts is close to the rate in untreated 
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groups. 
I found that five or six out of eight cases were potentially preventable. If five or six 
were prevented, the lowest possible incidence rates achievable was 192 to 128 per 
100,000/year for contacts of infectious cases, a figure which may be closer to that 
expected from a contact screening program. 
The high rate of disease described suggests that screening and preventive measures may 
be sub-optimal in Victoria. This can be attributed to two general factors - influences 
external to the TB program, and intrinsic program factors. The former certainly had an 
impact on TB control, with devolution of the TB program in the 1970s and 1980s. 
During this period, the TB program ran its own TB clinics, but its medical staffing and 
capacity were gradually reduced, leaving nurses to shoulder the majority of the 
responsibility by the early 1990s. During the preceding decade, we saw a change in 
patient mix, from a predominantly Australian-born patient population in the 1970s to a 
predominantly foreign-born patient population by 1992.1 Despite this, the nurses were 
left with outdated guidelines in use since the 1960s, written for a different patient mix 
and with an emphasis on mass CXR screening and case finding. 
Factors intrinsic to the program can only be determined by closer study of the screening 
process. Areas for study include the guidelines for screening and prevention, how well 
the guidelines are followed, and rates of commencement and completion of preventive 
therapy. Sorresso et al reported in Tennessee, USA, that only 30% of infected contacts 
deserving INH preventive therapy actually received it.85 Another study found that 59% 
of all TB patients notified to the Oregon health division had previous missed 
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opportunities for prevention. 88 Mehta et al found a decline in the rate of preventive 
therapy for infected contacts in Tennessee, dropping from 67% in 1979 to 37% in 
1985. 86 I have demonstrated significant missed opportunities for prevention of TB in a 
previous chapter, which showed that nearly half of notified cases of TB in Victoria have 
been screened for TB previously34 (see Chapter 2). 
My models for risk of disease suggest that BCG status should not be considered when 
interpreting the risk of disease and potential benefits of preventive therapy in recent 
contacts. A study of TST reactions in people with and without BCG vaccination 
showed that in groups at high risk for TB, TST reactivity is not significantly different in 
vaccinated and unvaccinated people. 101 Studies also suggest that BCG may not prevent 
infection, therefore preventive therapy may be beneficial for vaccinated, infected close 
contacts. 102' 103 My results also suggest that the use of a 20mm cut-off point to define 
infection in those who have had past BCG is not sensitive enough, and excludes the 
majority of at risk contacts. A 10 or 15mm cut-off point, regardless of BCG, may be 
appropriate for recent contacts, but not necessarily for other forms of population 
screening. A 10-15mm cut-off may still exclude some at-risk contacts. The process of 
choosing a definition of infection always involves a trade off between sensitivity and 
specificity, and the appropriate cut-off point varies depending on the population being 
screened. 104 My finding of increasing risk of disease with increasing skin test size 
reflects the higher prevalence of true infection with TB in persons with larger skin test 
reactions. 
In my study INH prophylaxis did not significantly predict decreased risk of disease. A 
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probable reason for this is the low number of individuals who received prophylaxis. My 
study also suggests that screening all contacts of non-infectious cases may not be the 
best use of resources, since all the incident cases were exposed to infectious TB. In 
Victoria nearly 1/3 of resources were expended tracing and screening contacts of non-
infectious cases of TB. The use of an age cut-off of 35 years, along with region of birth, 
whilst associated with infection rates, did not predict the risk of disease in recent 
contacts in my study. I did not examine the effect of age by more specific age groups, 
but the risk of active TB has been shown to be higher in very young children63 and 
adolescents. 14 
New TB program management in 1994 led to significant changes in the Victorian 
contact screening guidelines in that year, and the data presented in this study were used 
to support these changes. These included adoption of more sensitive skin test criteria for 
defining infection, skin testing for all contacts regardless of age, and recommendation of 
preventive therapy for all infected recent contacts, regardless of age. 
The considerable resources expended in tuberculosis screening programs, and the 
changing epidemiology of tuberculosis make periodic program evaluation imperative. 
This study provides some useful data to contribute to decision making, but program 
performance cannot be systematically improved without detailed data on each level of 
program operation. These data will be presented in the next chapter. In addition, it is 
vital to consider the impact of political and structural changes on program performance 
and efficacy. 
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Table 3.1: Estimation of preventability of incident cases of TB 
C Screened Skin Reaction CXR TB INH Potentially 
within 1 test >= done diagnosed at given preventable 
s month of done lOmm first 
E notification screening 
of index case 
1 
.I .I .I .I x 
2 X (7 months) x .I .I .I 
3 x .I .I .I x 
(5 weeks)** 
4 
.I .I .I .I x x .I 
5 
.I .I X(6mm) .I x x .I 
6 
.I .I .I .I x 
"* 
.I 
7 
.I .I .I .I .I x 
8 
.I .I .I .I x .I 
* It was known at the time that the index case had TB resistant to INH. 
* * By definition (see methods) a delay of more than four weeks in initiating contact 
screening makes case 3 potentially preventable. However, case 3 was diagnosed at the 
first episode of screening, making the likelihood of preventability, even if screening had 
been more timely, low. 
Shaded areas indicate that the variable was not applicable for that case. 
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Table 3.2: The risk of active TB by skin test reaction size in contacts. 
Skin test reaction % with past Incident cases rate of TB 
size (mm) N BCG (n) per 100 
contacts 
0-4 233 * 0 0 
5-9 52 72 1 1.9 
10-14 69 72 1 1.4 
15-19 71 73 3 4.2 
>19 29 70 2 6.9 
*BCG status documented in only 15% of negative reactors. 
Table 3.3: Poisson regression model for development of active TB in contacts. 
Variable RR 95%CI p value 
Age < 35 years 0.68 0.07-6.5 0.74 
Asian born 0.9 0.15-5.5 0.91 
Household contact 2.7 0.31-24.4 0.37 
BCG vaccination 0.6 0.1-3.3 0.53 
Skin test reaction 8.1 1.2-55.0 0.03 
>=15mm 
Isoniazid prophy lax.is 1.7 0.24-11.8 0.68 
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CHAPTER4. 
IMP ACT OF POLICY, PRACTICE AND POLITICS ON THE 
EFFECTIVENESS OF CONTACT SCREENING FOR 
TUBERCULOSIS. 
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Abstract 
Introduction: Screening programs are often expensive and resource intensive. As such, 
they are carried out for diseases of public health importance where intervention and 
change of outcome are possible. Screening of contacts of tuberculosis meets these 
criteria, and like any screening program, should be periodically evaluated. In previous 
chapters I have described missed opportunities for prevention of TB and higher than 
expected incidence of TB in recent contacts who had been screened. 
Aims: To consider whether the TB contact screening guidelines are evidence-based and 
appropriate, how well these guidelines are implemented, and to consider means of 
improving program outcomes. 
Methods: I reviewed the screening guidelines of the time and did a literature review to 
collect evidence to support the use of these guidelines. I used this to determine if the 
guidelines were rational and evidence-based. I then considered the contact screening 
procedures and whether the guidelines were implemented systematically, and assessed 
the outcomes of screening accordingly. A cohort of 1, 142 contacts screened from 231 
notified cases of active TB in 1991 in Victoria was used to describe screening 
procedures and outcomes. 
Results: I determined that the screening guidelines were not consistent with 
international evidence, and required updating, and that they were not implemented 
systematically. This is illustrated by the following findings: 
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Skin test screening and isoniazid preventive therapy were recommended only for 
contacts aged under 35 years. In nearly 60% (658/1,142) of all contacts, the presence or 
absence of infection could not be determined because a skin test was not done, and a 
chest radiograph (CXR), if done, was clear. CXR was used as the sole screening tool 
for nearly 40% ( 449/1, 142) of contacts. A total of 1,078 CXRs was performed on 646 
contacts, with more than 80% of repeat CXRs done following a normal initial study. 
Three cases of active TB were detected by CXR screening, all at first screening. Skin 
test conversion of>lOmm occurred in 15% of negative reactors. Thirty percent 
(120/403) of all contacts who received a skin test were infected. Only 22% (38/175) of 
identified, eligible contacts received INH preventive therapy. 
Discussion: The guidelines were outdated, and did not account for changes in the 
epidemiology of TB in Australia over the past 25 years. This, and the fact that the 
guidelines were not implemented systematically, resulted in the inability to determine 
the presence or absence of infection in nearly 60% of all contacts, as well as a poor use 
of program resources by mass CXR screening of asymptomatic contacts. In those whom 
infection was determined, there was a failure to refer and ensure preventive therapy, so 
that very few contacts deserving ofINH actually received it. This combined with the 
external pressures of political and structural changes had an overall negative impact on 
program efficacy. Changes in program management and the use of these data for 
decision making have contributed to the significant revision of the contact screening 
guidelines. 
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Introduction 
As previously mentioned, screening programs are often expensive and resource 
intensive, and should only be carried out for diseases of public health importance where 
intervention is possible and probable, and that intervention results in public health 
benefits.42 If, despite intervention being available, screening does not change the 
outcome, then that screening is a wasted opportunity and a poor use of resources. For 
this reason, screening programs should be periodically evaluated and updated. 
Contact tracing and screening for tuberculosis has two functions - firstly, the detection 
of asymptomatic infection; and secondly, case finding, particularly if the index case is a 
child with primary TB. The screening tool for the detection of asymptomatic infection 
is the tuberculin skin test, and for case finding is sputum examination and chest 
radiograph (CXR) combined with clinical assessment. In a country with a high 
prevalence of TB, case finding takes precedence over the detection of asymptomatic 
infection, but in a low prevalence country such as Australia, case finding is unlikely to 
have a high yield. In low prevalence countries the emphasis of contact screening should 
be on detection of asymptomatic infection. For persons with asymptomatic infection, 
outcome can be changed by the use of INH for prevention of progression to disease, and 
therefore screening is of practical value if it is followed by prevention where 
appropriate. 
As already discussed in Chapter 1, the benefits of preventive therapy outweigh any 
potential risks in all recent contacts, and in other persons at risk who are aged under 35 
years.10•73 Despite this, there still remain doubts about the safety ofINH in many 
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practitioners' minds, a factor which may be important in under-use of the drug in 
preventive therapy.85 One study reported that only 30% of infected contacts deserving 
INH preventive therapy in the USA actually received it.85 Another study found that 59% 
of all TB patients notified to a US State health division had previous missed 
opportunities for prevention. 88 A decline in the rate of preventive therapy for infected 
contacts in the US from 67% in 1979 to 37% in 1985 was described, and corresponded 
to changing attitudes to INH during that period.86 
I have already shown that nearly half of notified cases of TB in Victoria have been 
screened previously for TB (see Chapter 2), and that the two-year incidence of TB in 
screened contacts is higher than that expected if prevention had been successful (see 
Chapter 3). It is therefore appropriate to evaluate the contact screening program and the 
guidelines used at the time. 
Aims 
To consider whether the TB contact screening guidelines are evidence-based and 
appropriate, how well these guidelines are implemented, and to consider means of 
improving program outcomes. 
Methods 
TB is a notifiable disease in Victoria, with doctors and laboratories having a statutory 
obligation to notify cases of active disease to the Department of Human Services (DHS), 
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which is responsible for contact tracing and screening. The screening records for 
identified contacts of all cases notified in 1991 were reviewed, and screening practice 
was compared to the guidelines of the time. 
Screening guidelines and procedures 
The Victorian contact screening guidelines of 1991 recommend that contact screening 
be commenced as soon as possible and be completed within four weeks. In 1991, the 
Victorian guidelines recommended that all contacts aged 35 years and under receive a 
skin test. Negative reactors were recommended for repeat skin testing eight weeks after 
the case was rendered non-infectious. BCG was recommended for persistently negative 
reactors up to age 21 years, regardless of the risk of continued exposure. 
Chest radiograph (CXR) was recommended for contacts who had a skin test reaction of 
5mm or more; or as the sole screening test for contacts aged over 35 years. Infected 
contacts of pulmonary TB were recommended for repeat CXR at three and 12 months. 
Contacts of extra pulmonary TB were recommended for an initial CXR only. 
Prophylaxis with INH is only mentioned in relation to neonates of a culture-positive 
mother. 
Figure 4.1 describes the recommended procedure in 1991. In 1991, if screening tests 
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indicated TB infection, contacts were referred by the TB Program to a hospital clinic or 
a selected specialist. The consultant doctor then made a decision regarding 
administration of INH prophylaxis. 
The National Health and Medical Research Council (NH&MRC) guidelines of the time 
were slightly different from the Victorian guidelines in that they recommend that all 
close domestic contacts of notified cases of tuberculosis, whether pulmonary or extra 
pulmonary, be screened and re-examined with a CXR at three and 12 months. The 
NH&MRC recommends skin testing for all contacts, regardless of age. It recommends 
CXR as an adjunct to skin testing, to be done for adults and children with a positive skin 
test, but does not recommend it as an initial, sole screening tool. It classifies work 
contacts as casual contacts and a low priority for screening. It recommends as a general 
principle that only skin test reactors under the age of 35 be offered preventive therapy, 
and that those over the age of 35 be examined by CXR initially and again at six and 12 
months. The NH&MRC also recommends BCG vaccine for tuberculin negative close 
contacts of cases of active tuberculosis.91 
In 1991, infection was defined as a skin test reaction of 5mm or greater in the absence of 
previous BCG vaccination, or 20mm or more with a history of past BCG. Reactors of 
5-19mm post-BCG were recommended for CXR screening, and no further action ifthe 
CXR was clear. We consider these recommendations when examining rates of referral 
and prophylaxis. For analysis, we defined infection as: 
Skin test reaction of 1 Omm or more without a past history of BCG vaccine 
or 
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Skin test reaction of 15mm or more with past history of BCG 
or 
Conversion from negative to positive skin test of 1 Omm or more within three months 
or 
CXR evidence of calcification or fibrosis consistent with old, inactive TB 
This definition is recommended by the current Victorian contact screening guidelines, 
introduced in 1994. 
The following score for infectivity was used to classify notified cases: 
O= negligible infectivity 
extra pulmonary disease 
1 = low infectivity 
smear-and culture-negative pulmonary disease 
2= medium infectivity 
smear-negative culture-positive pulmonary disease 
3= high infectivity 
smear-positive, culture-positive pulmonary disease 
or 
culture-positive cavitating pulmonary disease 
or 
culture-positive laryngeal disease 
An infectious case of active TB was defined as a case scoring 1 or more, and a non-
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infectious case as one scoring 0. 
Data sources and analysis 
Records for contacts were available from two sources - the case notes, which contain a 
contact demographic details, investigations performed, results of investigations and 
intervention or follow up details; and individual contact records. 
Univariate analysis was performed in Epilnfo 6,93 and multivariate analysis in Egret.97 
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Results 
Demographics 
There were 231 cases of TB notified in 1991, resulting in 1,142 contacts being identified 
that year. There was a mean of 4.9 contacts screened per case. The mean number of 
contacts screened for infectious cases was higher (6.5 per case) than for non-infectious 
cases (3.3 per case). The majority of contacts (62%, 710/1,142) were aged 35 years or 
under; 32% (365/1,142) were over 35 years and in 6% (67/1,142) age was not 
documented. 
Time to initiation of the contact survey 
The mean interval from notification to commencing contact screening was four weeks, 
but 43% of contacts were screened more than four weeks, and 21 % more than eight 
weeks after notification. The median time to initiation of contact screening was four 
weeks for both infectious and non infectious cases. 
Type of contact screened 
The majority (55%, 626/1,142) were household contacts, 36% (407/1,142) were social 
contacts, 6% (63/1,142) were school contacts and 4% (42/1,142) were work contacts. 
Infectiousness of the index case 
Of the 231 notified cases in 1991, 54% (124/231) had pulmonary disease, 44% 
( 100/231) had extra pulmonary disease and in 2% ( 6/231) site was unknown. Of the 
1,142 contacts screened, 68% (783/1,142) were exposed to an infectious case, 28% 
(315/1,142) to a non infectious case and 4% (4411,142) to a case of unknown infectivity. 
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Only 4% (4/100) of the extra pulmonary cases investigated by contact tracing were aged 
five years or under. Among all the cases notified in 1991, there was only one case of 
primary TB, who was screened as a contact and identified through screening. There 
were no cases of extra pulmonary TB where contact tracing revealed a source case. 
Screening 
In 25% (291/1, 142) of contacts documentation of screening with either CXR or skin test 
(or both) was absent. Excluding these contacts, and including only those whose 
screening status was fully documented for both skin test and CXR, 23% (194/851) had 
past or present screening results of both skin test and CXR available, 23% (197/851) 
had only skin test results available, 48% ( 409/851) had only CXR results available, and 
6% (51/851) had no screening done. 
CXR screening 
Over half ( 646/1, 142) of the contacts screened received a CXR, and 24% (279/1, 142) 
received two or more CXRs at follow up. A total of 1078 CXRs were performed for 646 
contacts. CXR was the sole screening tool used for 36% ( 406/1, 142) contacts. Figure 
4.2 shows the results of the initial CXR, notably that three cases of active TB were 
detected. The three cases of active TB all had abnormalities detected on first CXR. 
Two were symptomatic at first screening and one did not have presence or absence of 
symptoms documented. Of the contacts with old TB on CXR, there were no changes 
found on repeat CXRs. 
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Figure 4.2 
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In contacts who had both CXR and skin test and who were not infected by 1991 
Victorian skin test criteria, 82/83 had a normal CXR. Only one had evidence of old TB 
on CXR. This contact had a skin test reaction of 14mm post BCG. No contact with a 
negative skin test had a positive CXR. 
On repeat CXR studies 11279 had possible changes documented. This was a 17 year old 
in close contact with a case of smear-positive pulmonary TB whose initial CXR showed 
abnormalities consistent with TB, and who could have been treated based on the history 
of close contact and the CXR finding at that time. The initial skin test reaction was 
1 Omm, and a repeat CXR was reported to show worsening of the CXR, but the repeat 
film was not compared with the initial film. There were no cases where the first CXR 
was normal and a subsequent one was definitely abnormal. Of the repeat studies, 81 % 
(576/713) were performed after a normal initial study. Contacts of extra pulmonary 
index cases accounted for 31/576 repeat studies after an initial normal CXR. The 
guidelines recommended CXR for all contacts aged over 35 years, but 21% (76/365) of 
contacts in this age group did not receive one. Yet 45% (321/710) contacts aged <35 
years did receive a CXR, of whom only 50% (159/321) had a specific indication for 
CXR according to the guidelines in 1991. Of the remaining 161 (50%) without an 
indication for CXR, 154 (96%) were screened only with CXR, and no skin test was 
done. 
CXR sensitivity and specificity using real data 
The sensitivity and specificity of CXR in detecting asymptomatic infection (by skin test 
criteria) in known recent contacts was calculated, as shown in Table 4.1. The sensitivity 
was 0.1 (10%), the specificity was 0.99 (99%), the positive predictive value was 0.91 
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(91%) and the negative predictive value was 0.44 (44%). 
Screening by the skin test 
A skin test was done for 35% (403/1,142) of all contacts, and was not done for 41% 
(472/1,142) of contacts. In 7% (76/1,142) an old result from past screening was used, 
and in 16% (191/1,142) it was unknown whether a skin test was done or not. Of those 
with a skin test result (current or past), the exact result in millimeters was known for 
454/479. Age-specific skin testing is described in Table 4.2, showing that testing of the 
under 35 age group (the only group recommended for a skin test in 1991) was 
incomplete with only half receiving a skin test. 
Figure 4.3 shows the distribution ofreactions in the contacts. There were 222 contacts 
with a negative (<5mm) initial skin test, of whom 53% (117/222) had a second skin test 
done and 30% (67/222) did not. Whether a repeat test was done was unknown in 17% 
(38/222). Of those with a negative skin test and no second test, the initial test was 
performed within four weeks oflast exposure in 54% (36/67) and within six weeks in 
74% (50/67). In only 13% (9/67) was it performed after eight weeks. 
BCG vaccination 
Past BCG status was not documented for 57% (647/1,142) of the cohort. Where it was 
documented, 53% (265/495) had never received BCG, and 47% (230/495) had. 
About half (115/222) the contacts with a negative skin test received BCG vaccine after 
screening, and a further 24/222 had received BCG in the past. Of those vaccinated after 
105 
Figure 4.3 
1000 --------------------... 
CJ) 100 
..... (.) 
ctS 
..... 
c 
0 (.) 
...... 10 0 
~ 
Q) 
..c 
E 
:J 
z 1 
0.1 
0 5 10 15 20 25 30 35 
log scale Skin test reaction size (mm) 
Tuberculin skin test reactions in recent contacts, Victoria 
screening, 22/116 had not received a second skin test. Of these 22, none were 
vaccinated 12 weeks after the last exposure. Five out of22 were vaccinated within two 
weeks, 4/22 within three weeks, 2/22 within four weeks, 2/22 within six weeks and 5/22 
within eight weeks of last exposure. 
TB infection and skin test conversion 
In negative reactors where a second skin test was performed, 15% (18/117) converted to 
a positive test, converting by at least 1 Omm. A further 6/117 had second reactions 
increasing by 5-9mm, and 93/117 were persistently negative. All converters were aged 
<35 years. 
Using both CXR and skin test evidence, 206/1,142 (18%) of contacts were infected, 
278/1,142 (24%) were not and in 658/1,142 (58%) infection status could not be 
determined because a skin test was not done and the CXR was clear, or no screening 
was done. Of contacts who had a skin test performed, 30% (120/403) were infected. 
Contacts of infectious cases were at significantly higher risk for infection than contacts 
of non-infectious cases, as shown in Table 4.3. This difference is even greater in non-
Asian-bom contacts, who have a very low risk of infection if exposed to a non-
infectious case. However, Asian-born contacts were at high risk regardless of the 
infectivity of the index case (see Table 4.3). Table 4.4 describes the best logistic 
regression model for risk factors for infection of contacts, with age and region of birth 
being the strongest predictors in stepwise testing. 
Referral of contacts 
Only contacts aged under 35 years were recommended for preventive therapy in 1991. 
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In 39% (276/710) of contacts in this age group, the presence or absence of infection 
could not be determined because no skin test was done or insufficient information was 
available. Fifteen percent (175/1,142) of contacts met the 1991 criteria for referral. 
Using a more sensitive definition of infection (15mm post BCG, or lOmm without 
BCG) would have made a further 43 individuals eligible for referral and prophylaxis. 
Of those with an indication for referral according to 1991 guidelines, 48/175 (27%) 
were referred for consideration of chemotherapy. Of these, 45/48 were aged 35 years or 
less. There were a further seven contacts referred who did not meet 1991 criteria for 
referral, resulting in a total of 5 5 referrals. Of those who met the 1991 criteria for 
infection but were not referred, 36/127 were aged 35 years or under, and 63/127 were 
aged over 35 years. 
Preventive chemotherapy 
Of those referred, 38/55 (69.1 %) commenced preventive therapy, so that 22% (38/175) 
of all eligible, identified contacts eventually commenced INH. Of those treated, 23/38 
were documented to have completed treatment, in 13 cases follow up data were not 
available and two cases did not complete treatment. Figure 4.4 describes the sequential 
steps in contact tracing and screening, and shows that failures at each level can 
cumulatively exclude proportions of contacts from the opportunity for prevention. 
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Figure 4.4 Potential sites of missed opportunities for prevention of TB 
asymptomatic infection, and its use as the sole screening tool in the age group over 35 
years is of little value, even if case finding was the only aim of the program. The 
guidelines of the time did not recommend skin testing for this older age group, so that a 
negative CXR, in the absence of skin test was of little value in determining infection. 
There were no cases documented where initial CXR was normal and a subsequent study 
was abnormal, yet over 80% of repeat studies were performed after a normal initial 
CXR. The majority of contacts screened with repeat CXR studies did not receive a skin 
test, which would have been the appropriate screening test. In fact, even in the age 
group <35 years, where skin testing was recommended, CXR was appeared to be the 
preferred sole screening tool. 
The practice of repeat CXR screening of asymptomatic contacts who have not been skin 
tested is a poor use of resources. It is well documented that the chance of detecting a 
case of active TB by CXR screening, even in high risk populations is low in 
asymptomatic subjects.56-59 In 1974 the World Health Organization ceased to 
recommend mass CXR screening, even in high prevalence countries, concluding that 
CXR was not a cost-effective means of case-finding.60 The Centers for Disease Control 
in the USA recommends the skin test alone as a sufficient screening tool for detecting 
asymptomatic infection.61 It would be reasonable, therefore, to skin test all contacts 
regardless of age, and to use a CXR as part of screening only if the skin test reaction is 
positive. If the skin test reaction indicates infection but the contact is asymptomatic, a 
CXR should be done only ifthe contact is a child under 5 years (the history may be 
difficult to obtain), or is immunosuppressed (e.g. HIV infection), or is elderly (65 years 
or more). The yield of CXR in asymptomatic subjects in these selected groups may be 
higher. 
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If CXRs are used as a screening tool, then some action should follow the finding of 
inactive pulmonary TB. Only 1/49 patients with inactive TB found on CXR received 
preventive therapy. INH is proven to greatly reduce the risk of reactivation of old TB,62• 
65 so that its use should be considered in these patients. 
The under-use of the skin test, even in the age group <35 years is of some concern, as is 
the low rate of repeat testing for negative reactors. When performed, repeat skin testing 
revealed a 15% skin test conversion rate in this cohort. This evidence suggests that the 
practice of repeat testing is worthwhile and should be followed, especially if BCG 
vaccine is to be given. The rationale for giving BCG in this situation is the risk of 
further exposure. For Australian-born contacts, however, the risk of subsequent 
exposure is low, and BCG vaccination may not be necessary. BCG vaccine may be 
worthwhile for Asian-born contacts, who may have an increased risk of subsequent 
exposure, particularly if they are children. 
There is negligible risk of new infection in a contact of a case of extra pulmonary TB, 
yet nearly 113 of contact surveys were initiated from an extra-pulmonary index case, 
using significant program resources. This is a key area where resources could be 
rationalised without reducing the efficacy of the program. It has been shown that close 
contacts of extra pulmonary cases of TB need not be screened at all.108 Theoretical 
reasons for screening these contacts include looking for a source of disease for a case of 
primary TB, particularly in a child. There was only one case of primary TB notified in 
1991, yet contact surveys were done for 84/100 extra pulmonary cases, and 
furthermore, no source cases were found by screening contacts of extra pulmonary TB. 
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We found a high rate of infection among contacts of non-infectious cases in the 
subgroup who were Asian-born. Among Asian-born contacts, there was no significant 
difference in infection rate among contacts of infectious and non-infectious cases. This 
probably reflects prior exposure to TB in these contacts. In contrast, in the non-Asian-
born contacts the risk of infection in those exposed to a non-infectious case was low. 
Non-Asian-born contacts of non-infectious cases had a 6.5% prevalence of infection, 
which is similar to the general population prevalence.109' 110 Screening ofnon-Asian-
born contacts of non-infectious cases gives a very low yield and is unlikely to be cost-
effective. 
The guidelines used by the program in 1991 recommend that contact surveys be 
completed within four weeks of notification of the index case, yet for 43% of contacts, 
investigation was commenced after four weeks. One may expect that this delay may be 
an artefact due to longer delay in initiating contact surveys for non-infectious cases, but 
the data show that this is not the case. Considering that four incident cases were 
detected at first screening (see Chapter 3), delay in screening potentially impacts on the 
transmission of disease. Possible levels of delay are the place of receipt of the 
notification form, the efficiency of exchange of information between the notifying 
doctor or laboratory and the Department of Health, the work load of the contact tracing 
nurses, prioritizing of contacts to be screened, and the delay in receipt of the 
supplementary medical form. This form, filled out by the treating physician and 
supplying clinical details of the index case, is usually necessary to initiate a contact 
survey. 
The current program focuses on household and social contact screening, which represent 
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over 90% of contacts screened. Only 3. 7% of contacts were from the workplace. 
Although the logistic regression model showed household contacts to be at highest risk, 
working persons and school children may spend more than half their waking hours in 
the workplace or school. We have already described a significant outbreak of TB in an 
office where work contacts were not screened comprehensively until a second case of 
active TB occurred in the same office. 18 Significant school outbreaks have also been 
described. 111 At a minimum, contacts should be prioritised and the stone-in-the-pond 
principle should be applied to expanding contact surveys. 112 
In Victoria a mean of 4.9 contacts is screened per case, which is lower than the mean 
numbers reported in the literature of 6-11 contacts per case. 6• 96• 113 The lower number of 
contacts traced, together with the high prevalence of infection in contacts of pulmonary 
cases suggests that the threshold for testing contacts may be high, and perhaps the circle 
of contacts tested could be wider. 112 Where it could be determined, 30% of all contacts 
and 36% of contacts of infectious TB were infected. US data estimate the prevalence of 
infection in contacts at around 21 %,53 a lower rate than we found in Victorian contacts. 
It is cause for concern that only 27% of contacts who met 1991 criteria for referral were 
referred for consideration of preventive therapy. Once referred, the majority do get 
preventive therapy, so the major pitfall seems to be referral rather than physician failure 
to treat. In addition, the contact screening process, because of exclusion of older 
contacts and lack of adequate skin testing for younger contacts, could not identify a 
large proportion of infected contacts. This combined with the low referral rate resulted 
in significant missed opportunities for prevention of TB. 
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The Victorian guidelines of 1991 excluded contacts aged over 35 years from preventive 
therapy. In contrast, the Centers for Disease Control recommends INH for infected 
recent contacts of infectious TB, regardless of age.61 In the age group 35 years and 
under there is no doubt about the benefit of INH, since the risk of hepatitis is extremely 
low. In the age group 35-49 years the incidence of hepatitis is around 1.2%.76 The risk 
of disease developing in contacts, however, is considered high enough to warrant 
preventive therapy regardless of age. Decision-analysis studies have shown an overall 
benefit ofINH prophylaxis, even in elderly contacts.114 
The failure of the program to significantly prevent TB despite high expenditure of 
resources may be explained by failures at many levels of the program structure, 
including the appropriateness of the guidelines themselves and the adherence to those 
guidelines. These two factors resulted in the inability to determine the presence or 
absence of infection in nearly 60% of all contacts, as well as a poor use of program 
resources by mass CXR screening of asymptomatic contacts. In those whom infection 
was determined, there was a failure to refer and ensure preventive therapy, so that very 
few contacts deserving of INH actually received it. The early 1990s were years of flux 
and instability for the TB program, reflecting multiple political and structural changes 
over the preceding two decades, including devolution, decentralization, partial 
privatization, relocation and re-centralization of the program. Along with this, decision 
making was increasingly transferred from medical to bureaucratic hands. 
The State system of chest clinics, along with its staff of dedicated TB physicians, was 
disbanded in stages between 1984 and 1991. The TB patients were absorbed into 
outpatient clinics at a number of different hospitals. By 1991 the State TB program was 
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left understaffed and run by a handful of nurses and one full-time doctor, who were left 
with outdated screening guidelines originating from the 1950s and very little support. 
Those guidelines had been developed for a predominantly Australian-born, elderly mix 
of patients, largely with pulmonary TB, seen prior to 1970. Over the past 25 years the 
epidemiology of TB in Australia has changed to the extent that the majority of new TB 
cases seen in the 1990s are younger and Asian-born, with a higher prevalence of extra-
pulmonary TB.1 The old guidelines also did not take account of emerging new diseases 
such as HIV/AIDS. 
These data provided evidence in support of a decision to revise the guidelines of the 
Victorian TB program in 1994. This included the adoption of more sensitive skin test 
criteria and the rationalization of screening of contacts of extra-pulmonary TB. The new 
guidelines also recommended skin testing for all contacts, and prophylaxis of infected 
contacts, regardless of age. The use of initial CXR screening for all contacts aged over 
15 years continues to be recommended (even if skin test negative), but the use of repeat 
CXR has been rationalized. It would be appropriate to conduct a follow up study of 
screening practice and outcomes in order to assess the impact of these changes. 
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Table 4.1: Sensitivity and specificity of chest radiograph in screening for infection 
in asymptomatic contacts. 
Infected* Not infected* Totals 
CXR ositive 10 1 11 
CXRne ative 85 67 152 
Totals 95 68 163 
*Using skin test criteria (see methods). 
Sensitivity = 10/95 =10.5% 
Specificity = 67 /68 =98.5% 
Positive predictive value = 10/11 =91 % 
Negative predictive value = 67/152 =44% 
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Table 4.2: Age specific skin testing of recent contacts* 
Age Skin test not Skin test Old result used Unknown/ not 
done done documented 
<=35 21% 52% 9.5% 17.5% 
Years (149/710) (367/710) (67/710) (127/710) 
>35 Years 78% 8% 2.5% 11.5% 
(284/365) (30/365) (9/365) (42/365) 
*Age documented for 1,075/1,142 contacts. 
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Table 4.3: Risk of infection for contacts exposed to infectious and non-infectious 
cases, by region of birth*. 
Region of birth Infectivity (site) of % contacts OR 95°/o CI 
of contact index case infected (n) 
All contacts Pulmonary 36 2.2 1.2-3.9 
(99/273) 
Extra-pulmonary 26 
(21/102) 
Asian-born Pulmonary 48 1.26 0.58-2.7 
(66/137) 
Extra-pulmonary 43 
(17/40) 
Non-Asian- Pulmonary 24 4.5 1.4-15.8 
born (32/135) 
Extra-pulmonary 6.5 
(4/62) 
*Using data only from contacts who received a skin test. Region of birth was not 
known for all contacts, so that totals for Asian and non-Asian-born are not equal to 
totals for all contacts. 
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Table 4.4: Risk factors for infection* of contacts - logistic regression model. 
VARIABLE OR 95%CI PVALUE 
Age <35 0.19 0.08-0.45 <0.001 
Contact of infectious case 2 1.2-3.4 0.01 
Asian-born contact 3.8 2.3-6.4 <0.001 
Household contact 2.3 1.3-4.1 0.004 
BCG vaccinated 1.3 0.81-2.2 0.26 
*Outcome variable, infection is defined as a skin test reaction of 1 Omm without 
previous BCG, or 15mm post BCG; or CXR evidence of inactive TB. 
120 
CHAPTERS 
THE COST EFFECTIVENESS OF CONTACT SCREENING AND 
PREVENTION FOR TB - TRANSLATING EVIDENCE INTO 
DOLLARS. 
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Abstract 
Introduction: The final stage in evaluating the contact screening program, having 
described suboptimal outcomes (Chapter 3), guidelines which require updating (Chapter 
4) and poor adherence to guidelines (Chapter 4), is to estimate the costs of the program, 
and the results which are achieved by the program for those costs. 
Aims: To compare the cost effectiveness of contact screening for TB for: 
1. Contact screening as it occurred in Victoria in 1991. 
2. The process which should have occurred had the 1991 contact screening guidelines 
been followed. 
3. A hypothetical alternative model based on internationally approved practice. 
Methods: Three models were constructed according to the aims above. The cost-
effectiveness of contact screening is presented as costs to government per unit outcome 
(in the form of cases prevented, cases found and contacts traced) for each model. 
Assumptions about disease behaviour were consistent between models. 
A sensitivity analysis was performed to examine the effect of the assumptions made in 
Model 3 about rates of referral and treatment of infected contacts, and about the efficacy 
ofINH in preventing TB. 
Results: All three models cost roughly 1 million dollars for a year. Model 1 (how 
contact screening was actually conducted in 1991) is the least cost-effective, costing 
$331,610 per case prevented, and Model 3 (an evidence-based, alternative model) is the 
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most cost-effective, costing $47,358/case prevented. The cost of Model 2 (contact 
screening according to the 1991 guidelines) was $81,892 per case prevented. 
The marginal cost effectiveness of Model 3 compared to Model 2 is $9,442 per 
additional case prevented. Compared to Model 1, Model 3 has a marginal cost 
effectiveness of $11,827 per additional case prevented. 
Case finding is expensive in all three models, ranging from $248, 708 in Model 1 to 
$319,670 in Model 3. The sensitivity analysis shows that the cost-effectiveness of 
Model 3 decreases with lower referral rates, lower rates of preventive therapy, and lower 
efficacy of INH. However, even allowing for reduced program parameters, Model 3 is 
more cost-effective than Models 1 and 2. 
Discussion: Cost needs to be considered in the context of the product being purchased 
for that financial outlay. In the case of the contact screening program, that product is 
either the prevention of disease, or case finding. Case finding as a product of contact 
screening is not cost-effective in any of the three models examined, ranging from 
$248, 708 to $319,670 per case found. In a developed country such as Australia, most 
cases are detected through normal health services, which function in a well developed 
infrastructure. Devoting a million dollars a year to finding a small number of cases may 
not be an appropriate or cost-effective primary aim of contact screening programs. 
Prevention of TB, on the other hand, can be cost-effective, as shown in Model 3. It was 
not cost-effective in 1991, costing over $300,000 per case prevented, largely because 
prevention was not considered a priority, and few infected contacts actually received 
preventive therapy. Clear program aims, adherence to guidelines and high rates of 
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preventive therapy are essential in order to achieve cost-effectiveness. 
124 
Introduction 
The final stage in evaluating the contact screening program, having described 
suboptimal outcomes (Chapter 3), guidelines which require updatjng (Chapter 4) and 
poor adherence to guidelines (Chapter 4), is to estimate the costs of the program, and the 
results which are achieved for those costs. 
The screening process can be viewed as a number of steps which may result in the 
prevention of TB (see Figure 4.4, Chapter 4). IfTB is not prevented, screening will not 
impact on the natural cycle of TB transmission. There are few cost studies which 
address entire screening programs for TB, but several which focus on specific steps of 
the screening process. Some studies have evaluated the cost-effectiveness of INH 
preventive therapy, considering only steps 6 -7(fig 1).115• 116 These studies conclude that 
six months ofINH is the most cost-effective regimen,116 and that INH is cost-effective 
even for low risk patients with a positive skin test. 115 Another study evaluated the cost 
of community based skin testing in Canada, but did not include the cost generated by 
secondary cases.117 They concluded that low patient and physician compliance made 
screening less cost-effective, and that compliance with recommendations for preventive 
therapy should be maximised.117 A comparison of a strategy for screening all school 
children (regardless of risk) in the US found that targeted screening of high risk children 
only is far more cost-effective than screening all children, and that in fact screening all 
children had a cost-benefit ratio of0.58.118 Recent contacts of TB are at very high risk, 
so that cost-effective screening should be achievable in this group. Another study, 
however, showed that cost-effectiveness was significantly reduced by poor patient 
participation and physician non-compliance with set guidelines for preventive therapy.47 
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Aims 
To compare the cost effectiveness of contact screening for TB for: 
1. contact screening as it occurred in Victoria in 1991; 
2. the process which should have occurred had the 1991 contact screening guidelines 
been followed; 
3. a hypothetical alternative model based on internationally approved practice. 
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Methods 
Three models for cost-effectiveness of contact screening are presented and costs per unit 
outcome (in the form of cases prevented, cases found and contacts traced) for each 
model are compared. The models are: 
Model 1. Contact tracing as the process was actually conducted in 1991, using real data 
from Victoria. 
Model 2. Contact tracing as the process would have been conducted ifthe guidelines of 
1991 had been followed closely. 
Model 3. A more internationally appropriate, alternative model for contact tracing. 
Only costs to the health sector are considered in the analysis. 
Data sources 
The screening records for identified contacts of all cases notified in 1991 were reviewed, 
and screening practice was compared to the guidelines of the time. A retrospective 
cohort study was done (see Chapter 3) to measure the two-year incidence of active TB in 
identified contacts. 
Model 1- what it actually cost 
The first model uses real data from 1991, and uses the costs of the contact screening 
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program as they were that year. I have already described the fact that guidelines were 
not followed systematically, and that screening activities were focused on mass CXR 
screening and case finding, with minimal emphasis on preventive therapy (see Chapter 
4). 
Model 2 - what it would have cost if the guidelines had been closely followed 
This model calculates costs that would have been incurred if the recommendations of 
1991 had been followed, namely that contact screening be carried out for all notified 
cases of TB, whether pulmonary or extra-pulmonary; that only contacts aged 35 years or 
under receive a skin test; that all contacts aged over 35 years receive a CXR; that 
contacts aged 35 years or under receive three CXRs ifthe skin test reaction is 5-19mm 
and be referred to a physician if the reaction is 20mm or more; that all skin test negative 
contacts receive a BCG vaccine if aged 21 years or less; and that only infected contacts 
aged 35 years or under receive INH (see Chapter 4, figure 4.1). 
Model 3 - a hypothetical "ideal" model 
The third, hypothetical model used a more internationally appropriate method of contact 
tracing. Model 3 screened more contacts, using a figure of 9 contacts per case of 
infectious TB.6' 96' m, 119 This model had increased staffing and operational budgets to 
allow for the greater work load. 
The increase in staff (salary) budget was calculated based on what the program achieved 
with current resources, using this figure to estimate requirements for increased activities. 
The nursing staff requirements were calculated on a maximal number of contacts-per-
nurse basis, since the TB nurses spend over 80% of their time tracing and screening 
128 
contacts. No additional clerical staff were required for this model. The additional non-
salary operational budget requirements were calculated on expected marginal costs 
(provided by DHS) for additional supplies including office requisites, books and 
publications, heat, light, power, electronic data processing, cleaning and incidental 
expenses. The other additional components of the non-salary operational budget were 
calculated assuming a fixed price per contact or per nurse, and were calculated on a per 
contact or per nurse basis. These included motor vehicles (each nurse requires a 
vehicle), travelling expenses, and postal and telephone charges. 
Contact screening for extra-pulmonary index cases of TB was not routinely 
recommended. However, the model allows for a maximum of 10% of extra-pulmonary 
cases of TB to receive screening, since screening of contacts may be required if the 
index case is a young child with primary TB. In this situation, case finding has a higher 
yield. 
Skin testing was done for all contacts. Chest radiographs were only done for infected 
contacts and for symptomatic contacts. Case finding was the same as the other two 
models, based on the assumption that the majority of cases will be symptomatic, or if 
not symptomatic will warrant a CXR because of a positive skin test. The assumption 
that the number of cases found will be the same in all three models is also supported by 
evidence that mass CXR screening (which is practised in Models 1and2, but not in 
Model 3) does not increase case finding. 56-59 BCG was only given to 5% of skin test 
negative contacts (children 5 years or younger with continued risk of exposure). All 
infected contacts were referred to a physician. INH was commenced for 80% of 
infected contacts, but rather than monthly follow up physician visits, they received two-
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monthly physician follow up, and had follow up at clinics on alternate months. Patients 
seen at clinics are also seen by doctors, but the clinic is within the public system and is 
costed separately from private physician fees. 
A sensitivity analysis was performed on this assumption (see section of methods headed 
"Sensitivity analysis"). Community-based directly observed therapy was used (see 
costing method under section titled "Cost of outpatient treatment of TB"). 
The majority (90%) of incident secondary cases were treated entirely on an outpatient 
basis, with an initial phase of two months consisting ofINH (on average 300mg/day), 
rifampicin (on average 600mg/day), ethambutol (on average 1200mg/day) and 
pyrizinamide (on average 2000mg/day); and a continuation phase of four months of 
three times weekly INH and rifampicin (summarised as 2HRZE, 4H3 R3). The basic 
differences in the models are summarised in Table 5.1. 
Estimation of component costs 
Table 5 .2 outlines the costs of individual components of contact screening. Costs for 
contact tracing and preventive therapy were based on direct health sector costs in 1991. 
Indirect costs and benefits such as days of work lost and quality of life indices were not 
included. The cost of a physician visit was calculated by using the Medicare rebate, 
which is the cost to government in dollars refundable under the Australian national 
health scheme. 120 The non-salary operational budget costs include costs of travel, 
vehicles, cleaning, office supplies, electricity, heating, postal and telephone expenses 
and electronic data processing costs incurred by the TB program. The cost of the skin 
test included the cost of tuberculin, syringes, needles and swabs. The cost of a chest 
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radiograph (CXR) was based on the Medicare rebate. 120 The cost of drugs is based on 
1991 costs. It was assumed that 20% of patients receiving INH preventive therapy 
would require pyridoxine supplementation. The cost of INH induced hepatitis was 
calculated by a published method,115 assuming a 0.6% average rate of hepatitis, and that 
I 0% of hepatitis patients will require hospitalisation (on average for two weeks ). 115 The 
remainder of hepatitis patients require monitoring of liver function tests. 
Calculating hospital cost of active TB 
The cost of hospital care for TB was calculated by studying all TB cases in the 
Victorian In-patient Minimum Data Base (VIMD),121 the hospital morbidity data base 
for the financial year 1994/95. This year was chosen since costs by Australian National 
Diagnosis Related Group (ANDRG) 122were not available in 1991, and the 94/95 cost 
data are more accurate than previous years.122 The frequency of ANDRGs to which TB 
cases were classified was obtained from the VIMD. Average costs of hospitalisation by 
ANDRG are available in a published source. 122 These costs include all costs incurred by 
hospital in-patients, such as bed costs, the cost of drugs, investigations and physician 
consultations. The ANDRG costs and the frequency of ANDRGs assigned to TB cases 
were used to calculate a weighted average cost of hospitalisation for TB. The consumer 
price index (CPI) rose from 106.8 in 1991to116.2 in 1995, an 8.8% increase.123• 124 The 
hospital and clinical price index125 rose by 3.3% in the same time, and was used to adjust 
hospital costs. All other costs were adjusted using the CPI to 1991 dollar values and 
were applied uniformly to the different models. 
Calculating the proportion of hospitalised TB patients 
In Victoria, the majority of TB patients are treated initially in hospital. I used 1994/95 
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VIMD data (which is more accurate that 1991 data) to calculate the proportion of 
patients hospitalised for TB, and then assumed that the ratio was similar in 1991. This 
is a reasonable assumption, since Victoria has traditionally had (and still has) a high rate 
of hospitalisation of TB cases for initiation of therapy. The total number of TB cases 
notified in the financial year 1994/95 was matched to the total number of cases 
hospitalised (as recorded in the VIMD) in order to determine the proportion of notified 
cases which were hospitalised that year. 
Cost of outpatient treatment of active TB 
The cost of treating the majority (90%) of TB patients entirely on an outpatient basis 
was calculated using the 1991 figure of232 TB cases per year, and adding the salary 
cost for five full time nurses dedicated to the care of these patients, including the 
administration of directly observed therapy, three times a week in the community. 
Currently, TB nurses are not available to participate in the care of TB patients, since 
they are fully occupied with contact tracing activities. The nursing requirement to 
initiate outpatient management of TB was based on the expected number of TB cases in 
Victoria per year of232. A manageable work load for each nurse was estimated to be 
50 cases per year, each on an average of six months of therapy. It was assumed these 
nurses could be integrated into the existing TB program and hospital outpatient clinics. 
Other costs included in the calculation were additional non-salary operational cost, the 
cost of physician fees, anti-tuberculous drugs, pyridoxine, liver function tests, serum 
creatinine, sputum microscopy and culture, chest radiographs, and drug costs for 
2HRZE, 4H3R3• 
The cost of treating 90% of patients entirely as outpatients and 10% as inpatients for an 
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average of two weeks hospitalisation was then compared to the cost of current practice. 
Current practice in Victoria is the opposite - 90% of patients are treated as inpatients for 
two weeks and only 10% are treated on an entirely outpatient basis. The outpatient cost 
of continuation therapy for current practice was less than for the scenario described 
above, since the latter includes 5 additional nurses salaries and additional non-salary 
costs. The cost of drugs and investigations were the same in both groups. 
Outcome measures 
Prevention of cases of TB, cases of TB found and number of contacts screened were the 
outcomes measured. The maximum incidence of secondary cases was estimated using 
two-year follow up data from 1991-1993 and the figure for lifetime incidence of TB of 
10% of infected contacts.62• 100 In all three models I assumed that there were nine at-risk 
contacts per case of pulmonary TB, based on an average of figures reported in the 
literature, 6• 96• 113• 119 and that of all at-risk contacts, 21 % were infected. 53 These figures 
were constant for all three models, regardless of how many contacts were actually 
screened, or how many were identified as infected. 
Using these figures and the number of notified infectious cases of TB in 1991 gives a 
total of 1613 at risk contacts, of whom 339 would be expected to be infected. If 10% of 
infected contacts developed TB in a lifetime, we would expect 34 cases of TB. The 
proportion of incident cases prevented was calculated according to the number of 
infected contacts who could be identified, who were identified and who were treated in 
each model. The efficacy of six months of INH prophylaxis was assumed to be 80% in 
all models.62 
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For all three models the best case scenario was calculated assuming that all secondary 
cases were investigated with full contact tracing with nine contacts screened per case 
and that 80% of infected contacts received and completed preventive therapy. The cost 
of preventing a case of TB was calculated from the initiation of contact tracing to 
preventive therapy, and includes the cost of incident cases not prevented and contact 
tracing generated from those cases. 
Sensitivity analysis. 
Model 3 assumed that all infected contacts were referred to a physician, that 80% of 
those referred were treated with INH, and that the efficacy of INH in preventing TB was 
80%. The figure of 80% efficacy assumes high compliance, which in the model is 
supported by the use of community based directly observed therapy. Model 3 was 
therefore tested for sensitivity to changes in these assumptions. Three scenarios were 
tested: 
1. Only 65% of infected contacts were referred. 
2. All infected contacts were referred, but only 65% received INH. 
3. All infected contacts were referred, 80% received INH (as in Model 3) but the 
efficacy of INH was 65% rather than 80%. 
The figure of 65% was arbitrarily chosen as a suboptimal figure compared to the ideal 
minimal figure of 80% used in Model 3. 
A sensitivity analysis for Model 3 was also performed using six physician visits 
compared to the three visits used in the model. 
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Quattro Pro was used for all modelling.126 
Results 
Cost of treating TB with initial hospitalisation 
There were 239 hospitalised cases of TB (documented in the VIMD) in the financial 
year 1994/95, and 269 cases notified in the same period. The hospitalised cases were 
assigned to 35 different ANDRGs, but 75% (179/239) of cases were in 5 ANDRGs. 
The total cost of hospitalisation of the cases for the financial year 1994/95, adjusted for 
the 1991 dollar value, was $735,591 for a mean length of stay of two weeks, giving a 
mean cost of hospitalisation per case of TB of$3,078. The addition of the cost of 
continuation therapy after two weeks of in-patient care resulted in a total treatment cost 
of $3,732 per TB patient for six months of therapy. The annual cost for 239 TB cases, 
therefore, was $891,948. 
Cost of treating TB on an outpatient basis 
The alternative cost of treating 90% of cases on an outpatient basis for the first two 
weeks was $125 per case (compared to $3,078 per case for two weeks for hospital 
therapy), and for the entire six months was $1,804 per case. The annual cost for 239 
patients, therefore, is $431,165. The cost saving per year by using outpatient treatment 
as opposed to hospitalisation is $460,783. 
Contact tracing costs and effectiveness 
Table 5.3 describes the cost of each step of contact screening for the three models. The 
cost-effectiveness of each model in terms of cases prevented, cases found and contacts 
traced is shown in Table 5.4. Model 1 is the least cost-effective, and Model 3 is the most 
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cost-effective. Case finding is expensive in all three models. 
The marginal cost effectiveness of Model 3 compared to Model 2 is $9,442 per 
additional case prevented (an additional $132, 195 for the prevention of an additional 14 
cases). Compared to Model 1, Model 3 expends an additional $283,850 and prevents an 
additional 24 cases, giving a marginal cost effectiveness of $11,827 per additional case 
prevented. 
Sensitivity analysis 
The models were most sensitive to the number of cases prevented. Table 5.5 describes a 
sensitivity analysis which examines the assumptions made in Model 3 about rates of 
referral and treatment of infected contacts, and about the efficacy of INH in preventing 
TB. It shows that the cost-effectiveness decreases with lower referral rates, lower rates 
of preventive therapy, and lower efficacy ofINH. However, even allowing for reduced 
program parameters, Model 3 is more cost-effective than Models 1 and 2. 
If Model 3 assumed six (rather than three) physician follow up visits for contacts on 
INH, the cost per case prevented increased by $4,007 from $47,358 to $51,365, and the 
cost per case found increased by $28,311 from $319 ,670 to $34 7 ,981. 
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Discussion 
All three models cost roughly one million dollars for a year, but the cost of contact 
tracing as it was practised in 1991 (Model 1) was slightly less than the cost of 
implementing the guidelines (Model 2), which in turn was less than the cost of the final 
model presented. Cost, however, means little unless it is considered in the context of 
the benefits of the product being purchased for that financial outlay. In the case of the 
contact screening program, that product is either the prevention of disease, or case 
finding. 
As shown in Table 5.4, case finding as a product of contact screening is not cost-
effective in any of the three models examined, ranging from $248,708 to $319,670 per 
case found. In a developed country such as Australia, most cases are detected through 
normal health services, which function in a well developed infrastructure. Devoting a 
million dollars a year to finding a small number of cases may not be an appropriate or 
cost-effective primary aim of contact screening programs. In developing countries 
where TB is of high prevalence, case finding takes precedence over the detection of 
asymptomatic infection.92 This is appropriate for countries with poor health 
infrastructures, high TB mortality and high proportions of chronic, untreated TB. The 
WHO recommends case finding by sputum smear, rather than CXR, in high prevalence 
countries.92 In Victoria, however, TB is of low prevalence, mortality is less than 0.1 per 
100,000 cases, and chronic disease comprises less than 3% of all cases.1 In this setting, 
case finding is not cost-effective. Prevention of TB, on the other hand, can be cost-
effective, as shown in Model 3. The marginal cost effectiveness of Model 3 compared 
to Model 1 is $11,827 per additional case prevented. It was not cost-effective in 1991, 
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costing over $300,000 per case prevented, largely because prevention was not 
considered a priority, and few infected contacts actually received preventive therapy. 
The costs calculated in these models are the minimal costs, since indirect costs and the 
cost of third generation incident cases were excluded. In addition, all three models 
assumed the best-case scenario for the cost of secondary cases, which involves the 
practices recommended in Model 3. In practice, therefore, the difference in cost-
effectiveness between Model 1 and Model 3 would be even greater, with lower cost-
effectiveness for Model 1, and higher cost-effectiveness for Model 3. 
This study demonstrates low cost-effectiveness of contact screening as it was conducted 
in 1991, and of the guidelines of 1991. This is partly due to a lack of clear aims for the 
TB program, which resulted in significant expenditure on contact screening without any 
clear expectation of specific outcomes. The guidelines of the time also focused more on 
case finding than on detection of asymptomatic infection and prevention of TB. 
Physician adherence to guidelines and high rates of preventive therapy are essential in 
order to achieve cost- effectiveness.47 This is borne out by the sensitivity analysis, 
which shows that cost-effectiveness decreases as rates of referral and preventive therapy 
decrease. 
The key differences proposed in Model 3 in order to achieve a cost-effective program 
are an increased emphasis on detection of asymptomatic infection, reflected by skin 
testing all identified contacts (as opposed to only skin testing contacts aged under 35 
years), and the recommendation for preventive therapy for all infected contacts, 
regardless of age. This, together with the screening of a mean of nine contacts per case 
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(compared to the mean of 4.9 contacts per case as practised in 1991 ), and the use of a 
more sensitive skin test definition of infection increases the probability of prevention by 
increasing the ability to identify persons at risk. 
Other strategic differences include cost saving by ceasing to screen contacts of extra-
pulmonary TB, and by reducing the number of CXRs performed. In Chapter 4 I showed 
that about 30% of contacts screened were for contact with an extra-pulmonary index 
case, that all contacts aged over 35 years received a CXR, and that the majority of repeat 
CXRs were performed following normal initial studies. In addition, cost saving is 
achieved by providing initial TB therapy for the majority of incident cases on an out-
patient basis rather than in hospital. If 90% of TB patients in Victoria were treated on 
an outpatient basis, nearly $500,000 per annum would be saved. There is evidence that 
the main risk to contacts is before the diagnosis of TB is made, and that hospitalisation 
for initial therapy does not impact significantly on the risk to contacts.127•130 
In addition, hospitalisation of TB patients may result in significant risks for other in-
patients, particularly if immunocompromised.20• 131 In New South Wales, for example, 
patients with TB are routinely commenced on treatment on an outpatient basis, and 
hospitalisation is reserved for medically complicated cases. 132 In the USA in 1991, the 
direct cost of TB was estimated to be $703 .1 million, with over 60% of that cost being 
for in-patient treatment and only 14% for preventive activities.133 These data highlight 
the potential for cost savings with a rationalised approach to TB control utilising greater 
outpatient treatment and an increased focus on prevention.133 
The greatest impact and lowest cost-effectiveness ratio is achieved in Model 3 by 
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increased prevention of TB. My sensitivity analysis shows that even allowing for a 
lower than expected efficacy ofINH, that cost-effectiveness is improved by high rates of 
referral and preventive therapy. Table 5.5 shows that a program with lower rates of 
referral and preventive therapy (but a high theoretical efficacy oflNH) is less cost-
effective than a program with a reduced efficacy of INH, given high rates of treatment. 
Put more simply, the rates of referral and preventive therapy are more important 
determinants of cost-effectiveness than theoretical variations in the efficacy of INH. 
These findings bring us back to the aims of any TB screening program. Firstly, there 
should be a clear aim for any screening program. Screening should not be performed 
without an aim or without expected interventions and outcomes. Secondly, that aim 
should be evidence-based and reasonable, and should be communicated by clear 
guidelines and education to all personnel involved in screening to ensure uniform 
standards of practice. Prevention of TB in infected contacts would appear to be a 
reasonable aim for the contact screening program in Victoria. Without a focus on 
prevention of TB and maximal efforts towards this end, the program is unlikely to be 
cost-effective. 
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Table 5.1: A comparison of three models for contact tracing 
FEATURES MODELl MODEL2 MODEL3 
Mean n contacts 4.9 per case 4.9 per case 9 per case 
traced 
Index case for All pulmonary All pulmonary and all All pulmonary 
which contact and all extrapulmonary (Maximum of 10% of 
tracing done extrapulmonary extra-pulmonary only) 
Total n contacts 1142 1142 1613 
traced 
Skin testing 35% of contacts Only for contacts aged For all contacts 
<35 years =100% 
= 62% of contacts 
Initial CXR 57% of contacts For all contacts aged For contacts with a 
> 3 5 years and all positive skin test or 
contacts with positive who are symptomatic 
skin test >5mm =21 % of contacts 
=94 % of contacts 
RepeatCXR 24% of contacts All contacts with a <10% 
positive skin test or 
initial abnormal CXR 
=64% of contacts 
Presence or 35% of contacts 62% contacts 100% contacts 
absence of 
infection can be 
determined 
Preventive 38/1,142 15211,142 338 contacts infected, 
therapy =3 % of contacts =13% of contacts 271/1,613 get INH 
given = 17% of contacts 
BCG for negative 10% of contacts All aged <21 years Aged <5 years if high 
reactors =17% of contacts risk of continued 
exposure 
=4% of contacts 
Lifetime number 34 34 34 
of secondary 
cases 
Cases prevented 3 13 27 
(80% of those 
treated) 
Initial treatment 90% hospitalised 90% hospitalised 10% hospitalised 
of incident cases 
in hospital for 
two weeks 
Cases found 4 4 4 
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Table 5.2: 1991 unit costs of contact tracing, screening and preventive therapy 
Item Cost (A$) 
Salary (1991, per annum rates) 
Nurse manager 43,466.00 
Nurse 36,500.00 
Clerical staff 25,000.00 
Non-salary operational budget (1991) 166732 
Skin test (lx syringe, needle and tuberculin) 1.3 
CXR 27.45 
Physician fee (1 visit) 106.25 
Isoniazid lOOmg x 100 tablets 2.66 
Ethambutol 400mg x 100 tablets 56.69 
Rifampicin 150mg x 100 tablets 12.5 
Pyrizinamide 500mg x 100 tablets 67.41 
Pyridoxine 25mg x 100 tablets 3.3 
Liver function test 9.55 
BCGvaccine 7.79 
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Table 5.3: Comparison of costs of contact tracing between models* 
Item MODEL I MODEL2 MODEL3* 
Amount spent Amount that Amount spent in 
1991 (A$) would have been Alternate model 
spent if guidelines (A$) 
had been followed 
Salary (nurses 316665 316665 447269 
and clerical staff 
in TB program) 
Non-salary 166732 166732 214774 
operational 
budget 
Skin test 676 2375 3355 
CXR 29591 20230 9298 
Physician fee 35062 161288 107970 
(referral and 
follow up) 
Isoniazid 50944 203777 363292 
(300mg per day 
for six months) 
Pyridoxine 128 511 911 
(25mg/day for 
20% of patients) 
Liver function 2177 8710 15527 
tests 
BCG vaccine 904 2633 475 
CostofINH 8016 28144 57162 
hepatitis 
Cost of contact 241614 143600 47652 
tracing for 
secondary cases 
Cost of 142,321 91,820 10,997 
treatment of (90% inpatient (90% inpatient (10% inpatient 
secondary cases initiation of initiation of initiation of 
therapy) therapy) therapy**) 
TOTAL cost 994831 1146486 1278681 
*Method of contact tracing varies in each model (see methods) **In Model 3, 90% of cases are treated as outpatients. 
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Table 5.4: Comparison of cost-effectiveness between models 
MODELl MODEL2 MODEL3 
Contact screening Contact screening Alternate model 
as it actually that would have for contact 
occurred in 1991 occurred if screening 
guidelines had been 
followed 
Total cost (A$) 994831 1146486 1278681 
n contacts 1142 1142 1613 
cost per contact 871 1004 793 
screened 
n cases found 4 4 4 
cost per case 248708 286621 319670 
found 
n cases 3 14 27 
prevented 
cost per case 331610 81892 47358 
prevented 
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Table 5.5: Sensitivity analysis for Model 3. 
Assumption Model3 Scenario 1 Scenario 2 Scenario 3 
tested 
% infected 100% 100% 
contacts 
referred 
% of referred 80% 
contacts 
treated with 
/NH 
% efficacy of 80% 80% 
/NH in 
preventing TB 
Outputs and 
costs 
Total cost 1278681 1117103 1264857 1320573 
n cases 27 18 18 22 
prevented 
Cost per case 47358 62061 70270 60026 
prevented 
cost per case 319670 279276 316214 330143 
found 
Cost per 793 692 784 818 
contact 
screened 
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CHAPTER6 
PREVENTABILITY OF INCIDENT CASES OF TUBERCULOSIS 
IN REFUGEES SCREENED IN VICTORIA 
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Results: There were 6/1,101 cases occurring over five years, or 109/100,000/year. Of 
these, 516 cases were assessed as potentially preventable, which if prevented would have 
resulted in an annual incidence of 18/100,000 over the first five years. There were no 
incident cases of TB in refugees with initial skin test reactions less than 1 Omm. 
Discussion: The rates of disease observed in the refugee population appear to be 
consistent with expected rates. In practice, a minimum rate of 18/100,000 seems an 
unrealistic aim, although some improvement in case prevention may be possible. 
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Introduction 
Refugees endure conditions of displacement, famine, war and overcrowding, and as a 
result suffer a high rate of physical, emotional and mental health problems.134-136 Studies 
have found high rates of chronic malnutrition, hepatitis B, tuberculosis, genetic 
haematalogic abnormalities, psychosomatic problems and intestinal parasitaemia in 
South-East Asian refugees. 135' 137-140 
Refugees are at high risk for TB, because of the living conditions they endure in refugee 
camps137• 141-143 and often because of a high prevalence of TB in their country of origin. 
The stress of displacement and migration itself may contribute to breakdown of inactive 
TB soon after immigration. Studies have shown that the highest risk of TB in new 
immigrants is during the first few years after arrival in the new country, although the 
exact reason for this observation is unknown. 1• 4• 144• 145 
In Victoria, 80% of new cases of TB are in foreign-born persons, most commonly from 
South-East Asia. 1 Refugees in particular are targeted as a group at high risk for TB, and 
are screened accordingly by a dedicated refugee screening program. They receive initial 
screening in their country of origin, with a focus on case finding; and they receive 
further screening at State level once they arrive in Australia. The purpose of this post-
migration refugee screening is both case finding and prevention. 
Case finding is important, particularly pre-migration, because of the high prevalence of 
TB in refugee populations.92' 142 Studies of post-migration refugee screening programs 
have found a high incidence of TB in newly arrived refugees 146-149 as well as a high rate 
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of tuberculin skin test reactivity .135• 137 If screening and preventive measures are 
effective, we would expect a high rate of case finding and a reduced subsequent 
incidence of active TB in refugees who have been screened. 
Aims 
To assess the outcomes ofrefugee screening in Victoria, particularly whether prevention 
is successful as measured by the incidence of active TB in refugees during five years of 
follow up. 
Methods 
A retrospective cohort study of all South-East Asian refugees screened by the State of 
Victoria in the six month period from July 1989 to January 1990 was performed. In 
Victoria all refugees from the South-East Asian region were from Laos, Cambodia and 
Vietnam. There were 1, 101 refugees screened during this period. This time frame was 
selected because records for refugees screened after July 1990 were incomplete. The 
selected time frame was the latest possible with good documentation and allowing at 
least five years of follow up. 
Screening policy and procedure 
The majority of refugees screened in 1989 were from Laos, Cambodia and Vietnam.37 
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All refugees receive pre-migration screening in their country of origin according to the 
standards determined by the Australian government and implemented by the IOM. 
Those with active TB are treated and rendered non-infectious before being allowed into 
Australia. Those with evidence of inactive TB sign a health undertaking for TB (TBU), 
• 
which requires them to present to State health authorities upon arrival in Australia. 
TBUs also apply to migrants, and are not legally enforceable. 
Persons with refugee status receive routine post-migration screening within four weeks 
of arrival in Australia, regardless of the results of pre-migration screening. Policy in 
1989 dictated that refugees aged 35 years and under were screened with a Mantoux test, 
and those over 10 years with a CXR. Persons with Mantoux reactions of 20mm or more 
post-BCG, or 15mm or more without BCG, or those with abnormal CXRs, were recalled 
for further evaluation, chest clinic follow up and/or preventive therapy or full treatment. 
INH was recommended for refugees with a skin test reaction of 20mm or more post-
BCG or 15mm or more in the absence ofBCG. 
Data sources 
Refugee name, number, date of birth, age, sex, marital status, Mantoux reaction and 
CXR result were documented on a multi-case recording sheet, filed in six monthly log 
books and stored at the TB Program. I entered these data from paper records into a 
computerised database. Incident cases were identified by matching the refugee database 
with the notification database for 1989-1994, giving five years of retrospective follow 
up data. Records were initially matched on name, and matching was then confirmed by 
date of birth and record number. 
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Case definition 
For the purpose of this study, and as discussed in previous chapters, infection with TB 
was defined as a Mantoux reaction of 15mm post-BCG or lOmm without past BCG, or 
CXR evidence of inactive TB. This is consistent with current Victorian guidelines. 
The guidelines of 1989, in contrast, defined infection as a Mantoux reaction of20mm or 
more post BCG or 15mm or more without BCG, or CXR evidence of inactive TB. 
These guidelines were changed in 1994, as a result of this work. 
Preventability of cases 
I estimated the preventability of each incident case as assessed by a number of factors 
listed below. 
1. Whether the individual was aged 35 years or under at the time of screening, as in the 
absence of recent contact, preventive therapy is indicated only for this age group.150 If 
aged over 35, the case was deemed not preventable. 
2. Whether a skin test was done. If not, the case may have been preventable. 
3. Skin test reaction size. If the reaction was lOmm or greater, I considered the case 
potentially preventable, had the guidelines of the time considered this an appropriate 
level to define infection in refugees. BCG status was not taken into account. The TST 
interpretation is based on internationally appropriate guidelines.61 
4. Whether a CXR was done. If not, the case may have been preventable (for example if 
a CXR had shown inactive TB and the case could have been given preventive therapy 
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on that basis). 
5. Whether the diagnosis of TB was made at the time of first screening. If so, the case 
was considered not preventable (unless there was a significant delay in initiating 
screening). 
6. Whether preventive therapy was given. If given, the case was considered 
unpreventable, unless non-compliance was a factor, and suitable measures such as DOT 
were not instituted. 
Data analysis 
Univariate analysis was performed in Epi Info 6,93 and Poisson regression in Egret.97 
Results 
Demographics 
The refugee population was young, with 87.9% (968/1,101) aged 35 years or under and 
a mean age of 33 years. The gender distribution was approximately equal, with 54% 
(595/1,101) male and 46% (506/1,101) female. There were 86/1,101 (8%) refugees who 
entered the country having signed a TBU. 
Incident cases of active TB 
There were 6/1,101 cases occurring over five years, or 109/100,000/year. All cases were 
aged under 35 years, 3/6 were identified through screening (one at initial screening and 
two during follow up) and 3/6 presented acutely, remote from screening. Of the cases, 
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516 had a Mantoux test at initial screening, 4/5 were infected using current criteria (the 
remaining 1/5 had a reaction of 14mm post BCG); and 2/5 met the 1989 criteria for 
infection. All 6/6 had a CXR at initial screening and 1/6 had an abnormal microfilm 
which was passed as normal initially. This patient was reviewed when he became 
symptomatic, and grew MTB on sputum culture. In retrospect his CXR was interpreted 
as abnormal. A further 2/6 had chest clinic follow up - both were lost to follow up after 
the first visit, one intermittently and one permanently. Of the cases, 1/6 received 
prophylactic INH. This person had a Mantoux reaction of 24mm (no BCG), but was 
openly non compliant with prophylaxis, was lost to follow up intermittently and ceased 
treatment altogether after four months. A CXR taken three months after ceasing 
treatment showed a new shadow, but sputum was negative. He was commenced on full 
treatment and notified at this time. 
Table 6.1 presents an assessment of preventability of the incident cases, and shows that 
516 cases were potentially preventable, giving a minimum achievable incidence of 
18/100,000 per year over the first five years. Table 6.2 shows the incidence of active 
TB by skin test reaction size, with no cases in refugees with reactions less than 1 Omm. 
Table 6.3 describes univariate statistics for risk factors for the development of active 
TB, including two different skin test cut-off points. Although INH prophylaxis was 
significantly associated with risk in univariate analysis, in the Poisson regression model 
(Table 6.4), neither INH or any of the other variables were significant. 
Relative risks were incalculable for refugees by age group over 35 years, by TBU and by 
skin test reaction size less than 1 Omm as risk factors, since none of the incident cases 
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were aged over 35 years, entered the country on a TBU or had skin test reactions less 
than lOmm. 
Discussion 
The demonstrated incidence of TB in this cohort of refugees was moderately high, at 
109/100,000/year (6 cases), with half the cases identified through screening and follow 
up, and half presenting independent of screening. This rate is over three times higher 
than the general population incidence rate of about 30/100,000 in Victoria in 1948, 1 the 
year that the Australian national TB program began. 
I assessed that five of the six cases were potentially preventable, giving a lowest 
possible incidence of 18/100/000/year. This appears improbably low in the context of 
described rates of TB in refugees. One study found 984 smear positive cases of 
pulmonary TB among 240,000 Kampuchean refugees prior to migration, a rate of 
410/100,000.151 Another study of Kampuchean refugees found a rate of 
240/100,000/year of smear positive pulmonary TB and 500/l 00,000/year for all forms of 
TB.142 This study also found an increased risk of disease for older refugees. 
A study of newly arrived refugees in Canada, who had already completed pre-migration 
screening and presented for post-migration screening, found a range of incidence from 
353-1,890 per 100,000 per year, with the incidence decreasing with increasing length of 
residence in Canada.146 In this study, the higher rate of 1,890/100,000 was thought to be 
partly due to over diagnosis of TB. A study which described rates of 1,375/100,000 in 
refugees stated that most cases were diagnosed radiologically, and only 32% were 
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proven bacteriologically. 149 
However, the pre-migration rate of TB could be expected to be higher than the post-
migration rate, since pre-migration screening focuses on case finding. Post-migration 
screening as practised in Victoria focuses on both prevention of TB in refugees younger 
than 35 years and case finding, so that the incidence of TB post-migration may be 
expected to be reduced. Even if20/100,000 is an unrealistic rate of TB to expect in 
screened refugees, the analysis of preventability shows that some cases may have been 
prevented. 
Compared to contacts, the incidence of TB in refugees during follow up is lower. This is 
expected, since the cohort of refugees represent a group who have acquired TB infection 
at different times, whereas the contacts have (presumably) acquired TB recently and so 
have a higher risk of disease in the first two years. 
The association with INH prophylaxis and increased risk of TB may be explained by the 
fact that only one of the incident cases received INH, and was openly noncompliant with 
therapy. In addition, INH was given to those at highest risk, so that INH is a marker for 
high risk. 
The 1989 criteria for identifying individuals at risk (Mantoux reaction of at least 20mm 
post BCG or 15mm without BCG) have a reduced sensitivity compared to the current 
guidelines (15mm post-BCG or lOmm without BCG). Using 1989 criteria for 
prophylaxis, only 2/6 cases were eligible compared to 416 using current criteria. Of the 
two remaining cases, one did not have a Mantoux test performed and had a clear CXR, 
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and the other had a Mantoux reaction of 14mm post BCG at initial screening. This 
suggests that the 1989 criteria excluded a proportion of individuals at high risk. Even 
the current criteria would have excluded the case with the Mantoux reaction of 14mm 
post BCG. All incident cases occurred in refugees with skin test reactions of lOmm or 
greater, suggesting that the most sensitive definition of infection may be lOmm. The 
refugee population is at high risk, and guidelines from the Centers for Disease Control 
recommend interpreting the Mantoux reaction in refugees without regard to BCG 
history.61 
In summary, the rates of disease observed in the refugee population appear to be 
consistent with expected rates, although some improvement in case preventjon may be 
possible. The following chapter examines the refugee screening process and potential 
points for improvement in more detail. 
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Table 6.1: Estimation of preventability of incident cases of TB in refugees. 
c Age Skin Reaction CXR TB INH Potentially 
A <=35 test >= lOmm done diagnosed given preventable 
s years done (reaction at first 
E (age) size in screening 
mm) 
1 
.I (18) .I .1(14) .I x x .I 
2 
.I (35) x .I x x .I 
3 
.1(23) .I .1(15) .I x x .I 
4 
.1(30) .I .1(22) .I .I x 
5 
.1(19) .I .1(24) .I x .I* .I 
6 
.1(27) .I .1(10) .I x x .I 
Shaded areas indicate that the variable was not applicable for that case. 
* Non-compliant, failed to attend follow up clinics, preventive therapy abandoned 
after four months, not given DOT . 
.I =yes 
X=no 
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Table 6.2: The risk of active TB by skin test reaction size in refugees. 
Skin test reaction Incident cases rate of TB per 100 
size (mm) N (n) refugees 
0-4 191 0 0 
5-9 183 0 0 
10-14 283 2 0.7 
15-19 181 1 0.6 
>19 97 2 2.1 
*A total of 938/1,101 refugees received a skin test, of which results were available for 
935/938. 
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Table 6.3: Risk factors for development of active TB (univariate analysis) 
Risk factor RR 95%CI Pvalue 
Past BCG vaccination 1.04 0.18-6.25 0.96 
Isoniazid prophylaxis 6.02 1.007-36.05 0.049 
Known recent contact with TB 4.89 0.55-43.8 0.16 
case 
Skin test >=15mm 3.5 0.59-21.0 0.17 
Skin test >=20mm 5.8 0.97-34.7 0.054 
Abnormal CXR 5.3 0-51.0 0.21 
Table 6.4: Risk factors for development of active TB (Poisson regression) 
Risk factor RR 95%CI Pvalue 
Past BCG vaccination 0.8 0.14-4.6 0.8 
Isoniazid prophylaxis 1.7 0.18-15.0 0.7 
Known recent contact with TB 3 0.3-26.0 0.33 
case 
Skin test >=15mm 0.8 0.07-9.2 0.87 
Skin test >=20mm 2.5 0.19-33.4 0.5 
Abnormal CXR 3.3 0.33-33.5 0.23 
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CHAPTER 7 
REFUGEE SCREENING IN VICTORIA: POLICY, PRACTICE 
AND OUTCOME 
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Abstract 
Introduction: Refugee screening for tuberculosis has two functions - firstly, case 
finding, since the refugee population is at high risk for TB; and secondly the detection of 
asymptomatic infection. For refugees with asymptomatic infection, outcome can be 
changed by the use of INH for prevention of progression to disease. As with contact 
screening, refugee screening can be expensive and resource intensive. As such, it 
should be periodically evaluated and updated. 
Aims: To review policy and practice of refugee screening in Victoria, and to identify 
areas for potential improvement. 
Methods: Refugee screening policy for TB and adherence to this policy was reviewed 
and compared to outcomes for 1,101 refugees from Laos, Cambodia and Vietnam, 
screened by the State of Victoria in the six month period from July 1989 to January 
1990. 
Results: There was one case of active TB detected at initial screening. 
There were 257 repeat CXR studies performed for 206 refugees with a normal initial 
study. Of the repeat studies, no changes were found in 200/206 (97 .1 % ), and new or 
worsening changes in two (1.0%) and clearing of old changes in the remaining four 
CXRs. 
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Introduction 
In the previous chapter, I found an incidence of TB of 109/100,000 per year in refugees 
screened by the State program. Refugee screening for tuberculosis has two functions -
firstly, case finding, since the refugee population is at high risk for TB; and secondly the 
detection of asymptomatic infection. The screening tool for the detection of 
asymptomatic infection is the tuberculin skin test (TST), and for case finding is chest 
radiograph (CXR) and sputum examination combined with clinical assessment. The 
yield of case finding in post-migration refugee screening can be high,146 and is an 
important priority in the refugee population, which has a high prevalence ofTB.142• 147• 151 
In addition, for refugees and foreign-born persons with asymptomatic infection, 
outcome can be changed by the use of INH for prevention of progression to disease, 62• 152 
and therefore screening is of practical value if it is followed by intervention where 
appropriate. 
As with contact screening, refugee screening can be expensive and resource intensive. 
There are many aspects of screening which need to considered, including rates of 
detection of disease and infection, the action that results from findings of disease and 
infection, and rates of intervention, compliance and follow up. A study of the 
effectiveness ofTBUs in Australia found that the overall compliance rate with TBUs 
was 58%, but 89% of migrants who made contact complied with their undertakings.82 
This suggests that issues of compliance and follow up are likely to be important for 
refugee screening. Any screening process should be periodically evaluated for 
appropriateness, efficacy and outcomes,42 and up-dated as required. 
164 
A high proportion of refugees (91 %, 884/968) who had an indication for a tuberculin 
skin test (TST) actually received one. The distribution of TST reactions in refugees was 
bimodal, and the cutoff point for defining infection which was used in 1989 (20mm) 
was of low sensitivity, excluding the majority of individuals at risk. A 15mm definition 
of infection is more sensitive than the 1989 definition, identifying 245 more individuals 
as being at risk of TB, with the potential to prevent two further incident cases of TB. 
Of all candidates who received either full or preventive therapy, non-compliance was 
documented in 18% (26/148). Not all candidates given preventive therapy were eligible 
for it according to guidelines of the time. Preventive therapy was given to 59% (96/162) 
eligible refugees, in whom completion was documented for 69% ( 66/96), and non-
completion in 27% (26/96). 
Discussion: The process of refugee screening appears to have been conducted 
systematically, with a high degree of adherence to guidelines. In contrast to contact 
screening, over 90% of refugees eligible for a TST received one, and nearly 60% of 
eligible refugees received INH prophylaxis. 
The major area for potential improvement of refugee screening is increasing the 
sensitivity of the definition for infection, which would increase the proportion of 
refugees eligible for INH therapy, and hence increase the potential for prevention. 
Failure to complete preventive therapy was documented in 27% of those treated. 
Focusing on issues of compliance may improve the efficiency of refugee screening. 
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Aims 
To review policy and practice of refugee screening in Victoria, and to identify areas for 
potential improvement. 
Methods 
Refugee screening policy and adherence to this policy was reviewed and compared to 
practice and outcomes in 1,101 consecutive refugees from Laos, Cambodia and Vietnam 
screened by the State of Victoria in the six month period from July 1989 to January 
1990. 
Screening policy and procedure 
The majority of refugees screened in 1989 were from Vietnam, Laos and Cambodia.37 
They received mandatory pre-migration screening, and mandatory post-migration 
screening within four weeks of arrival in Australia. The subject of this chapter is post-
migration screening. In 1989 refugees aged 35 years and under were screened with a 
TST using the Mantoux method, and those over 10 years with a CXR. Persons with 
TST reactions of 20mm or more, or 15mm or more without BCG, or those with 
abnormal CXRs, were recalled for further evaluation, chest clinic follow up and/or 
preventive therapy or treatment. INH was recommended for refugees aged 35 years or 
under with a TSTreaction of20mm or more, or 15mm or more in the absence ofBCG. 
Data sources 
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Refugee name, number, date of birth, age, sex, marital status, TST reaction and CXR 
result were documented on a multi-case recording sheet, filed in six monthly log books 
and stored at the TB Program. All refugees are allocated a refugee screening number. If 
screening results are satisfactory, these are the only records available. Selected cases 
who arrived in Australia on a TBU, or who were identified as being at risk of TB after 
arrival in Australia (due to a significant TST reaction or abnormal CXR detected at State 
screening) were followed by the chest clinic and have more detailed records kept in the 
TB Program. If TB Program records were available, the unit record number was 
documented in the screening log book. For all refugees where a unit record number was 
documented (303/1,101, 28%), the additional records were sought. The majority of 
these records, 259/303 (85.5%) were located and reviewed. These records include 
details of pre-migration screening by the IOM. All screening data were entered into a 
computerised database. 
Case definition 
Infection with TB was defined according to the guidelines of the time - a TST reaction 
of20mm or more post BCG or 15mm or more without BCG, or CXR evidence of 
inactive TB. This was compared with the current Victorian definition of 15mm post-
BCG or lOmm without past BCG, or CXR evidence of inactive TB. 
The distribution of skin test reactions was plotted in order to estimate the appropriate 
cut-off point to define infection, and to compare the likely sensitivities and specificities 
of various cut-off points used. 51 • 104• 153• 154 
Using the data sources and case definitions, I compared prescribed policy with practice 
166 
and outcomes. 
Results 
The demographics of the study population are described in the previous chapter. There 
were 27 refugees who had active TB diagnosed at pre-migration screening, all of whom 
had treatment commenced prior to arriving in Australia. The rate of TB found in pre-
migration screening for this cohort was 2,452/100,000 (95% CI 1,620/100,000-
3,550/100,00). A further 24 refugees had a past history of treated TB. 
CXR screening 
Of the refugees, 851/1,101 (77%) received a CXR. By age group, 120/133 (90%) of 
those 35 years and over, and 731/967 (76%) of those under 35 years, had a CXR. The 
total number of CXRs performed for each refugee was known for 98% (830/851 ), and 
Table 7 .1 shows the number of CXRs performed, and indicates that 25% received two 
or more CRXs. 
The majority (761/851, 89%) had a normal study, 92/851 (11%) had an abnormal study 
and in 1/851 (0.1 %) the result was unknown. The abnormalities detected on CXR were 
old TB (75/92, 76 %), active TB (1/92, 6.5 %) and abnormalities of unknown 
significance (16/92, 17 .5 % ). The case of active TB was in a person treated for 
pulmonary TB in Vietnam 15 years prior to arrival. He was recalled due to a large TST 
reaction (22mm), and was found to be symptomatic with a productive cough. The CXR 
was reported normal, but sputum cultures taken at recall were positive. He was recalled 
again two months later and a repeat CXR showed active TB, which was also evident in 
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retrospect on the initial CXR. Pre-migration films were unavailable and he did not 
enter the country on a TBU. He was notified as a case of active TB. The rate of active 
TB detected at initial screening (based on one case) was 91/100,000 refugees screened 
(95% confidence intervals 6/100,000-501/100,000). 
The finding of old TB on CXR resulted in chest clinic follow up for 92% (69/75), repeat 
CXRs (with no changes documented) for 91 % (68/75), and INH prophylaxis for 40% 
(30/75). In addition, 28% (21/75) had past treatment or prophylaxis documented. 
There were 257 repeat CXR studies performed for 206 refugees with a normal initial 
study. Of the repeat studies, no changes were found in 200/206 (97 .1 % ), and new or 
worsening changes in two (1.0%). The first of these was a case with an abnormality of 
unknown significance on initial CXR, which on repeat study was said to have changed. 
This person did not have TB on further assessment. The second was a case who was 
commenced on INH prophylaxis because of a 24mm TST reaction at screening, who 
was non-compliant and repeatedly failed to attend follow up visits. She took INH 
sporadically for four months. A screening CXR three months after ceasing treatment 
showed a shadow in the left mid zone. At the time she had symptoms of fever and 
lethargy. Sputum culture was negative, and she was commenced on four drug treatment 
and notified as an active case. There was subsequent clearing of the CXR changes. 
A further four cases (2%) had documented clearing of abnormalities on repeat CXR 
studies. These were all cases diagnosed with presumptive pulmonary TB at overseas 
screening and commenced on treatment overseas. Follow up CXRs in Australia showed 
clearing. 
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Skin testing 
Eighty eight percent (968/1,101) of the cohort were aged <35 years, and therefore 
eligible for a TST. Of these, 91 % (884/968) received a TST and 75/968 (8%) did not. 
Whether a TSTwas done was unknown in the remaining 9/968. In addition, 54/133 
refugees aged >35 received a TST. The distribution ofTST reactions in refugees is 
shown in Figure 7.1. 
Infection 
Table 7 .2 compares the number of "infected" refugees using the 1989 definition and a 
more sensitive definition of 15mm, and shows the number of refugees who developed 
TB in the "infected" and "not infected" groups for the two different criteria. It shows 
that the current definition is more sensitive than the 1989 criteria, identifying 245 more 
individuals as being at risk of TB, with the potential to prevent two further incident 
cases of TB that occurred during the study period, and 10% (24.5 cases) over a lifetime. 
BCG vaccination 
BCG status was unknown in 21 % (234/1,101). Of the remainder, 59% (508/867) had 
past BCG vaccination, and 41% (359/867) had no history ofBCG. 
Past and present intervention and follow up 
By 1989 criteria, 214/1,101 (19%) were eligible for treatment, prophylaxis and/or follow 
up, 778/1,101 (71%) were not eligible and eligibility was unknown in 109/1,101 (10%) 
because a TST was not done and the CXR was clear. Table 7.3 summarises the pre- and 
post-migration treatment, prophylaxis and completion rates for eligible candidates. Of 
the 52 cases treated for presumptive active TB, 9/52 had positive sputum cultures. The 
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one case treated for active TB in Australia was sputum culture-positive. Of those 
eligible for follow up, prophylaxis or treatment 183/214 (85.5%) had chest clinic follow 
up. 
Of those without a 1989 screening indication for prophylaxis, treatment or follow up, 
80/789 (10%) had chest clinic follow up. Of these 80 refugees, however, 3 7 were 
followed up as contacts of active TB, rather than primarily as refugees. Therefore a total 
of263/l,101 refugees received chest clinic follow up. Preventive therapy was given to 
16/789 (2% ). These refugees had TST reactions ranging from seven to 18 mm with no 
history of BCG and clear CXRs, and were commenced on prophylaxis in Australia. Of 
these, 15/16 were aged under 20 years. 
Completion of drug treatment and follow up 
Completion of treatment was documented for 47/52 refugees who received full therapy 
for TB, and in 5/52 it was unknown whether treatment was completed. For refugees on 
INH preventive therapy, completion was documented for 69% ( 66/96), non-completion 
was documented in 27% (26/96), and completion was unknown for 4/96. Reasons for 
not completing treatment included failure to attend clinic (8/26), non-compliance 
despite attending clinic (5/26), drug side effects (10/26) and pregnancy (2/26). The drug 
side effects documented were rash (5/10), peripheral neuritis (1/10), and non-specific 
symptoms (4/10). The non-specific complaints included feeling "hot and unwell" after 
taking INH. No biochemical abnormalities were documented in any person with drug 
side effects. 
Of all candidates who supposedly received either full or preventive therapy, non-
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compliance was documented in 18% (26/148), good compliance was stated in 75% 
(112/148), and level of compliance was unknown in 7% (10/148). Among refugees 
recalled for chest clinic follow up after initial screening, 21 % (55/263) were lost to 
follow up. 
Discussion 
The process of refugee screening appears to have been conducted systematically, with a 
high degree of adherence to guidelines. In contrast to contact screening, over 90% of 
refugees eligible for a TST received one, and nearly 60% of eligible refugees received 
INH prophylaxis. 
The use of skin testing in the recommended age group was much higher than for 
contacts (90% vs 52%). Possible reasons for the stricter adherence to guidelines in this 
group include differential perception of risk in the two groups, a more regimented 
system of screening for refugees and the fact that refugee screening takes place at a 
single location with the refugee attending a clinic, rather than a nurse visiting 
individuals (which is the case with contact screening). In the case of refugee screening, 
conducted in a single location, standardisation of practice is more likely. In the case of 
contact screening, where different nurses visit contacts in their homes, a greater 
variation in practice is likely. 
Using 1989 guidelines 15% (162/1,101) of the cohort were eligible for preventive 
therapy. Nearly 60% of eligible refugees received preventive therapy, compared to 22% 
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of eligible contacts. 
The major area for potential improvement of refugee screening is increasing the 
sensitivity of the definition for infection, which would increase the proportion of 
refugees eligible for INH therapy, and hence increase the potential for prevention. 
Skin test reactions in a population often have a bimodal distribution, with the first peak 
representing negative reactions and the second peak representing positive reactions. The 
evidence in the literature suggests that if the TST reactions in a given population are 
bimodally distributed, then the midpoint between the two peaks represents a cut-off 
point of good sensitivity and specificity with which to define infection.51• 104• 153• 154 If, 
however, the curve is unimodal (reflecting high rates of exposure to non-tuberculous 
mycobacteria), choosing a cut-off point becomes more difficult, but plotting the 
distribution allows for evaluation of the appropriateness of the cut-off point selected.153 
Figure 7 .1 shows that the distribution of skin test reactions is bimodal, and that the 
cutoff point used in 1989 excludes the majority of refugees tested, and is probably not 
sensitive enough. If the mid point of the second peak of distribution was used as the 
cut-off point, the reaction size for defining infection would be 10-1 lmm. Even using 
current guidelines, screening would miss individuals at risk, reflected in the fact that 
incident cases occurred in the group with TST reactions of 10-14mm post BCG. 
However, increasing the sensitivity of the guidelines will decrease the specificity, and in 
practice, TB screening guidelines can never be 100% sensitive, regardless of the cut-off 
point used. 153 
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Using either TST or CXR criteria 42% of the cohort were infected with TB. Comparing 
the graphs of TST distributions for contacts and refugees, the distribution of TST 
reactions is skewed further to the right for refugees than for contacts, with a higher 
proportion displaying a positive reaction. The rates of BCG vaccination in the contact 
and refugee populations was not significantly different, with approximately half with a 
history of past BCG in both populations, so that the greater proportion of positive 
reactions in the refugee population is unlikely to be attributable to higher rates of BCG 
vaccination. In addition, it has been shown that in populations at high risk for TB, 
BCG vaccination does not influence TST reactivity. 101 
Potential areas for cost saving include repeat CXR screening since nearly 90% of CXRs 
were normal. Pre-migration screening by CXR is essential, since this is a population 
with a high underlying prevalence of TB infection and a high incidence of disease. 
Active TB was detected on CXR in 111,101 (0.7%) refugees. This case was detected 
post-arrival in Australia, after being recalled for a large TST reaction. On recall, he was 
found to be symptomatic, and a sputum specimen taken at this time grew MTB. In 
retrospect, the microfilm was abnormal, confirmed by a repeat CXR. This case may 
reflect a failure in the overseas screening process, or he may have developed TB during 
the interval between pre and post migration screening. The failure to detect TB on the 
first post-migration microfilm resulted in a delay of two months in commencing 
treatment. 
No case with old TB on initial CXR or an initially clear CXR had changes detected on 
repeat studies. The findings here are similar to those of the cohort of contacts, with the 
presence of symptoms closely correlated with the finding of active TB on CXR. 
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For South-East Asian refugee populations entering Australia, the purpose of CXR is to 
identify active pulmonary TB. Theoretically, pre-migration screening should be 
sufficient to achieve this, but the time between pre-migration screening and arrival in 
Australia may be as long as six months. For this reason, many TB physicians consider 
post-migration screening essential and the repetition of CXR screening on arrival 
justified. In 1989, one case of active TB was found in 1, 101 refugees screened, a rate of 
91/100,000 refugees. Other studies have also described moderate to high detection of 
culture-positive TB in post-migration refugee screening.146• 147• 155 The yield of repeat 
CXR testing, however, is low in asymptomatic subjects, and should be reviewed, 
especially for refugees with a normal initial CXR. Repeat CXR studies identified 
significant new changes in one refugee who had been commenced on preventive 
therapy, was non-compliant and ceased therapy prematurely. She was symptomatic at 
the time. One study found a high yield of asymptomatic "cases" of TB by mass 
miniature CXR screening of new immigrants in Switzerland.155 However, the majority 
of "cases" were sputum culture negative, and in fact only 34 culture-positive cases were 
detected from 50,778 CXRs. All 34 of the culture positive cases were symptomatic.155 
The yield of mass CXR screening in this study was 67 /100,000 CXRs.155 
This cohort provides valuable data on follow up, treatment and compliance, since these 
services were provided and documented by the TB program in 1989. A high proportion 
of refugees commenced on full anti-TB treatment overseas were treated for presumptive 
disease, with less than 20% being sputum positive. This would indicate a cautious 
approach to pre-migration screening and treatment. A partial explanation may also be 
that documentation of sputum smear results from pre-migration screening was missing, 
so that the true rate of smear positivity may be higher. Other studies have also described 
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high proportions of culture negative cases of TB detected at refugee or migrant 
screening. 146, 147, 155 
Of the cohort who had chest clinic follow up after the first screening, 21 % were lost to 
follow up. This high figure may reflect difficulties faced by geographically dispersed 
subjects who are required to attend a central location, which may be distant from their 
home or work place. This problem was anticipated by the TB program, which provided 
incentives in the form of taxi vouchers to improve attendance. However, attendance is 
likely to remain a problem when screening cannot be legally enforced. King et al found 
low rates of attendance at screening clinics for migrants on TBUs.82 
Non-compliance with therapy was documented in 18% of refugees who received 
treatment, a figure which is of some concern. This is probably a minimal figure, since 
non-compliance is not often obvious, and if documented is likely to be at the extreme of 
a spectrum of non-compliant behavior. Studies have shown that compliance cannot be 
reliably predicted or assumed in patients, regardless of socioeconomic or educational 
background.156 
Failure to complete preventive therapy was documented in 27% of those treated. Non-
attendance and non-compliance despite attendance are important factors in failure to 
complete a prescribed course of treatment, accounting for 13/26 of the subjects who did 
not complete treatment. Possible reasons for non-compliance in this group include the 
lack of immediate, perceptible benefits of treatment in an asymptomatic patient, as well 
as cultural, social and language barriers. 
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Side effects of treatment (10/26) was the second major reason for stopping treatment. 
No patient had documented biochemical abnormalities warranting cessation of 
treatment. Of the ten cases whose treatment was ceased, 5/10 had a rash, one developed 
peripheral neuritis and 4/10 complained of non-specific symptoms but had no physical 
signs. These latter cases may reflect a low threshold for ceasing INH on the part of the 
treating physician, due to fear of serious side effects and a lack of faith in the benefits of 
the drug.85, 86, 88 
Overall, the results of refugee screening indicate an overall adherence to guidelines, 
resulting in a high rate of preventive therapy. Areas for potential improvement include 
rationalisation of repeat CXR screening for refugees with a normal CXR, as well as the 
adoption of a more sensitive definition for infection, based on the distribution of TST 
reactions in the refugee population, and improvement of rates of completion of 
preventive therapy. This may require education of providers regarding indications for 
cessation of preventive therapy. 
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Table 7.1: Chest radiographs performed on South-east Asian refugees. 
NUMBER OF CXRS NUMBER OF TOTAL NUMBER OF 
PER PERSON REFUGEES CXRs 
1 624 (75%) 624 
2 65 (8%) 130 
3 57 (7%) 171 
4 42 (5%) 168 
50RMORE 42 (5%) 252 
TOTAL 830 1345 
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Table 7.2: A comparison of infection and development of TB in refugees using 
1989 criteria and revised criteria. 
NOT INFECTED UNKNOWN 
developed n developed n 
% TB % TB % 
1989 214 2 778 3 109 
(19) (71) (10) 
Current 459 4 533 109 
(42) (48) (10) 
1989 criteria: 20mm post BCG or 15mm without BCG. 
Revised criteria: 15mm post-BCG or lOmm without BCG. 
Infection status unknown= skin test not done and CXR clear. 
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developed 
TB 
1 
1 
TOTAL 
n 
1101 
1101 
Table 7.3: Treatment and follow up of refugees 
Full anti-
tuberculous 
treatment 
lsoniazid 
prophylaxi 
s 
TOTAL 
Past Arrived Treatment Total Total 
treatment on commenced eligible treated 
treatment in (o/o of 
eligible) Australia 
24 27 52 52 (100%) 
7 14 75 162 96 (59%) 
31 41 76 214 148 (69%) 
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Completion 
rates (o/o of 
treated) 
47 (90%) 
66 (69%) 
113 (76%) 
CHAPTERS 
A STUDY OF SKIN TEST REACTION DISTRIBUTIONS IN HIGH 
AND LOW RISK POPULATIONS IN VICTORIA - RE-
EVALUATING THE APPROPRIATENESS OF SKIN TEST CUT 
OFF POINTS USED IN VICTORIA. 
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Abstract 
Introduction: Epidemiologic studies in guinea pigs and in humans have shown that 
TST reactivity varies according to the populations studied, and that different cut-off 
points are appropriate for different populations. In any given population, the 
distribution of the TST reactions allows us to determine the most appropriate cut-off 
point for defining infection .. 
Aims: The aims of this chapter are to determine the appropriateness of the cut-off points 
used in Victoria, and to compare TST reaction distributions in different populations in 
Victoria and thereby contribute to the development of evidence-based cut-off points. 
Methods: The distributions of TST reactions to 10 TU tuberculin using the Mantoux 
method were compared for recent contacts, refugees, school children and persons 
exposed to TB in an outbreak situation. Cut off points used in 1991 were compared for 
each population with more sensitive cut-off points. 
Results: The comparison shows that the distributions of TST reactivity is different for 
each population, and therefore the appropriate cut-off point for defining infection varies 
for different population groups. The cut-off points used in Victoria are highly specific 
but of low sensitivity and exclude the majority of at-risk refugees. 
Discussion: Cut off points used in Victoria in 1991 were highly specific, but lacked 
sensitivity and excluded a large proportion of individuals at risk. The use of highly 
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specific cut-off points may be appropriate for low-risk populations, but not for high risk 
populations. If used as a screening test for high risk populations, a high degree of 
sensitivity is desirable, and a sensitive cut-off point should be used for interpreting the 
TST. These data indicate that the cut-off points used for defining infection in Victoria 
are not appropriate and need to take into consideration the population prevalence of 
infection, and be adjusted accordingly. 
183 
Introduction 
Epidemiologic studies in guinea pigs and in humans have shown that TST reactivity 
varies according to the populations studied, and that different cut-off points are 
appropriate for different populations. 104 The selection of a cut-off point with good 
sensitivity and specificity depends on the prevalence of tuberculous infection in the 
population under study, and also on the prevalence of exposure to non-tuberculous 
mycobacteria. Selection of a cut-off point becomes increasingly difficult with 
increasing prevalence of exposure to non-tuberculous mycobacteria, which also cause a 
positive TST reaction. 104 In general, however, reactions caused by non-tuberculous 
mycobacteria elicit smaller TST reactions than are elicited by tuberculous infection.104 
Studies done on the Alaskan population, which has minimal infection with non-
tuberculous mycobacteria, are the basis of the current understanding of the distribution 
ofTST reactivity.s1 If the population has minimal exposure to non-tuberculous 
mycobacteria, a bimodal distribution curve is expected, with an initial peak at Omm and 
a second peak at 20mm, and a roughly normal distribution around this second peak.s1 
The two peaks are clearly separated, thus classifying the population as reactors and non-
reactors. If the population has significant exposure to non-tuberculous my co bacteria 
(including BCG vaccination), a more unimodal curve, with a high proportion of smaller 
reactions representing false positives, is expected.st In this situation, classifying the test 
as positive or negative becomes more difficult. The relative contributions of non-
tuberculous and tuberculous infections have been estimated by using both human 
tuberculin (PPD-S) and avian tuberculin (PPD-B, the "Battey" antigen), as well as a 
variety of other PPD antigens.si. is3 These studies show that the geographic distribution 
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of reactions to 5 TU of PPD-S was different to the geographic distribution of reactions 
to PPD-B.157 In addition, persons with large reactions to PPD-B tended to have small 
reactions to PPD-S. During follow up of persons with positive TST reactions to PPD-S, 
the risk of developing TB increased with increasing size of the TST reaction.158 
The positive predictive value of the TST varies for different populations depending on 
the prevalence of tuberculous infection in any particular population. 52 The positive 
predictive value increases with the prevalence of infection in the population. 52 The TST 
is generally thought of as being a highly sensitive test, ranging from 85-95% 
sensitivity,52 but the specificity of the test is lower, particularly in populations with high 
levels of exposure to non-tuberculous mycobacteria. 
The size of the TST reaction elicited also depends on the dose of tuberculin used. 154 
Studies of dose response to tuberculin have shown that there is little advantage to using 
doses larger than 5 TU, and that in fact using higher doses may elicit more false 
positives.154• 159 In Australia, a 10 TU dose of tuberculin is used. The National Health & 
Medical Research Council recommended in their Immunisation Procedures handbook in 
1991 that reactions to 10 TU be classified as negative if less than 5mm, weak positive if 
5-9mm, intermediate positive if 10-14mm and strong positive if 15mm or larger.160 
There are many studies to support the use of a 5 TU dose of tuberculin, which provide 
data for the interpretation of TST reactions to this dose. However, the data on 
interpretation of reactions to a 10 TU dose are few, and the historical basis for choosing 
this dose in Australia is unclear. Possibly, the high prevalence ofBCG vaccination in 
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Three-point averages were used in plotting the TST distributions so as to minimise the 
effect of terminal digit preference. Terminal digit preference refers to the tendency of 
the skin test reader to round off the reading to the nearest five figures, so that peaks may 
be seen at 0, 5, 10, 15 and 20 mm, with a very low frequency of readings in between 
these values (particularly at 1, 4, 6, 9, 11, 19 and 21 mm). A truer distribution is 
obtained by averaging the frequencies of readings for each three consecutive points on 
the x-axis. Cut off points used in 1991 were compared for each population with more 
sensitive cut-off points. 
The data source for school children was the 1985 school skin testing survey. Until 
1985, school children received mass annual skin testing and BCG vaccination. A 
number of different schools were tested each year, with an average total of 30,000 
students screened annually.161 The last year of this screening program was 1985, by 
which time the screening activities had reduced significantly, with fewer schools being 
surveyed. Obtaining skin testing data on a low risk population such as school children 
would entail a TST population survey, which would be expensive. Therefore the last 
year of the school testing data was used retrospectively, and school children aged 15-18 
were selected in order to approximate the adult population. A total of 15 schools in 
three municipalities were tested in 1985. Data on testing were stored on microfiche, 
which were manually reviewed. Five schools were randomly selected from these 15, 
and 250 school children aged 15-18 years were systematically selected from each 
school. Although the epidemiology of TB has changed since 1985, studying the school 
children data can provide important information on TST reaction distributions in a low 
risk local population which was largely BCG vaccinated. 
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Results 
Figure 8.1 shows the TST distribution in recent contacts screened in Victoria. The 
curve is clearly bi-modal, with the second part of the curve beginning at 6mm. The peak 
ofreactions in this distribution is at 12-13mm. Of the recent contacts who received a 
TST and had a reaction of>5mm, 70-72% had a history ofBCG vaccination (see Table 
3.2). Therefore, if a skin test definition of 20mm post-BCG vaccination is used to 
define infection (compared to a definition of 1 Omm), 132 contacts with reactions of 10-
19mm, and a history ofBCG, will be defined as un-infected. Only 29 contacts had 
reactions of 20mm or more. 
Figure 8.2 shows the distribution in Indo-Chinese refugees screened in Victoria. This 
curve is less clearly bi-modal, with a greater number of reactions between 0-5mm, 
suggesting an influence of non-tuberculous mycobacteria. The peak of this curve is 
between 9-1 lmm. A total of 561 refugees had skin test reactions of lOmm or more, 
with 70% of refugees with a positive (>5mm) skin test having a history of BCG 
vaccination. There were 97 refugees with skin test reactions of> 19mm, and 464 with 
reactions of 10-19mm, of whom 70% (325/464) had a history ofBCG vaccination. 
Therefore, 325 refugees were with skin test reactions of 10-19mm post-BCG were 
defined as un-infected. 
Figure 8.3 shows the distribution of reactions in workers at an office screened during an 
outbreak.18 This curve is bimodal, with the second curve beginning at 6mm, and the true 
peak probably at 13mm. The "dip" between 10 and 15 mm probably represents terminal 
digit bias by the readers at 10 and 15 mm, rather than being a true "tri-modal" 
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distribution. There were 87 workers with a skin test reaction of 1 Omm or greater, but 
only 9 with a reaction of 20mm or more. Over 88% (77 /87) of the workers with a 
reaction of lOmm or more had a history ofBCG vaccination. Therefore, 77/78 workers 
with reactions of 10-19mm, post-BCG would be excluded from the chance of 
prevention because they would be defined as "un-infected", despite being in contact 
with a case of smear positive, pulmonary TB. 
Figure 8.4 shows the distribution of reactions for school children aged 15-18 years in 
1985. This curve is also bimodal, with the second curve beginning at 6mm and a lower 
peak at 1 Omm. This curve shows that defining infection as 20mm post-BCG excludes 
almost all children. 
All figures show the currently used cut-off point for defining "infection" (20mm), which 
is highly specific, but has low sensitivity, particularly in the refugee population, and 
compare it with cut-off points of increased sensitivity at 15mm and lOmm respectively. 
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Discussion 
In a classic bimodal distribution curve of TST reactions, the first curve represents true 
negative reactions (the un-infected population), while the second curve represents true 
positive reactions (the infected population). The area of overlap between the two curves 
represents the false positives and false negatives. The selected cut-off point should be 
the point which confers maximal sensitivity and specificity, and should lie between the 
two curves in the area of overlap. Studying the distributions shows that increasing the 
sensitivity of the definition of infection decreases the specificity, and vice-versa. It also 
shows that cut-off points of20 or even 15mm are shifted far to the right of the area of 
overlap between the infected and un-infected populations, and so would be very specific 
but in-sensitive definitions. 
The comparison shows that the distributions of TST reactivity is different for each 
population, and therefore the appropriate cut-off point for defining infection varies for 
different population groups. In the school children group, the prevalence of infection is 
low, and the number of persons with large reactions is small. The use of a 15mm cut-
off for school children with no risk factors would be appropriate. The positive 
predictive value of the TST in this group would be low, and so the cut-off point used to 
define infection should be higher. For screening purposes, high sensitivity is a 
desirable characteristic of the screening test. 
For recent contacts, who are at high risk of TB, the use of a 15 or 20 mm cut-off point is 
clearly not sensitive enough, and excludes most of the persons at risk. Examining the 
distribution of TST reactions in this group indicates that a 5mm cut-off point may be 
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appropriate. 
The distribution of TST reactions in the office workers exposed to TB represents a 
population at intermediate risk, since in that instance the contact tracing was extended 
beyond the circle of close contacts to more remote contacts.18 In this population, the use 
of a 1 Omm cut-off point may be appropriate. 
The data indicate that all the curves, except for the South-East Asian refugee population, 
were clearly bimodal, so that the effect of BCG vaccine on TST reactivity in recent 
contacts, school children and office workers appears to be minimal. In the refugee 
population, there was a significant number of reactions between three to eight mm, and 
the curve was not clearly bimodal. This population may have received multiple BCG 
vaccinations and have had exposure to other non-tuberculous mycobacteria. 162 
Regardless of this, examining the distribution shows that a 20mm cut-off point is not 
sensitive enough, since this is a population at high risk of TB. In Victoria the 20mm 
cut-off point was used for refugees who gave a history of past BCG vaccination. 
However, the refugee population has a high prevalence of infection, so that the positive 
predictive value of the test is higher, despite the high rates of BCG vaccination in this 
population. Therefore a lower cut-off point is appropriate for refugees, particularly in 
light of the low sensitivity of the cut-off point used in 1991 (see Figure 8.2). The use of 
the cut-off points of20mm post BCG in Victoria excludes most of the second part of the 
curve, and therefore excludes the majority of at-risk refugees, and is of low sensitivity. 
A recent study compared TST reactivity in two populations at low and high risk for TB, 
stratified for BCG vaccination status.101 They found a significantly higher rate of 
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positive TST reactions in the low risk population who had received BCG compared to 
the low risk population who had not received BCG, but found no significant difference 
in TST reactivity in the high risk populations who had and had not received BCG.101 
This confirms that BCG status should not be considered when interpreting the TST 
reaction in the refugee population, which is known to have a very high prevalence of 
TB.163 
These data indicate that the cut-off points used for defining infection need to take into 
consideration the population prevalence of infection, and be adjusted accordingly. The 
current CDC guidelines (see Chapter 1, Table 1.2) define levels of risk for TB and 
allocate different cut-off points for defining infection for different levels of risk.61 This 
approach has also been incorporated into screening guidelines in Australia in recent 
years. 
The use of highly specific cut-off points may be appropriate for low-risk populations, 
but not for high risk populations. If used as a screening test for high risk populations, a 
highly sensitive cut-off point should be used for interpreting the TST, since a screening 
test of low sensitivity is of limited use and defeats the very purpose of screening. 
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CHAPTER9 
IMP ACT OF TUBERCULOSIS CONTROL MEASURES AND 
CROWDING ON INCIDENCE OF TUBERCULOUS INFECTION 
IN MARYLAND PRISONS 
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Abstract 
Introduction: Prisons are a high risk setting for the transmission of tuberculosis. The 
Maryland Division of Correction has a program of annual inmate screening for TB, 
which presents an opportunity to study the risk of new infection in inmates. 
Aims: To determine the incidence of tuberculin skin test conversion in the Maryland 
State correctional system, and risk factors associated with skin test conversion. 
Methods: I conducted a retrospective cohort study. A sample of 1289 inmates 
incarcerated in 16/23 prisons, who had a negative tuberculin skin test (TST) and a repeat 
test within 24 months was selected. A number of risk factors were tested for association 
with skin test conversion by Poisson regression. The relationship between rates of INH 
prophylaxis and prison population density with skin test conversion was studied. 
Results: The incidence of recent conversion was 6.3 per 100 person-years. Risk 
factors for conversion included high prison population density (RR=2.4, 95% CI 1.5-
3.8) and being incarcerated in a higher security institution (RR=2.4, 95% CI 1.4-4.3). 
Being incarcerated in an institution with higher levels of INH prophylaxis (>65% of 
TST positives) reduced the risk of infection by 50% (RR= 0.5, 95% CI 0.3-0.7). 
Crowding was strongly correlated with risk of conversion (r = 0.83, p<0.001), while 
rates ofINH prophylaxis initiation were inversely correlated with risk of infection (r=-
0.82, p<0.001). In stepwise regression, higher prison population density was the 
strongest predictor of increased infection. In a final model, inclusion of rate of INH 
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initiation reduced the risk associated with crowding (RR=l.4, p=0.4). 
Discussion: Annual screening programs for prisons can identify recent conversions 
which may not otherwise be detected. Prison population density and rates of INH 
prophylaxis were the most important determinants of skin test conversion. Prisons with 
high population density had higher rates of conversion, and those with high rates of INH 
prophylaxis had lower rates of conversion. Crowding is not easily amenable to change 
in correctional systems, but preventive therapy is an easily implemented, effective 
strategy. 
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Introduction 
In the US the annual incidence of tuberculosis rose by 20% between 1985 and 1992, and 
has since declined by 8. 7%.11• 28 Outbreaks of tuberculosis in prisons has been well 
documented, 29• 30 making these sites important targets for tuberculosis control. 
Screening and prophylaxis of individuals at high risk is recommended by the Centers for 
Disease Control (CDC) as a priority method of tuberculosis control.61 Preventive 
therapy with INH has been shown to be up to 90% effective in preventing tuberculosis 
in both HIV positive and negative infected persons, as long as they are compliant with 
therapy .66, 68, 164, 16s 
The prevalence of tuberculous infection varies demographically in the US. Studies have 
shown a point prevalence of 2.5% tuberculin skin test (TST) reactivity among Navy 
recruits in 1990, varying from 26% in Asian-born recruits, 5.2% in African-American 
recruits and 0.8% in white recruits. 166 The prevalence of tuberculous infection in 
prisons is higher than in the general population. Prevalence rates of up to 25% have 
been described in correctional institutions.167"171 In HIV sero-negative intravenous drug 
users in Baltimore the prevalence was 25%. 172 Infectious tuberculosis in prison inmates 
can be spread back into the community167 as well as within the prisons, and should be an 
important target for tuberculosis control. The factors associated with the transmission 
of tuberculosis in prisons in the USA include the high prevalence of infection in the 
source population, HIV infection, overcrowding and systematic rotation of prisoners. 
Stead described conversion from negative to positive TST status among 12% of 
prisoners exposed to infectious tuberculosis. 167 Whilst contact tracing around discrete 
outbreaks of tuberculosis in prisons has been well described, and point prevalence of 
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tuberculous infection in prisoners is easily studied, there are few data on the background 
incidence of new infection acquired within correctional facilities. The Maryland 
correctional system instituted systematic annual re-testing of all inmates whose initial 
test was negative since March 1992. This provides a unique opportunity to study the 
overall incidence of tuberculous infection, associated risk factors and impact of control 
measures. 
Aims 
To determine the incidence of tuberculin skin test conversion in the Maryland State 
correctional system, and risk factors associated with skin test conversion. 
Methods 
Study population 
MDOC is a State prison system encompassing 23 prisons contained in four regions of 
Maryland, with an average daily population of20,247 in 1994. Only one prison is 
solely for women, who comprise 5% of the inmate population. The study population 
consists of male inmates of the Maryland Division of Correction (MDOC). The study 
population was selected from two of the four regions in Maryland, Baltimore (Region 
1) and Jessup (Region 2), which house 46% (9308/20,247) of the population. The 
demographic features of inmates do not vary significantly between the four regions. In 
the entire population, 77% of inmates are African-American and 22% are white 
Caucasian. The mean age of inmates is 33 years, the mean duration of incarceration, 74 
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months, and the mean turnover, 21 %. All 16 prisons in Regions 1 and two were 
included. The facilities studied included the intake facility, a home detention unit, five 
pre-release units, three minimum, two medium and two maximum security units, one 
combined medium and maximum security unit, and a solitary confinement unit. 
MDOC tuberculosis control program 
Between 1991and1993 the MDOC tuberculosis program re-structured its activities to 
include administration of INH prophylaxis under direct observation, construction of 
tuberculosis isolation units, and mandatory annual skin testing for all inmates. Contact 
tracing is conducted for all cases of tuberculosis in co-ordination with State and local 
health departments. MDOC defines infection as a TST reaction of 5mm or greater. 
Inmates with an initial TST reaction of 5mm or greater are recommended for preventive 
therapy with six months ofINH if they are aged under 35 years. Inmates with 
documented conversion ofTST, or positive TST with: known exposure to infectious 
TB, or known HIV infection, or known intravenous drug use in the past year, or medical 
conditions predisposing to TB are recommended for INH regardless of age. All inmates 
are offered HIV testing, which is voluntary. Special efforts are made to ensure that 
tuberculin-positive inmates agree to HIV testing. 
Study design 
A retrospective cohort study of incidence of new infection acquired within the prison 
system was performed. Inmates receive a TST on entry into the prison system, and 
since March 1992 annual re-testing has been done for negative reactors during their 
birth month. Therefore the interval between the first and second test may vary, which I 
accounted for by measuring person years of incidence. If, however, an individual's 
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birthday falls within three months of the initial test, re-testing is postponed until the 
following year. Complete two-year follow up data were available for inmates whose 
most recent birthday fell between August and December 1994 (inclusive). 
A systematic sample consisting of all inmates born between August 1 and December 31 
(inclusive) of any year, regardless of when they entered the prison system, was selected. 
All inmates receive annual screening or review for tuberculosis during their birth month, 
therefore the inmates in my sample (n=2,606) were due for review between August 1 
and December 31 1994. Those with a previously negative TST receive repeat testing, 
and those with previous positive results are screened by clinical examination and chest 
radiograph. Prevalence of infection was calculated only for those (n=l,977) who 
received an initial test between 1990-1994. 
A positive reaction was defined as one equal to or greater than 1 Omm. If HIV infection 
was present, a reaction of 5mm or more warranted consideration for preventive therapy. 
A cohort of 1,289 individuals within this sample who had a negative initial skin test and 
a repeat test within 24 months, was stud.ied to determine the incidence of recent TST 
conversion. The dates of repeat testing for this cohort ranged from February 1993 to 
December 1994, and all inmates had the initial and repeat test performed in the same 
institution, while serving the same sentence. The following definition was used for 
newly acquired tuberculous infection -
An initial negative TST reaction (<5mm) and no previously documented positive 
reactions; 
and 
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A repeat TST reaction with an increase in size of 1 Omm or more* within 24 months of 
the initial test. 
*In HIV infected individuals, a reaction of 5mm or more warranted consideration for 
preventive therapy. 
Tuberculin testing procedure 
All inmates receive tuberculin testing on admission to Maryland prisons, unless 
documented prior positive test results (most commonly from previous admissions) are 
available. Testing is performed and read by licensed nurses using the Mantoux method, 
utilizing O.lml of tuberculin containing 5 TU (Tubersol™, Connought). 
Data sources and collection 
Tuberculin testing data were collected from MDOC testing logs. These data were 
merged with additional information from the correctional system database. If tuberculin 
testing data were incomplete, medical records were reviewed. Medical records were 
also reviewed for inmates with a positive TST or documented conversion. HIV testing 
results were matched to my database from the MDOC HIV testing records and unique 
identifiers were then delinked. HIV testing is voluntary in the MDOC. 
Estimates of population densities in each prison were made using total population and 
area of the prison. Estimates of population turnover for each prison were made using 
monthly admissions, discharges and resident populations for the time period studied. 
Three binary variables were created and 0-1 values were assigned to individuals based 
on which prison they were in. In order to dichotomise the variable, the cut-off points 
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were selected at the median value for the variable being studied- INH prophylaxis rates 
for infected individuals >65% per prison; prison population turnover > 30%; and 
prison population density > nine inmates per 1000 square feet. 
The results of screening for the intake institution were significantly different to the other 
institutions, so screening data for all of 1994 at this institution was reviewed. 
Data analysis 
Univariate analysis was performed in Epi Info 5,93 using Chi square, Taylor series 95% 
confidence intervals (CI) for relative risks and Cornfield 95% CI for odds ratios. 
Multiple regression was performed in Egret.97 Poisson regression was used to analyze 
risk factors for TST conversion. The most significant increases in likelihood were used 
to select the best multivariate models. I computed Pearson's moment correlation 
coefficients (r values). I excluded the intake institution in the correlation studies 
because of the unusually high conversion rates therein. I also excluded the solitary 
confinement unit, in which no inmate intermingling occurs and therefore degree of 
crowding is not a relevant factor. 
A sensitivity analysis for incidence of TST conversion was performed to allow for the 
boosting effect, assuming a maximum of 30% of all positive reactions in recent 
converters were due to boosting. This figure was based on the highest quoted incidence 
of boosting in the literature. 162 
Institutional approval 
The study was approved by the Committee for Human Research, School of Hygiene and 
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Public Health, Johns Hopkins University. This committee includes a prisoner advocate. 
Results 
Demographics and tuberculosis case rates 
In 1992, the incidence of active tuberculosis in Maryland prisons was 58/l 00,000, over 
five fold greater than the incidence rate in the State of Maryland. However, the annual 
number of cases in the MDOC decreased from 11 in 1992 to four (20 per 100,000) in 
1994. 
The sample comprised 28% (2,606/9,308) of the inmates of the two regions studied, and 
13% (2,606/20,247) of the total MDOC inmate population. The total number of inmates 
eligible for screening between August and December 1994 was 2,606. Of these, 82% 
(2, 143/2,606) had at least one TST done. The remainder, 463/2,606 (18% ), were 
excluded because no TST was done. The reasons for this were transfer to another 
institution, 347/463 (75%), release or leave, 107/463 (23%), and refusal 9/463 (2%). 
Over 90% (1,977/2,143) were tested after 1990, and only 1.5% (32/2143) were tested 
before 1980. 
Within this sample, 1,708/2,143 had an initial negative TST. Of these, 86% 
(1,466/1,708) received a repeat test, and 1,289/1,466 (88%) had the second TST 
performed within 24 months. The remainder were transferred to other prisons or 
discharged, and were excluded from the study. 
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Of the inmates, 72% (1,532/2,143) were housed in Region 2, and 28% (61112,143) in 
Region 1. The mean age of inmates was 33 years (median age 32 years), and the mean 
duration of incarceration was 72 months (median 42 months, range less than one month 
- 437 months). The majority (77%, 1651/2,143) were African-American, and 22% 
(473/2,143) were white Caucasian. The majority of inmates (99.5%, 2134/2143) were 
born in the USA, and 70% (1492/2,143) were born in the State of Maryland. Most 
inmates (1,393/2,143, 65%) resided in Baltimore city prior to incarceration. The 
remainder included 7.7% (164/2,143) from Prince Georges County, Maryland, 3.9% 
(83/2,143) from Baltimore County, 16.8% (361/2,143) from other counties in Maryland, 
and 6.6% (142/2,143) from other States. 
Prevalence of infection 
The prevalence of infection was 18% (358/1,977). There was no significant difference 
in prevalence of infection between Region 1 (17.5%, 104/594) and Region 2 (18%, 
254/1383), P=0.7. There was a higher prevalence of infection in inmates aged over 35 
years (33%, 212/651) than those aged under 35 years (11 %, 146/1326), OR=3.9, 95% 
CI=3.0-5.0. The strongest risk factor associated with prevalence was age over 35 years. 
Prevalence was also associated with duration of incarceration greater than 10 years (OR 
2.0, 95% CI 1.6-2.6). Prevalence increased from 13% for inmates incarcerated for 12 
months or less, to 31% in those incarcerated over 10 years (p<0.001) (Figure 9.1). 
Prison population density and rate ofINH prophylaxis were not associated with 
prevalence. African American inmates had a prevalence of 18.8% (287/1523) and white 
inmates, 15.6% (71/454), OR 1.3, 95% CI 0.9-1.7. 
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Incidence of conversion 
There were 70/1,289 inmates whose TST converted from positive to negative within 24 
months. The incidence ofrecent conversion was 6.3 per 100 person-years. To be 
certain that boosting did not significantly influence the estimated incidence ofTST 
conversion, a sensitivity analysis was done, which assumed that 30% of positive 
reactions in recent converters were due to boosting. Even adjusting for this high 
hypothetical rate of boosting, the rate of conversion was 5.0 per 100 person-years. 
The mean reaction size among recent converters was 15mm. There were significant 
differences in conversion rates between regions, and between prisons. Region 1 had a 
significantly higher conversion rate (8.5/100 person years) than Region 2 (5.4/100 
person years), RR 1.6, 95% CI 1.1-2.5). Six prison facilities had no conversions - these 
were the solitary confinement unit, the home detention unit and four pre-release units. 
The remaining pre-release unit had only one conversion. Table 9.1 shows the wide 
variation in rates of recent conversion by institution type. 
Because of the extremely high rate of conversion in the intake facility, I reviewed 
screening data for all of 1994 for that institution to determine if I had inadvertently 
sampled a period with unusually high incidence. In fact, all the conversions in the 
intake facility for 1994 occurred in just one month (September 1994), giving unusually 
high rates in my sample. These conversions were all associated with exposure to a 
single infectious case of TB in the intake institution. The incidence of conversion for 
the intake institution for all of 1994 was nine per 100 person years, which was not 
significantly higher than the overall rate (RR 2.0, 95% CI 0.9-4.8). 
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Table 9.2 shows risk factors for conversion in univariate analysis. In stepwise Poisson 
regression using all variables in Table 9.2, prison population density was the most 
significant variable (RR 2.22, p<0.001), followed by proportion-of-inmates-given-
INH>65% (RR 0.44, p=0.001), medium and maximum security level (RR 2.35, p=0.01) 
and race (RR 2.15, p=0.03). In all multivariate Poisson regression models tested, rate of 
INH and population density were consistently the most significant variable when only 
one or the other was included. However, when these two variables were included 
together, rate ofINH reduced the risk associated with crowding. 
Table 9.3 shows three multivariate models (A,B and C) using variables which were 
significant in stepwise testing, and illustrates the effect of INH rates on crowding. In 
Model A, prison population density is the most significant variable, and in Model B rate 
of INH is the most significant variable. When both are included in Model C, both 
ceased to be significant, while race and security level remained significant. 
Impact of INH prophylaxis and crowding on tuberculous infection. 
Prison population density (crowding) and rates of INH prophylaxis were strongly 
associated with risk of tuberculous infection and varied between institutions. These 
variables were examined further to determine if tuberculous infection rates in each 
institution were correlated with the level of crowding and the level ofINH prophylaxis 
initiation per institution. These data are shown in figures 9.2 and 9.3, where each point 
on the graph represents an individual institution. Figure 9.2 shows that prison 
population density was strongly correlated with conversion rates per institution (r=0.83, 
95% CI=0.56-0.94, p<0.001), with conversion rates increasing as population density 
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increased. There was also a significant inverse correlation between INH prophylaxis 
initiation rates and recent TST conversion rates per institution (figure 9.3). As INH 
rates increased, conversion rates decreased (r= -0.82, 95% CI= -0.94 to -0.54, p<0.01). 
HIV infection 
Overall, 36% (774/2,143) inmates were tested for HIV. The prevalence of infection was 
9% (70/774). The prevalence of HIV infection in those aged less than 35 years was 7% 
and over 35 years, 12% (OR=0.55, 95% CI=0.32-0.92, p=0.02). The mean age of HIV 
positive inmates was 36 years and HIV negative inmates, 33 years (p<0.001). 
In the cohort tested for recent TST conversion, 398/1,289 received an HIV test, of 
whom 38/398 (9.5%) tested positive for HIV. In the HIV positive group, 2/38 had a 
TST conversion (5.7 per 100 person-years) compared to 48/360 (14.0 per 100 person-
years) in the HIV negative group. This difference was large, but did not reach statistical 
significance (RR= 0.41, 95% CI=0.1-1.60, Yates corrected p=0.26). The TST reaction 
sizes of the two HIV positive individuals who converted increased from 0 to 12mm and 
16mm respectively. The mean TST reaction size in converters was not significantly 
different in HIV positive (14 mm) and HIV negative (14.3mm) individuals (p=0.6). 
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Discussion 
It has been shown that the rate of active TB in prisons is nearly four times higher than in 
the general community.173 Braun et al showed by phage typing that intramural 
transmission of TB in prisons does occur,169 and Stead167 showed that active TB may go 
undetected in prison. A study of New York State prisons identified 171 cases of active 
TB between 1990-1991.174 The occurrence of significant transmission of tuberculosis in 
prisons is also supported by the strong association I found between duration of 
incarceration and prevalence, with rates as high as 31 % after 10 years. The relationship 
of active tuberculosis to number of admissions and increasing duration of incarceration 
has been described previously .168 
With this background, high conversion rates would be expected in prisons. My study 
found a TST conversion rate of 6.3 per 100 person-years. A contact study in a 
correctional facility in California demonstrated conversion in exposed employees of 
6.4/100 person-years.30 Another study reported an initial prevalence of positive TS Ts of 
23% among 107 inmates residing in the same tier as an infectious inmate, with 71% of 
initially negative reactors subsequently converting.175 In the same study, new inmates 
admitted to the same tier after the exposure period, had a significantly lower prevalence 
of initial positive tests (13% ).175 This is similar to the 13% prevalence I have described 
in inmates incarcerated for less than 12 months, a figure which probably approximates 
the pre-incarceration prevalence. 
Crowding of prisons and rates of INH administration were the strongest predictors of 
TST conversion, but the effect of crowding is reduced significantly by rates of INH 
214 
administration. This finding has important public health implications. The direct 
relationship between TST conversion and population density is not surprising, and 
indicates that crowded conditions facilitate tuberculosis transmission. The relationship 
of prison crowding to the transmission of pneumococcal disease was described by Hoge 
et al, who found significantly higher attack rates in more crowded prison units.176 The 
biological plausibility of my findings is supported by the fact that the solitary 
confinement unit (where no prisoner interaction takes place) and the home detention 
unit (where inmates have access to the community and live in less crowded conditions) 
had no conversions. In addition, the pre-release units (where conditions are less 
crowded) had minimal TST conversion. Institutions at greater risk for tuberculosis 
transmission included the intake institution, and the maximum and medium security 
institutions, which have crowded conditions, daily prisoner intermingling and no 
community access. 
The intake institution has the highest case rate of active tuberculosis, the highest staff 
TST conversion rates, and is the only facility where a staff member has developed active 
tuberculosis, (unpublished data, Kendig N). Inmates diagnosed with active TB in the 
intake institution are likely to have acquired their disease outside the prison system, but 
uninfected inmates in the same institution are still at high risk of exposure during the 
initial holding period. The association of conversion with institution type, independent 
of levels of crowding and preventive therapy, may reflect a different inmate mix in 
different institutions. The independent association of race is consistent with the findings 
of Stead et al. 177 
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The inverse correlation between use ofINH prophylaxis and incidence of tuberculous 
infection in institutions could indicate that a prison with high prophylaxis rates is more 
likely to have a more disciplined and systematic approach to tuberculosis control and 
therefore, less conversions. The wide variation in INH rates between prisons may 
indicate underutilisation in some institutions. A study of preventive therapy in older 
contacts of infectious TB found that only 30% of infected contacts who were deserving 
of preventive therapy actually received it.85 Mehta et al found a decline in the rate of 
preventive therapy for infected contacts in Tennessee, dropping from 67% in 1979 to 
37% in 1985.86 In the case of tuberculosis screening, where an effective intervention is 
available, it is essential that adequate resources are made available to the correctional 
system to ensure uniformly high initiation and completion ofINH prophylaxis. 
The incidence ofTST conversion in this study is subject to certain caveats. For 
example, transient anergy, or observer error may have contributed to false negative TST 
reactions on initial testing. I compared the groups with prevalent and incident infection 
to test the hypothesis that if anergy at the time of entry into the prison system, and test 
failure were largely responsible for "conversions" (that is, the inmates who converted 
from negative to positive were actually infected but anergic at the time of the first test), 
then the demographics and risk factors for the two groups would be similar. In contrast 
to those with prevalent infection, there was no significant difference in the incidence of 
infection by age group, suggesting that the risk of negative reactors acquiring infection 
remains uniformly high, regardless of age. In addition, conversion rates were 
significantly higher in prisons in Region 1 than in Region 2, but prevalence of infection 
was the same. Duration of incarceration was associated with prevalence (as expected), 
but not with incidence. This makes intuitive sense, since the risk of an un-infected 
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inmate acquiring TB infection would not depend on duration of incarceration, but on the 
risk of exposure at any given time. Furthermore, risk factors such as rate of INH and 
population density were associated with incidence but not prevalence. This suggests 
that anergy and test failure probably make only a minimal contribution to the results. 
Boosting cannot be excluded, since two-step testing was not used, but several factors 
suggest its contribution was also minimal. Boosting is associated with larger initial TST 
reactions, previous BCG vaccination, birth in a foreign country and older age.178 The 
MDOC group had initially negative (Omm) TST reactions, a mean age of 33 years, and 
minimal prior vaccination with BCG since over 99% were US born. In largely 
unvaccinated North American populations with and without HIV infection, no more 
than 3-5% of reactions of more than 1 Omm can be attributed to boosting.178• 179 Boosting 
is also associated with past exposure to non-tuberculous mycobacteria, and Thompson et 
al showed that residents of Pennsylvania had significantly lower rates of boosting than 
residents of South-Eastern and Western States.ss Maryland, which is adjacent to 
Pennsylvania, is not known to have high prevalence of non-tuberculous mycobacterial 
exposure. 1s7 Higher rates of boosting (up to 30%) have been described in South-East 
Asian refugees, who have a higher levels of BCG vaccination and exposure to non-
tuberculous mycobacteria,162 but there are very few South-East Asian refugees in 
Maryland prisons. Nevertheless, ifl assumed 30% of positive reactions in recent 
converters were due to boosting, the adjusted conversion rate would still be 5.0 per 100 
person years, so it is unlikely to have had a major impact on the estimated incidence in 
this study. 
The fact that lower conversion rates were described for HIV positive inmates compared 
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to HIV negative inmates may suggest that the cutoff point used is not sensitive enough 
to detect all cases of TB infection in the HIV positive group. One study found a 
significantly lower rate of TST reactions >5mm in HIV positive inmates compared to 
HIV negative inmates of correctional and drug treatment facilities.84 In MDOC, HIV 
testing is voluntary, with only 30-40% consenting to testing and a higher HIV sero-
prevalence in inmates who initially refuse testing.180 Anonymous sero-surveys 
conducted in MDOC since 1985 show a 7-8.5% HIV seroprevalance among male 
inmates. 180 This is lower than the 21 % HIV seroprevalence reported in a survey of 
prisons in 25 States. 84 Studies have described HIV seroprevalence of 49-56% in prison 
inmates with active TB.84• 169 For this reason, the MDOC uses a 5mm cutoff point for all 
inmates, to define infection and guide decisions to treat. The rationale for this is that 
the potential sequelae of missing TB infection in an HIV positive inmate by using a 
higher cut-off point are more serious than increasing the false positive rate in non-HIV 
infected inmates. 
The annual screening program at MDOC identified and treated infected individuals 
who may otherwise have gone undetected. The occurrence of undetected transmission 
of TB in prisons has been described before, 167• 170 and may be due to high rates of 
population turnover in prisons. For this reason, contact screening alone, in response to 
discrete outbreaks, may not be adequate for TB control. Increasing incarceration rates 
and longer inmate sentences mean that crowding in prisons is not readily amenable to 
change. Instead, a practical approach would be to maintain annual screening, and to 
target the most crowded institutions for increased support and resources in tuberculosis 
control. 
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Table 9.1: Incidence of recent conversion in Maryland prisons by institution type. 
Type of unit n* n* n* person- conversion per 
units conversions years 100- person yrs 
Home detention 1 0 7.3 0 
Pre-release 5 1 195 0.5 
Minimum 3 9 131 6.9 
security 
Medium security 2 28 319 8.8 
Medium& 1 9 139 6.5 
Maximum 
security 
Maximum 2 18 276 6.5 
security 
Solitary 1 0 44 0 
confinement 
Intake 1 5 9.4 53 
Total 16 70 1119 6.3 
n = "number of' 
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Table 9.2: Incidence of recent tuberculin skin test conversion in Maryland prisons 
- univariate analysis 
Variable number of person incidence/ RR 95o/o CI p 
conversions years 100 person value 
yrs 
African- 61 858 7.1 2.1 1.1-4.l <0.05* 
American 
race 
Age<35 44 804 5.5 0.7 0.4-1.1 0.08 
years 
Prison 40 399 10 2.4 1.5-3.8 <0.001* 
population 
density 
>9/1000 sq 
ft 
lsoniazid > 22 561 3.9 0.5 0.3-0.7 <0.01* 
65%* 
Region 1 27 316 8.5 1.6 1.0-2.5 <0.05* 
Pre-release 1 195 0.5 0.1 0.01-0.5 <0.001* 
units 
Medium& 56 704 8 2.4 1.4-4.3 <0.01* 
maximum 
security 
Duration of 10 178 5.6 0.9 0.5-1.7 0.7 
incarceratio 
n> lOyrs 
Turnover 14 213 6.6 1.1 0.6-2.0 0.68 
>30% 
TOTAL 70 1119 6.3 
*Residence in a prison where 65% or more of infected inmates are treated with INH 
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Table 9.3: Incidence of recent TST conversion in Maryland prisons - multivariate 
analysis by Poisson regression 
Model A 
African-American Race 
Prison population density >9/1000 sq ft 
Medium/maximum security 
Age< 35 years 
ModelB 
African-American Race 
Isoniazid rate > 65% 
Medium/maximum security 
Age>35 years 
ModelC 
African-American Race 
Isoniazid rate > 65% 
Medium/maximum security 
Age> 3 5 years 
Prison population density >9/1000 sq ft 
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RR 95%CI ll 
2.1 
2.2 
1.9 
0.6 
2.2 
0.4 
2.4 
0.6 
2.1 
0.6 
2.1 
0.6 
1.4 
1.1-4.3 
1.4-3.6 
1.1-3.5 
0.4-1.1 
1.1-4.3 
0.3-0.7 
1.3-4.2 
0.4-1.0 
1.1-4.3 
0.3-1.4 
1.1-4.0 
0.4-1.0 
0.6-3.2 
0.04* 
<0.01 * 
0.04* 
0.06 
0.03* 
0.001 * 
0.03* 
0.05 
0.04* 
0.20 
0.02* 
0.053 
0.43 
CHAPTER 10 
LACK OF IDENTIFIABLE EXPOSURE TO TUBERCULOSIS IN 
SKIN TEST CONVERTERS IN MARYLAND PRISONS -
BOOSTING OR MISSED CASES OF TB? 
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Abstract 
Introduction: In the previous chapter I described skin test conversion of 6.3/100 
person-years in Maryland prison inmates. The finding of skin test conversion in annual 
screening can be explained in three ways - identified exposure to TB in the time period 
between testing; unidentified exposure to TB in the time period between testing; or 
boosting without new exposure to TB. 
Aims: To determine retrospectively if inmates with recent skin test conversion had 
identifiable exposure to infectious TB in the correctional system; to determine if 
undetected TB can occur in correctional facilities; and to estimate the relative 
contributions of identified exposure, unidentified exposure and boosting to observed 
skin test conversion in the study population. 
Methods: All inmate movements within the correctional system were used to ascertain 
whether converters were exposed to cases at any time between the first and second PPD 
test. Exposure was classified as probable, possible and unlikely. In order to test the 
hypothesis that undetected transmission of tuberculosis occurs due to high inmate 
turnover, I matched all inmates discharged from the prison system after January 1992 
(n=34,331) with all cases of tuberculosis notified to the Maryland Department of Health 
& Mental Hygiene tuberculosis registry in 1994 (n=363). This was done to detect cases 
of active TB which may have been undiagnosed within the correctional system. 
Results: There were 70/1,289 inmates whose skin test converted within 24 months, 
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between 1992-94. All cases of infectious TB in inmates diagnosed between 3/91 and 
12/94 were identified. There were 13 cases of infectious tuberculosis within the prisons, 
identified during the study period. Of these, 6/13 were diagnosed in the intake 
institution, all within two months of being admitted. The relative risk for active 
tuberculosis in the intake institution was 9.89 (95% CI 3.33-29.36), p<0.0001. For 
recent converters, probable exposure was found in 13%, possible exposure in 10% and 
unlikely exposure in 72%. In a further 5% exposure status could not be determined. I 
identified four new cases of pulmonary tuberculosis notified to the State in 1994, in 
inmates discharged after 1992 (12/100,000). These individuals were not known to have 
tuberculosis whilst incarcerated, and at least one was likely to have been infectious prior 
to discharge from prison. 
Discussion: For the majority of recent skin test converters, exposure to infectious TB 
could not be identified. This may indicate that transmission is undetected due to high 
prison population turnover. This is supported by the finding of cases of infectious TB 
who were undiagnosed during incarceration. Boosting may also be a factor. 
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Introduction 
The finding of skin test conversions is often reported in at-risk populations, 181-184 but the 
meaning of these conversions is the subject of debate and speculation.185-188 Conversion 
may be linked to identifiable exposure to infectious TB, or may be due to unidentified, 
undetected exposure to TB. Some cases of infectious TB may be missed in the 
correctional system - for example, an inmate may have TB in prison, but be discharged 
before the diagnosis is made. This is plausible due to the high population turnover in 
prisons. Alternatively, conversion may simply reflect boosting in the absence of any 
new exposure to TB. 
In the absence of documented exposure to TB, it is unclear in a mobile population 
whether the finding of skin test conversion during annual screening indicates boosting, 
or true newly acquired infection with TB. 
It is particularly difficult to ascertain exposure to TB retrospectively. Captive populations 
such as incarcerated prison inmates are an exception, and provide an opportunity to 
determine retrospective exposure to TB. The inmates described in Chapter 9 represents a 
"captive" population in the true sense, since they were incarcerated between the first and 
the second skin tests. All inmate movements can be traced, due to meticulous records of 
inmate movements within the correctional system, and all potential source cases of TB can 
be matched to skin test converters to determine likely exposure. 
Aims 
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period of exposure were identified. Location and movement of cases were matched with 
those of converters 
Detailed medical case histories for all inmates diagnosed with active TB in the correctional 
system are kept at MDOC. All cases of active, infectious tuberculosis in inmates diagnosed 
between 3/91 and 12/94 were identified. All inmate movements within the correctional 
system are documented rigorously. Dates and duration of housing and site visits (for 
reasons other than housing) within the correctional system were obtained for each case. 
These data were used to ascertain whether recent converters were exposed to cases at any 
time between the first and second PPD test. 
The following definitions were used 
1. Probable exposure: If the case and converter resided in the same institution for any 
period of time within six months prior to and one month after the diagnosis of TB 
2. Possible exposure: If the case and the converter did not reside in the same institution, but 
were present in the same institution during the specified time period for other reasons. 
3. Improbable exposure: If the case and converter had never been present together in the 
same institution during the specified time period. 
In order to test the hypothesis that undetected transmission of tuberculosis occurs due to 
high inmate turnover, I matched all inmates discharged from the MDOC system after 
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January 1992 (n=34,331) with all cases of tuberculosis notified to the Maryland Department 
of Health & Mental Hygiene Tuberculosis Registry in 1994 (n=363). If a case of TB was 
notified to the State registry within one month of discharge from the prison system, but had 
not been identified in the prison, I deemed that the case was possibly suffering from TB 
during the period of incarceration. The time period of one month was selected because 
using a longer time period after discharge from prison would have reduced 
the certainty of the case being infectious during incarceration. 
Prison population turnover for the 16 prisons in the study was calculated using annual 
figures for admissions, discharges and resident populations and expressed as a percentage 
of the inmate population. A weighted mean was calculated for all 16 prisons according to 
the population. 
Results 
Exposure to infectious tuberculosis 
The movements of all recent converters were matched with those of known infectious cases 
of tuberculosis in the prison system during the possible time periods of exposure. Probable 
exposure was found in 13%, possible exposure in 10% and no documented exposure in 
72% of recent converters, as shown in Table 10.1. In a further 5% exposure status could 
not be determined. 
Source cases 
There were 13 cases of infectious tuberculosis from 1191to12/94 in the study prisons. Of 
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these, 6/13 occurred in the intake institution. The cases which occurred in the intake 
institution were all diagnosed within two months of being admitted. The relative risk for 
active tuberculosis in the intake institution was 9.89 (95% CI 3.33-29.36), p<0.0001. 
Matching with State notifications 
I identified four new cases of pulmonary tuberculosis notified to the State in 1994, in 
inmates discharged after 1992 (12/100,000). These individuals were not known to have 
tuberculosis whilst incarcerated, and one of the four was likely to have been infectious prior 
to discharge from MDOC, being notified within one month of discharge from the prison. 
Prison population turnover 
Mean prison population turnover was 21 %. The highest turnover was in the intake facility 
(61%). 
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Discussion 
Exposure to possible source cases of TB could not be determined for the majority of skin 
test converters. This indicates two possibilities, or a combination of both - firstly, that 
significant undetected transmission of TB occurs in prisons due to the high inmate turnover, 
so that an inmate with infectious TB may be admitted and discharged before the diagnosis 
is made. The second possibility is boosting, which cannot be excluded, since two-step 
testing was not used, but, as pointed out in the previous chapter, several factors suggest its 
contribution was minimal. The prevalence of infection was the same across institutions and 
regions, but the incidence of conversion varied significantly. In addition, the prevalence 
of infection was age related, whereas the incidence of conversion was unrelated to age. If 
the observed conversions were largely due to boosting, we would expect the incidence of 
conversion to be equal across institutions and regions, and to be age related. Even if I 
assumed 30% of positive reactions in recent converters were due to boosting, the adjusted 
conversion rate would still be 5 .2 per 100 person years, so it is unlikely to have had a major 
impact on the estimated incidence in this study. 
The finding that over 70% of new converters have not been exposed to known cases of 
active tuberculosis in the prisons was unexpected, considering the aggressive policy of 
isolation and evaluation for inmates with suspected pulmonary tuberculosis. Even in the 
unlikely event that 30% of conversion reactions are due to boosting in the study population, 
there would still be 40% of conversions without known exposure. 
A pseudo-outbreak of skin test conversions was described in Illinois, where 89/1,800 
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inmates identified with skin test conversion of> 1 Omm.189 In this inmate population, no 
exposure to active TB could be determined, and subsequent review indicated that the nurses 
reading the TST had measured erythema rather than induration, so that the observed skin 
test conversions were false positives. This is unlikely in the MDOC setting, since the skin 
test readers are experienced and formally trained in reading the TST. 
The high prison population turnover may result in some inmates with infectious 
tuberculosis leaving the correctional system before the diagnosis is suspected - I identified 
at least one case of pulmonary tuberculosis fitting this description. My definition of a 
possibly infectious case, undiagnosed in prison was one discharged within one month, 
which is a highly specific definition, but is unlikely to be highly sensitive. I may have 
identified more missed cases had I expanded the definition to two or three months post-
discharge, but felt that specificity was more important in this exercise. In addition, my 
study only matched cases of tuberculosis reported in Maryland, but released inmates may 
be diagnosed with tuberculosis in other States or evade detection altogether. Others, due 
to transfer between prisons, may temporarily escape detection. In addition, the natural 
history of untreated tuberculosis includes up to 50% survival, so that some cases may be 
undetected for extended periods within prisons, particularly in a population where chronic 
respiratory symptoms are common. Routine sputum smear testing for inmates with 
respiratory symptoms persisting over three weeks may reduce such transmission. However, 
fluid population dynamics of correctional systems may preclude identification of all cases, 
even with the best of efforts. 
This study indicates that certain types of institutions are at greater risk for tuberculosis 
transmission. These include the intake institution, which has highest case rate of active 
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tuberculosis. The cases in the intake facility probably were acquired outside the prison 
system, but this still places inmates at risk while in that facility. 
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Table 10.1: Exposure to TB in skin test converters in Maryland prisons 
EXPOSURE N O/o 
Probable exposure 9 13 
Possible exposure 7 10 
Improbable exposure 50 72 
Undetermined 4 5 
TOTAL 70 100 
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CHAPTER 11 
UTILISATION OF ISONIAZID PROPHYLAXIS IN MARYLAND 
PRISONS - POLICY VERSUS PRACTICE 
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Abstract 
Introduction: In Chapter 9 I described an inverse correlation between rates of INH 
prophylaxis and rates of conversion by institution in the MDOC prisons. I also found a 
variation in rates of INH use for infected inmates in different facilities, despite common TB 
control guidelines for all institutions in the MDOC. It is essential to evaluate the efficacy 
of preventive strategies, especially preventive therapy with INH, in these settings. 
Aims: The aims of this chapter were to determine the extent of utilisation of INH 
preventive therapy in Maryland prisons, and to determine reasons for inconsistent use of, 
and under-use of, INH. 
Methods: The study subjects were 2,143 inmates of 16 prisons in the Maryland Division 
of Corrections (MDOC) who had at least one TST done. If tuberculin testing data were 
incomplete, medical records were reviewed. Medical records were also reviewed for 
inmates with a positive TST or documented conversion. Information on INH preventive 
therapy, side effects, completion of therapy and compliance were sought from the medical 
records. 
Use ofINH use for inmates with an indication for preventive therapy according to MDOC 
guidelines is described by institution. If INH preventive therapy was indicated but not 
given, reasons were ascertained from the medical records. 
Results: Overall, 12% (25112,143) of inmates met the criteria for INH preventive therapy 
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defined by MDOC. Of these inmates, 61% (153/251) received INH in the correctional 
system. There was a wide variation in rates of preventive therapy between prisons. Recent 
skin test converters were significantly less likely (30%) than inmates positive on the first 
TST, to receive preventive therapy. 
Record review identified a reason for lack of prophylaxis in inmates with an indication for 
prophylaxis in 38% (37/98). In the remaining 62% (61/98), a clear reason for omitting 
preventive therapy was not found. Given reasons included age over 35 years (18%, 18/98), 
subjective decision making by the treating physician (11 %, 11198), refusal by inmate (6%, 
6/98), and medical contraindications (2%, 2/98). Of those who commenced INH 
prophylaxis, 62% (95/153) completed therapy. Of those who did not complete prophylaxis, 
only 3/21 were due to genuine medical contraindications. 
Discussion: Although the overall rate of preventive therapy for eligible inmates was 60%, 
those at highest risk, the recent converters, had the lowest rate (30%) oflNH prophylaxis. 
For the majority of eligible inmates who did not receive INH, no reason was apparent. 
Where reasons were given, genuine medical contraindications to INH were rare. 
These findings suggest the need for education among providers. It is possible that some 
degree of confusion and concern exists among providers about the use of INH. In the case 
of tuberculosis screening, where an effective intervention is available, it is essential that 
adequate resources are made available to the correctional system to ensure uniformly high 
initiation and completion ofINH prophylaxis. 
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Introduction: 
Prisons are high risk institutions for the transmission of TB. As with all high risk groups, 
systematic screening and preventive strategies are in place in prison systems. In Chapter 
9 I described an inverse correlation between rates of INH prophylaxis and rates of 
conversion by institution. I also found a variation in rates of INH use for infected inmates 
in different facilities, despite common TB control guidelines for all institutions in the 
MDOC. It is essential to evaluate the efficacy of preventive strategies, especially 
preventive therapy with INH, in these settings. 
INH is proven to reduce the risk of TB infection progressing to active disease.62' 65 There 
has been a decrease in the use ofINH since the 1960s and 1970s, for reasons which are not 
clear and which are not consistent with the evidence of the time. 86 Missed opportunities for 
prevention of TB in Victoria by underutilisation of INH were described in previous 
chapters, and have also been described in the USA. 85' 88 
An approach to preventive therapy which is more conservative than current CDC guidelines 
has been espoused by several people,190, 191 Although there have been recent reports of fatal 
INH induced hepatitis,77' 78 the more conservative approach is supported by anecdote and 
very little evidence. The reports of fatal INH hepatitis indicate that deaths occurred in 
patients who continued taking INH for weeks despite the onset of symptoms suggestive of 
hepatitis.77 In a prison setting, with selection of candidates for INH based on recommended 
CDC criteria61 and close monitoring of treatment, such adverse effects would be rare. The 
current recommendations for eligibility are evidence-based,62-65, n, n, 76' 80, 89, 115 and should 
be followed until definitive evidence to the contrary is available. 
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Many non-specific adverse events attributed to INH may not be true drug side effects. In 
a randomised controlled study of INH versus placebo in HIV infected patients, the rate of 
adverse events was not significantly different between the INH group and the placebo 
group.192 This suggests that many of the non-specific side effects may be wrongly attributed 
to INH, and may be the reason for prematurely ceasing therapy. 
The MDOC guidelines recommend that recent skin test converters be treated with INH 
preventive therapy. Inmates with baseline positive TST reactions are recommended for 
preventive therapy if they are aged under 35 years and have no history of recent exposure 
to TB. 
Aims 
The aims of this chapter were to determine the extent of utilisation of INH preventive 
therapy in Maryland prisons, and to determine reasons for inconsistent use of, and under-
use ofINH. 
Methods 
The study subjects were 2, 143 inmates of 16 prisons in the Maryland Division of 
Corrections (MDOC) who had at least one TST done. The selection of the inmate 
population, inmate demographics, the 16 study institutions and the tuberculin testing 
database are described in Chapter 9. If tuberculin testing data were incomplete, medical 
records were reviewed. Medical records were also reviewed for inmates with a positive 
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TST or documented conversion. Information on INH preventive therapy, side effects, 
completion of therapy and compliance were sought from the medical records. 
Rates of INH use for inmates with an indication for preventive therapy according to MDOC 
guidelines is described by institution. 
According to the MDOC guidelines, directly observed INH preventive therapy should be 
offered to the following inmates: 
1. An initial skin test reaction of 1 Omm or more, if aged <3 5 years and no known recent 
exposure to TB. 
2. An initial skin test reaction of Smm or more, if HIV infected, regardless of age. 
3. A documented conversion from negative to positive skin test within 24 months of lOmm 
or more, regardless of age. 
4. A skin test reaction of 1 Omm or more, regardless of age, if recently exposed to infectious 
TB. 
For study purposes, inmates fitting these criteria were classified as having an indication for 
1NH preventive therapy. The significance of differences in rates of preventive therapy for 
inmates fitting the above categories was calculated by using category 1 as the reference 
group and assigning an odds ratio of 1.00 to this group. 
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IfINH preventive therapy was indicated but not given, reasons were ascertained from the 
medical record and grouped into the following categories: 
I. Medical contraindication (such as liver disease). 
2. Age greater than 35 years (for inmates with prevalent infection). 
3. Refusal by inmate. 
4. Other reasons 
5. Subjective decision made by physician (at odds with MDOC guidelines). 
Results 
Overall, 12% (25112,143) of inmates met the criteria for INH preventive therapy defined 
by MDOC, as shown in Table 11.1. Of these inmates, 61 % (153/251) received INH in the 
correctional system and a further 3% (8/251) had a past history of receiving INH. In 
Region 2 prisons, 69% (109/159) of infected individuals were treated, compared to 43% 
(32/75) in Region 1 prisons (OR=3.5, 95% CI= 2.38-5.15, p<0.0001). Table 11.2 describes 
rates of INH use for inmates with indications for preventive therapy, by institution. 
Of those who were eligible and received INH, 133/153 (87%) were aged under 35 years. 
Among those who were eligible but did not receive treatment, 62/98 (63%) were aged under 
35 years. Thirty percent (21/70) ofrecent converters received INH. Of recent converters 
who were not treated, 59% (29/49) were aged under 35 years. In the group that received 
INH, 62% (13/21) were aged under 35 years. 
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Record review identified a reason for lack of prophylaxis in inmates with an indication for 
prophylaxis in 38% (37/98). In the remaining 62% (61/98), a clear reason for omitting 
preventive therapy was not found. Given reasons included age over 35 years (18%, 18/98), 
subjective decision making by the treating physician (11 %, 11/98), refusal by inmate (6%, 
6/98), and medical contraindications (2%, 2/98). 
Of those who commenced INH prophylaxis, 62% (95/153) completed therapy, 14% 
(211153) did not, 19% (29/153) did not have sufficient documentation in the notes to 
ascertain completion, and 5% (8/153) were still on treatment at the time the record search 
was performed. Of those who did not complete prophylaxis, only 3/21 were due to genuine 
medical contraindications, 8/21 were due to subjective decision making by the treating 
physician, 7 /21 were due to non-compliance and 3/21 had no reason documented. 
Discussion 
Over 60% of eligible inmates received INH, which is a higher rate of preventive therapy 
than that for Victorian contacts. Paradoxically, those at highest risk, the recent converters, 
had the lowest rate (30%) ofINH prophylaxis. It is possible that there may be a delay of 
several months before referral for and commencement of INH, so that more inmates may 
eventually receive prophylaxis. This does not, however, explain the difference in INH rates 
between recent converters and inmates with an initial positive test. Nor does it explain the 
considerable variation in rates of INH prophylaxis between institutions, and the low 
threshold for discontinuing INH. 
For the majority of eligible inmates who did not receive INH, no reason was apparent. 
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Where reasons were given, genuine medical contraindications to INH were rare. 
INH has been shown to be effective in preventing TB,62' 65 and decision analyses weighing 
the risks and benefits of the drug have shown low rates of hepatitis, and clear benefits in 
life expectancy except in the very elderly (>80 years of age ).74 Another decision analysis 
found clear benefits for all CDC recommended low risk groups under the age of35 years.75 
A comprehensive meta-analysis of published studies of over 20,000 patients given INH 
according to CDC recommendations showed no deaths from hepatitis. 81 A review of 
unpublished data showed 2/202,497 hepatitis deaths, or a rate of 0.001 %.81 
The apparent haphazardness of administration of INH is similar to that seen in Victoria. 
A lack of faith in INH may be quite common, rather than being specific to any particular 
screening program.45• 47 Even though the CDC and MDOC guidelines are clear in their 
recommendations for preventive therapy, some current publications disagree with these 
recommendations and suggest a more conservative approach.191 Furthermore, many of these 
views are based on anecdote rather than evidence.193 The evidence is that if patients are 
given INH according to CDC guidelines and are monitored for liver toxicity, the risk of 
hepatitis is negligible.81 
Prison inmates once released often re-enter a cycle of poverty, drugs and crime, where even 
the best preventive health measures would fail. As such, the period of incarceration is a 
valuable opportunity to intervene and provide effective health care to this population who 
would otherwise evade standard community health measures. 
No matter how evidence-based guidelines are, a health practitioner who reads several 
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conflicting opinions about the use of INH is less likely to follow those guidelines. A case 
in point is the use of pertussis vaccination in childhood, which was clouded by the 
scientifically flawed National Encephalopathy Study.194 This study, despite been 
subsequently proven to be incorrect in its conclusions, has influenced the use of pertussis 
vaccine for decades and still continues to do so by describing vaccine-induced irreversible 
encephalopathy. Long after it was agreed that there is no scientific evidence that pertussis 
vaccine causes irreversible encephalopathy,195 providers failed to increase pertussis 
immunisation rates. A survey of the attitudes of health care providers to pertussis vaccine 
in Victoria revealed a high level of confusion and a lack of faith in the vaccine, as well as 
inconsistent immunisation practices that conflicted with the immunisation guidelines.196 
The findings of this study suggest the need for education among providers. It is possible 
that some degree of confusion and concern exists among providers about the use of INH. 
It is not uncommon for practice to lag behind current knowledge for preventive 
interventions, particularly those with controversial side effects. In the case of tuberculosis 
screening, where an effective intervention is available, it is essential that adequate resources 
are made available to the correctional system to ensure uniformly high initiation and 
completion of INH prophylaxis. 
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Table 11.1: Likelihood of receiving isoniazid preventive therapy for eligible inmates 
Eligibility criterion n INH % OR 95°/o CI 
given treated 
TST >=1 Omm and <35 167 120 72 1 
years age 
Recent skin test 70 21 30 0.19 0.09-0.32 
conversion of>= 1 Omm 
HIV positive, TST 14 12 86 2.35 0.47-15.8 
>=5mm 
TOTAL 251 153 61 
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Table 11.2: Rates of isoniazid prophylaxis for eligible inmates, by institution. 
Institution n eligible n treated with % treated Total 
INH institution 
population 
1 16 8 50 86 
2 9 0 0 74 
3 33 17 51 289 
4 43 25 58 283 
5 8 6 75 110 
6 16 10 62 129 
7 8 7 87 60 
8 28 17 61 315 
9 11 8 73 118 
10 34 23 68 254 
11 10 6 60 51 
12 5 2 40 35 
13 6 2 33 76 
14 6 6 100 43 
15 17 15 88 199 
16 1 1 100 21 
Total 251 153 61 2143 
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CHAPTER 12 
DISCUSSION 
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The null hypothesis revisited 
"Health services, policy and practice achieve maximal prevention and control of 
tuberculosis, in the most cost-effective manner. " 
The null hypothesis, as stated above was disproved in this thesis. Prevention of TB was not 
maximal, as evidenced by significant missed opportunities for prevention of TB in Victoria, 
low rates of preventive therapy in screening programs in Victoria as well as in Maryland 
prisons, and a high incidence of TB in contacts and refugees who had been screened for TB. 
Cost effectiveness was assessed for the Victorian contact screening program, and showed 
that the program as it was run in 1991 was not cost effective due to an emphasis on case 
finding rather than prevention, and poor implementation of guidelines. 
The sub-hypotheses revisited 
"The limited resources for control of tuberculosis are not maximally utilised in Victoria; 
current activities may not be cost-effective, but a cost-effective program is achievable." 
The study of cost effectiveness of contact screening in Victoria confirmed that this 
hypothesis was correct. Over one million dollars was spent in Victoria on contact tracing 
alone, and yet rates of prevention were low, as was the yield of case finding. As practised 
in 1991, contact screening was an expensive exercise but was not cost-effective, largely 
because intervention in the form of prevention was an unlikely outcome at the end of a 
sequence of screening tests. The potential outcome would have been slightly better if 
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guidelines had been properly implemented, but a large increase in cost effectiveness would 
be achieved by adopting updated, evidence-based guidelines and increasing the emphasis 
on preventive therapy. 
The findings also emphasise that in a community with a low prevalence of TB and a well 
developed health infrastructure, case-finding is an expensive exercise and should not be the 
main focus of screening. In contrast, in developing countries, where the burden of disease 
is high and the health care infrastructure is poor, the rates of detection and treatment of 
cases are low. In this situation, case finding should be the main goal of preventive 
measures,92 since the untreated pool of people with smear positive pulmonary TB represent 
a major public health problem. The natural history of untreated TB includes 50% mortality, 
25% spontaneous cure and 25% chronic relapsing disease. It is the pool of people with 
chronic relapsing disease who are the most likely to transmit TB in a community. Figure 
12.1and12.2 compare the pool of people with chronic TB in a developed and developing 
country. The developed country data are drawn from Australia, which has about 1000 new 
cases of TB annually, over 97% of which are diagnosed 39 with less than 3% (30 cases) 
being relapsed or chronic TB.1 The developing country data are drawn from Pakistan, which 
has 
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Figure 12.1 
Proportion of untreated new cases of TB contributing to the 
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an estimated 210,000 new cases each year with only 25% ever being diagnosed.197 Even if 
all the diagnosed cases are effectively treated in Pakistan, of the remaining 75%, there 
would still be about 40,000 cases of chronic, relapsing TB in the community. Comparing 
Figures 12.1 and 12.2 shows that in Pakistan, which has a large case load of chronic TB, 
focusing on case finding would have a large public health impact. In contrast, in Australia 
which has a small load, the public health impact would be minimal. This emphasises the 
findings of Chapter 5, that case finding is not an appropriate or cost-effective primary aim 
in a developed country. 
"Preventive therapy for tuberculosis is underutilised in many settings, including Victoria, 
Australia and Maryland, USA." 
"Recommended guidelines for TB control are not implemented in a systematic fashion." 
The lack of adherence to screening guidelines and the inadequate use of preventive therapy 
were problems common to all screening programs. In the contact screening program, only 
22% of all eligible contacts received INH. A higher proportion of eligible refugees (59%) 
received INH. In Maryland prisons, 63% of inmates with an initial positive skin test 
received INH, compared to only 30% of recent skin test converters. It appears paradoxical 
that recent skin test converters, who are theoretically at greatest risk, and for whom 
preventive therapy is indicated according to the MDOC guidelines, were the least likely to 
be offered INH. 
Although under-use of preventive therapy in different settings has been reported in the 
literature85-88 this is a poorly studied area. The low rates of preventive therapy and the low 
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threshold for discontinuing it once started, suggest that confusion and fear about the use of 
INH may be prevalent, and that there is a need for education of providers. 
The poor implementation of guidelines applied not only to recommendations for preventive 
therapy, but to all aspects of screening including the initiation of contact screening and the 
application of screening tests. In Victoria, for example, although the guidelines 
recommended that all contact screening be completed within four weeks of notification of 
the index case, 43% of contacts had screening initiated later than four weeks after 
notification. In addition, the same guidelines recommended that all contacts under the age 
of 35 should receive a TST, but only 52% of contacts in this age group actually did. A 
study of a screening of children for TB in the US found that only 22% of physicians adhered 
to the American Academy of Pediatrics recommendations for screening.45 Another study 
in Canada found that the cost effectiveness of a screening program for high risk students 
was reduced by poor participation and poor rates of prescription of INH. 47 This problem 
has been described in several countries, in many different screening programs, suggesting 
that it may be quite common. 
"Some aspects of screening guidelines used in Victoria were not evidence-based For 
example, that the current cut-off points for defining infection with TB (in Victoria) are too 
specific and have low sensitivity; and that the use of mass CXR screening of contacts is 
costly and has a low yield." 
The guidelines used for contact and refugee screening in Victoria are not well supported by 
scientific rationale and exclude a large proportion of individuals who are at high risk. The 
use of cut-off points of 20mm post-BCG for defining infection, as illustrated by plotting the 
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skin test distributions in the study populations, is not sensitive enough to identify a large 
proportion of persons at risk. In Chapter 3 I showed that incident cases of TB occurred in 
recent contacts with skin test reactions of 5mm or more, and that only 2/8 cases occurred 
in contacts with TST reactions of 20mm or more. In refugees, incident cases occurred in 
people with TST reactions of 1 Omm and more, and only 2/6 cases occurred in people with 
reactions of 20mm or more. 
The historical rationale for using a 10 TU dose for skin testing in Victoria is also unclear. 
It is likely that Danish data from 1955198 were used to determining appropriate cut-off points 
in Australia. However, these data showed that using 1 OTU of Danish tuberculin, the 
prevalence of pulmonary calcification on CXR rose sharply at 8-9mm of reactivity, so the 
choice of a 20mm cut-off point in Australia to define infection in persons who have 
received BCG does not appear to be evidence-based. Studies have shown that past BCG 
vaccination does not influence TST reactivity in populations with high levels of exposure 
to TB, 101 so that the application of a 20mm cut-off point for South-East Asian refugees with 
a history of BCG vaccine is unsupported by evidence. 
Studies of dose response to tuberculin have shown that there is little advantage to using 
doses larger than 5 TU, and that in fact using higher doses may elicit more false 
positives.154• 159 In view of the widespread past use of BCG vaccine in Australia and the high 
rates of non-tuberculous my co bacterial exposure in some states, the use of 1 OTU does not 
make biological sense. 
In addition, the guidelines do not recommend directly observed therapy (DOT) for all 
patients. In 1991, as shown in Chapter 2, only 2% of all patients received DOT. Many 
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studies have shown that compliance with TB therapy cannot be predicted.156 Non-
compliance is not related to socioeconomic status, educational level, gender, race, severity 
of illness, medication side effects or the patients understanding of the disease. 156 
Furthermore, directly observed therapy (DOT) is proven to be superior to supervised, un-
observed therapy and has been shown to reduce the rate of relapse and drug resistance. 199-201 
In the face of such evidence, the World Health Organization (WH0),92 The NH&MRC 202 
and the Centers for Disease Control83 all recommend DOT for all TB patients. 
In the Maryland prisons, the guidelines used were well founded and evidence-based. The 
CDC guidelines, upon which the MDOC guidelines are based, have also kept abreast of 
changing evidence and evolved over time.61 • 150 The MDOC guidelines differ from CDC 
guidelines in that they define "infection" as a TST reaction of 5mm or more. The rationale 
for this is the high (9%) prevalence of HIV infection in inmates ofMDOC,180 together with 
the fact that HIV testing is voluntary, with only 30% agreeing to testing.180 The MDOC 
guidelines recommend defining infection as a reaction of 5mm or more for all inmates 
because the risk of TB in an HIV infected person is perceived as greater than the risk of 
giving preventive therapy to a non-infected person, and because in 70% of patients the HIV 
status in unknown. This recommendation, however, is empirical rather than evidence-
based, and would result in a large number of HIV-negative inmates with false positive TST 
reactions receiving INH preventive therapy. In practice, however, this did not happen. 
There was a wide variation in adherence to guidelines and in rates of preventive therapy. 
"A significant proportion of cases of active TB which occur may have been preventable." 
I found a high incidence of active TB at follow up among screened contacts, which suggests 
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that prevention was not optimal. This was confirmed by examining the features of each 
incident case for both refugees and contacts, which revealed a high degree of preventability 
in retrospect. If the definition of "infection" used in guidelines are not sensitive enough to 
detect people who are truly at risk, then opportunities for prevention are missed. At the next 
level, if guidelines are not followed, and skin testing is not carried out for people with an 
indication for it, more opportunities are missed. At the final level, if persons who are 
eligible for preventive therapy do not receive it, or do not complete it, opportunities are also 
missed. The studies of contacts and refugees confirmed the finding of a high rate of 
preventability of notified cases of active TB. 
These are not passive opportunities for prevention which are missed, but opportunities 
arising from active (and expensive) screening for TB. The purpose of screening, which is 
a resource intensive process, is to identify infected individuals and implement preventive 
strategies. As shown in Figures 12.l and 12.2, case finding should not be the primary aim 
of TB screening in a low prevalence country with a well developed system of health care 
delivery. In practice, however, case finding was the major emphasis in the Victorian 
screening programs. 
From data to action: public health outcomes of this research 
For the Victorian contact and refugee programs, the recommendation that more sensitive 
skin test criteria be adopted, that age should not be considered for contacts of TB when skin 
testing or offering preventive therapy, that CXR screening needs to be rationalised, and that 
contacts of non-infectious TB need not be screened en masse, have been accepted and 
adopted. These data contributed to significant revision of the screening guidelines in 1994. 
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It would be prudent to conduct a follow up study of the application and impact of these 
changes. 
In Maryland prisons, it was recommended that efforts be made to standardise preventive 
efforts across different prisons, and to prioritize TB control measures according to the level 
of risk of the prison. Crowding is not a risk factor which is readily amenable to change. 
Political directives in the US are to increase the number of prisons and the number of 
incarcerations, so that crowded inmate conditions are likely to become worse. My study 
suggests that despite this, maximal use of preventive therapy can diminish the risk 
associated with overcrowding. This is a contribution to new knowledge the field, and 
resulted in measures being taken to improve education of providers within the prison 
system. 
Guidelines used by screening programs are variable. In the case of Victoria, there was no 
convincing evidence or data for the use of their screening guidelines. This study provided 
sound data for decision making and impacted favourably on the revision of guidelines. This 
in itself is a public health exercise which proves that long standing policies should be 
questioned for validity, and if those policies are not supported by evidence, the collection 
of required evidence for change is indicated. The major problem faced by the screening 
programs studied, however, is not a lack of policies, but a failure to apply structured 
guidelines in the practice of prevention. In the case of Victoria, this is partly explained by 
factors extrinsic to the TB program, such the devolution of TB services in the 1970s and 
1980s, and lack of adequate resources and support for TB program staff. There is, 
nonetheless, considerable opportunity to improve the outcome of screening, which should 
not be carried out unless there is a commitment to intervention that makes a positive public 
256 
health impact. Screening without an end point of change in outcome is not good practice. 
In the case of TB, intervention in the form ofINH preventive therapy is available, and as 
such, should be used. 
This thesis demonstrates innovative new ways to use available data to influence public 
health practice. I used existing data from diverse sources such as the Victorian school 
children's skin testing program, the Victorian government contact and refugee screening 
programs and Maryland prison screening program, without using large research grants or 
significant resources or personnel to collect de novo, prospective data. This simple, 
practical approach resulted in useful public health information which has driven policy 
changes. The cost-effectiveness study was a new approach to demonstrating the problems 
of the existing Victorian contact screening program in a convincing manner and to 
illustrating a simple, evidence-based alternative. 
This thesis highlights the importance of evidence based public health practice, and 
demonstrates that even longstanding, entrenched policies may not be evidence based and 
should be assessed for their scientific merit. Evidence based practice of public health is 
necessary to ensure high standards and consistency of care. This thesis has demonstrated 
that existing policy should be evaluated periodically for appropriateness. The evidence that 
drives policy can change with new scientific developments and changing disease 
epidemiology, as shown in this work - public health policy should be viewed as an evolving, 
dynamic process rather than a static one that should never be challenged. 
Even the most appropriate guidelines are of no value, however, unless they are 
implemented. This thesis has explored a poorly studied area, the implementation of public 
257 
health policy, and demonstrated some universal problems related to the use of isoniazid 
preventive therapy and reluctance of providers to follow recommended guidelines. 
The final significant contribution to knowledge made by this thesis is the demonstration of 
a simple, inexpensive methodology for systematic evaluation of policy, practice and 
outcomes of screening, utilising existing data. This methodology can be applied not only 
to other TB screening programs, but to any public health screening or preventive programs. 
Most programs, such as breast cancer or cervical cancer screening programs or childhood 
immunisation programs, could be evaluated in the same manner, summarised in the 
following steps. 
1. Is the existing policy evidence-based and rational? 
2. Is it implemented systematically? 
3. What are the actual outcomes of the process in terms of disease prevention? 
4. How do actual outcomes compare with expected outcomes? 
4. Is it a cost-effective process? 
4. Can it be improved in a cost-effective manner? 
Such an evaluation can drive evidence-based change in policy and lead to more efficient and 
cost-effective public health practice. 
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Missed opportunities for prevention of tuberculosis 
in Victoria, Australia 
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---------------------------------SUMMARY 
SETTING: Victoria, Australia. 
OBIECTIVE: To ascertain missed opportunirics for pre-
wntion in all persons notified in 1991 to the state regis-
try with· actM: tuberculosis (TB), and to examine as-
pects of case management rdcvant to pRYeDrioa. 
DESIGN: A dcscripriw: scudy. llcconls were reviewed 
for 231/236 cases of TB norificd in the state of Victoria 
in 1991. DoculllCDtation of past saeening for TB, pre-
vcntive dtcrapy, tmabllcnt of ac:tift disease and follow 
up was sought for all cases. Past saeening was defined 
as past contact screening, migrant screening, refugee 
SCKCDing and health undertakings for TB. 
RESULTS: Of the 231 cases, 13 wen: Dot confirmed to 
have TB. Of the remaining 218 cases, 78% were foreign 
born, and of these, nearly half were diagnosed within 3 
years of arriving in Australia. Nearly half of all cases 
(971218) had some form of past saeening for TB. The 
THE PRIMARY AIM of a tuberculosis programme 
is control of the disease. The most imponant strategy 
in controlling the disease is prewntion. P.revmtion of 
cases can be achieved by two strategies: 6rsdy, reduc-
ing the risk of new infection, or secondly by pl'C\'Cn-
tion of disease in those already infected. Reducing the 
risk of new infection can be achieved by early diag-
. nosis of infectious tuberculosis (TB) and prompt treat-
ment, thereby reducing the period of infectivity and 
the risk of transmission to others, as well as by im-
proved infection control procedures. In addition, BCG 
vaccine is up to 50% effective in preventing TB in 
susceptible persons. l In the Australian population, 
where the incidence of tuberculosis is relatively low, 
mass BCG vaccination is not a cost effective measure. 
Screening and surveillance should be carried out 
only if intervention is possible and probable, and if 
intervention results in public health benefits.2 This is 
a basic principle of public health practice, and should 
be adheted to if screening resources are to be used op-
timally. In the case of tuberculosis, intervention in the 
most common type of screening was refugee and mi-
grant screening (45/218, 21%) followed by tubcn:ulosis 
health undertakings (25/218, U%) and contact screen-
ing (15/218, 7%). Of those with past screening, 70% 
(68/97) had a positive screening result at the time. 
Amoag these, the first screening episode resulml in the 
diagnosis of active TB in 5168, and TB infection in 
63/68. In the latter group only 5% (3/63) received pre-
ventive therapy. 
CONCLUSION: ThCR are significant missed opportuni-
ties for prevention in Victoria, particularly in the foreign 
bom cases who receive scrccning on entry into the coun-
. try. For sCRCOing to be a meaningful cxcmsc, preventive 
therapy should be used where medically indicated. 
KEY WORDS: tuberculosis; sc:rccning; preftntion; epi-
demiology; missed opportunities 
form of prevention is possible, and thaeforc saeen-
ing and surveillance arc of practical value. 
In those instances where TB infection is identified 
by screening, treannent is available to prevent the de-
velopment of active disease. Thae is general consen-
sus that the benefits of preventive therapy outweigh 
any potential risks in persons aged under 35 years • 
lsoniazid-associated hepatitis is a known risk factor 
in persons aged over 35 years;l h~r studies have 
shown that even in this age group where exposure to 
TB is known, the benefits of isoniazid may outweigh 
any potential risks. 4 Furthermore, a review of deaths 
previously attributed to isoniazid revealed no definite 
relationship betwttn isoniazid and fatal hepatitis. s 
Despite this, doubts still remain as to the safety of iso-
niazid in many practitioners' minds, a factor which 
may be imponant in under-use of the drug in prewn-
tive therapy. 
In Australia the best strategy is to identify those 
who are known to be at high risk and use preventive 
therapy for infected individuals. Each state in Aus-
Correspondence to: C. R. Madntyrc, 4 Laura St., Boronia Park, NSW, 2111, Australia. E-mail: raina@peg.apc.org. 
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tralia runs its own TB control programme and has its 
own guidelines for screening. There are also national 
guidelines, which may differ somewhat from state 
guidelines. In Victoria, the second most populated 
state in Australia, the incidence of TB in the general 
population is 6.2/100 000, a Jigure similar to the na-
tional rate. 6 Nearly 80% of new cases of tuber-
culosis (TB) occur in foreign born persons,6 the larg-
est group of which an: South East Asian born 
persons, with a case rate of over 100/100 000 popu-
lation. 6 The interventions used by the Victorian pro-
gramme are preventive therapy or long term follow-
up with chest x-ray (OCR), but only preventive ther-
apy is of proven value. 7,8 
The major screening progr.urimes in Victoria are 
for three groups-contaas of active TB, migrantS, 
and refugees. These screening programmes identify in-
fected individuals and aim to prnmt the develop-
ment of TB in these individuals. If the programmes are 
successful, a lower incidence of active TB in those at-
risk individuals who have undergone screening could 
be expected. 
Screening provides an opportunity to prevent TB, 
and as such, the utilisation of this opponunity should 
be evaluated. Despite a low general prevalence of 
TB in Australia, we believe we can benefit from crit-
ical evaluation and improvement of our TB control 
programmes. 
AIMS 
To assess missed opponunities for the prevention of 
notified cases of active tuberculosis by identifying past 
screening efforts for TB in patients notified with active 
TB. Also to examine patterns of treatment of active 
disease in the same group and assess the importance 
of these patterns in prevention of TB transmission. 
METHODS 
We undertook a descriptive study of all cases of TB 
notified to the Victorian Depanment of Health in 
1991, in order to determine missed opponunities for 
prevention. The Victorian Depanment of Health re-
ceives notifications of active tuberculosis and runs 
contact screening programmes and post-migration 
screening of refugees and selected migrants. Doctors 
and laboratories have a statutory obligation to notify 
cases of tuberculosis to the Victorian Health Depart-
ment. Accepted cases of TB are those which are con-
firmed as belonging to M-ycobacterium tuberculosis 
complex by culture or microscopy, or diagnosed as ac-
tive tuberculosis on clinical grounds. Once notifica-
tions are received, a clinical case record is compiled 
and stored at the Depanment of Health. Cases are 
also recorded in a computerised database. Clinical rec-
ords for all cases of active TB notified in 1991 were 
studied. These records contain documentation of all 
past screening carried out in the state of Victoria. 
In 1991, 236 cases of M. tuberculosis were notified. 
The records were found and reviewed for 231/236 
(98%) of the notifications-the 5 remaining records 
were located in rural centres and could not be ac-
cessed. The diagnosis of TB was mistaken in 5.6% 
(13/231) of notiJied cases, which were subsequently 
de-notified, so that the denominator population avail-
able for the study was 218 cases. These records con-
tained case information and information on past 
contact, refugee or migrant screening in Victoria. Past 
screening in other states or pre-migration screening 
were not consistently documented, and were not con-
sidered in this study. 
Information was sought from Department of 
Health medical records on past screening for tubercu-
losis and past follow up by the Depanment of Health. 
Past screening was defined as screening in the State 
of Victoria prior to the d~lopment of active TB. 
Such screening includes contact screening following 
notification of a case of TB, post-migration migrant 
screening, post-migration refugee screening and tuber-
culosis health undertakings, all of which are carried 
out by the Department of Health. Our results do not 
include screening which occurred overseas. Migrants 
and refugees entering the country are screened by CXR 
in their country of origin. Those with active TB are 
treated prior to arrival and cannot enter the country 
until rendered non-infectious. Treated persons, and 
those with inactive pulmonary TB on pre-migration 
screening, enter Australia with a health undertaking 
known as Tuberculosis Undenaking (TBU), which re-
quires them to present to their state health depart-
ment for follow up. A TBU is not enforceable by law. 
All refugees received additional post-migration screen-
ing from the Depanment of Health. The populations 
screened in refugee screening are mainly Indo Chinese 
(Vietnam, Cambodia and Laos), and have an average 
age of 33 years.' 
BCG vaccination is considered in interpreting Tu-
berculin skin tests (TSTs), as universal BCG vaccina-
tion for school leavers was in practice in Victoria until 
1985. In Australia, 10 TU of PPD are used for tuber-
culin testing by the Mantoux method. There is no re-
liable means of distinguishing a positive TST reaction 
due to M. tuberculosis from one due to BCG vacci-
nation or exposure to atypical mycobacteria. It is, 
however, accepted in the USA that infection with M. 
tuberculosis is likely if the TST reaction is 15 mm or 
more (regardless of previous BCG) in a low risk popu-
lation or 10 mm or more in a high risk population. 7 
In the USA, however, TSTs are performed using 5 unitS 
of tuberculin. 7 
We defined infection with TB according to the Vic-
toria guidelines of the time, since preventive therapy 
was administered according to these criteria. In 1991, 
the Victoria contact screening guidelines recom-
mended skin resting only for contacts aged under 35 
years, and referral to a treating facility for contacts 
with a TST reaction of 20 mm or more, regardless of 
previous BCG vaccination; or a reaction of 5 mm or 
more in the absence of previous BCG vaccination.10 
The Victoria guidelines recommend that refugees and 
migrants aged 35 years and under be screened with 
TST, and those over 10 years with CXR. Only per-
sons with a TST reaction of 20 mm or more, or 15 
mm or more without BCG, or those with an abnor-
mal CXR, were recalled for funhcr evaluation, chest 
clinic follow up and/or preventive therapy or treat-
ment. In the Victoria recommendations, prophylaxis 
with isoniazid for contacts, migrants and refugees is 
only mentioned in relation to neonates of a culture 
positive mother, and is not othcrWise explicitly defined. 
A potentially preventable case of TB was defined 
as one who received past screening for TB, was found 
to be infected by radiographic or skin test criteria, but 
did not receive preventive therapy; or one who was in-
dicated for a skin test at the time of screening but did 
not receive one. We also examined patterns pf treat-
ment, compliance and follow up of active TB in this 
group of patients, since these patterns inftuence the cy-
cle of transmission of TB, and are therefore relevant 
to prevention. Non-compliance was ascenained by 
documentation by the supervising TB nurse in the 
medical record. 
The Australian guidelines for the treatment of ac-
tive TB recommend standard six-month treatment 
with four drugs or nine-month treatment with three 
drugs, and directly observed intermittent treatment 
for specific patients or groups with suspected non-
compliance_ U The World Health Organization rec-
ommends that intermittent treatment should always 
be directly observed, and that daily treatment should 
be fully supervised in aRas with well developed pri-
mary health care services.12 
Data 1M:1C analysed using Epi Info version 5.ll Data 
were de-linked from unique identifiers during analysis. 
RESULTS 
We studied 218/223 records of cases of TB notified 
in 1991. The mean age of cases was 47 years, with a 
median of 44 years and a range of 2-91 years. There 
were 105 (48"/e) females and 113 (52"/o) males. The 
majority of ~ases (78.4%, 171/218) were foreign 
born, 18.4% (40/218) were Australian born, and in 
3.2% (7 /218) the country of birth was not docu-
mented. Figure 1 shows the cumulative percentage of 
foreign-born cases diagnosed with TB over the first 
10 years of residence in Australia. Only 27"/o were 
diagnosed after 10 years. Nearly half were diagnosed 
within the first three years after arrival-24% within 
the first year, 40"/o within the first 2 years, 49% with-
in the first 3 years and 59% within the first 5 years. 
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Figure 1 Tuberculosis in the foreign born-interval from 
arrival in Australia to diagnosis of TB (cumulative percentage of 
cases). 
Past screening for TB 
Of the cases notified in 1991, 97/218 (45%) had some 
form of past screening for TB, 100 (46%) had no past 
screening, and details were unknQWD for 21 (10% ). 
Over 21% (45/218) of the cases studied had post-
migration refugee or migrant screening, 7% (15/218) 
had past contact screening, 11.5% (251218) had been 
under a TBU and 5.5% (12/218) had other screening 
for tuberculosis. All these forms of screening had 
been carried out in Victoria. In total, 52% (89/171) 
of foreign-born cases, and 17.5% (7/40) Australian-
born cases had past screening for TB in Victoria. The 
likelihood of past screening for foreign-born cases was 
much greater (OR 5.12, 95% Cl 2.02-13.48). Over 
66% (81/122) of Asian-born cases had past screening. 
Results of past screening 
Of the 97 who had past screening, 68 (70%) had a 
positive result (either CXR or Mantoux), indicating 
infection with M. tuberculosis or active TB (see Fig-
ure 2). Only 15 (15.5%) had a negative result, and in 
14 (14.5%) the results of screening were unknown. Of 
the 68 with a positive result, 69% (47/68) had an ab-
normality on CXR and 63% (43/68) had a positive 
TST. This included 22/68 (32%) who had both pos-
itive CXR and TST. Nearly half (22/47) of the cases 
with an abnormal CXR had come into the country on 
a TBU. Of those with a negative screening result only 
8/15 had a TST, and of these 4/8 had reactions of 
11-13 mm with a past history of BCG. The remaining 
7 /15 were screened only with CXR and represent po-
tentially preventable cases had they had a TST- 2/7 
were aged <35 years at the time of screening. 
Intervention at the time of past screening 
Figure 2 describes the sequelae of positive screening 
results, whether preventive treatment was given, and 
the features of persons who did not receive preven-
tion. Of the cases who had past contact screening, 
14/15 were aged under 35 years at the time. In this 
group only 8/14.teceived TST, and only 5/8 had the 
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Figure 2 Sequelae of past screening for TB in cases of actiw TB notified in 1991. 
results recorded, all of which were >10 mm. Only 2 
received preventive treatment. 
Interval between screening and diagnosis of active T8 
The majority (71"/o, 69/97) of cases who had past 
screening presented with active TB unrelated to any 
screening or follow-up by the TB Programme. The re-
maining 28/97 cases were diagnosed during screen-
ing or follow up by the Department of Health. All 28 
had positive screening results. This represents 13o/o 
(28/218) of all notUications in 1991. Of these cases, 
20128 were culture positive, 5 w.:re culture negative 
and in 3 cases culture results were unknoWn. Only 5 /28 
were diagnosed with active TB at the initial screening 
episode, and 23/28 were found to be infected on ini-
tial screening and diagnosed with active TB during 
subsequent follow up. The exact date of past screen-
ing was documented for 92/97 cases. Figure 3 shows 
that 60"/o of cases who received past screening were 
diagnosed within 3 years of initial screening. 
Treatment of active cases 
The majority (211/218) of cases received treannent, 
treatment details were unknown in 4/218, and 3/218 
did not receive treannent-of these, 2 w.:re culture 
positive and the third had culture negative pleural 
effusion. One of the culture positive cases died before 
the diagnosis was made. It was unclear in the records 
why the other 2 were not treated. Duration of treat-
ment was documented in 66"/o (144/218) of cases: 
58% (84/144) received treatment for 6-9 months, 
and 11/144 cases (8o/o) w.:re treated for less than 6 
months, 3 of whom had extra-pulmonary TB. 
Treatment longer than 9 months was twice as 
likely to be given for cases of extra-pulmonary TB 
(OR 2.45, 1.07 < OR < 5.64, P < 0;05), but nearly 
half(23/50) of cases treated for longer than 9 months 
had pulmonary TB. Only 5123 of the cases treated for 
over 9 months had an obvious indication for pro-
longed treatment. Indications included immunosup-
pressive conditions, concurrent TB abscess and re-
lapse of disease. Details of completion of treatment 
were available for 56"/o (122/218) of cases. Of these, 
84o/o (1031122) completed treatment, and 16"/o (19/ 
122) did not. 
Perceived. level of compliance was documented in 
68% (149/218) of cases. Among these, &ank non-
compliance was documented in 17.5"/o (26/149). 
Only 2.3% (51218) of all cases received directly ob-
served treatment (Oaf). Incompletely treated or un-
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Figure 3 Interval between past saeening and subsequent 
diagnosis of active TB in 1991 (cumulatiw percentage of 
cases). 
treated past TB was documented in 8% (18/218) of 
cases. The number of drugs used to treat patients was 
documented in 95% (207/218) of cases. Almost 
equal proportions of patients were treated with 3 
(45%, 94/207) and 4 (51%, 106/207) drugs, and 3% 
(7 /207) of cases were treated with one or two drugs; 
only one of the seven had culture negative disease. 
Loss to follow up and death 
Over 15% (33/218) of cases were lost to follow up by 
the TB programme. Death was recorded in 16 (7%) 
of all cases. TB was the only diagnosis and the sole 
cause of death in only 2/16 cases-in one of these 
cases the diagnosis was made post-mortem, and in 
the other it was made 2 days before death. In 12/16 
cases there were other illnesses contributing to or re-
sponsible for death, and in 2/16 cases the cause of 
death was unclear from the records. 
DISCUSSION 
Nearly half of the tuberculosis cases notified in 1991 
had been screened specifically for tuberculosis in the 
past; this screening and follow up was instrumental 
in identifying some of the cases of active TB, but ap-
pears to have failed to prevent them. Furthermore, 
70% of those screened in the past had a positive 
screening result at the time. These represent poten-
tially preventable cases, yet only 5% received prophy-
lactic or full treatment after screening. Surprisingly, 
70% of those who did not receive treatment were 
aged under 35 years: this indicates significant missed 
opportunities for prevention at the time of screening. 
In addition, a further 8% (18/218) of cases had pre-
viously untreated or inadequately treated TB, repre-
senting further missed opportunities. 
The Victorian guidelines of the time lacked empha-
sis on preventive treatment, and focused mainly on 
screening procedures. The Australian National Health 
and Medical Research Council (NH/MRC) guide-
lines are slightly different from the Victorian guide-
lines in that they recommend as a general principle 
that only TST reactors under the age of 35 be offered 
preventive treatment, and that those over the age of 
35 be examined by CXR initially and at 6 and 12 
months.11 Yet the majority of positive reactors aged 
under 35 years were not treated, showing a failure to 
adhere to current guidelines. The potential for pre-
vention is further hindered by the likelihood that the 
guidelines are too specific, and exclude a large propor-
tion of infected, at-risk individuals. The US Centers 
for Disease Control defines contacts as being at high 
risk, and recommends TST for all contacts, regardless 
of age, as well as using a lower cut-off point to deter-
mine infection. 7 Furthermore, these guidelines rec-
ommend preventive . treatment for all infected con-
tacts, regardless of age. 7 
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If opportunities for prevention are to be maxi-
mised, then the guidelines for preventive treatment 
need to be re-assessed, and measures should be taken 
to ensure they are followed whenever possible. It is un-
likely that all 60/63 infected individuals (identified at 
past screening) were not given prophylaxis due to gen-
uine medical contraindications. A small proportion 
of these individuals may not have been treated be-
cause they were aged over 35 years, but the majority 
(42/60) were aged under 35 years at the time, and 
contraindications are even less likely in this younger 
age group. If guidelines were followed, these 42 cases 
might have been prevented, representing 19% of all 
the notified cases in 1992. If the additional 8% of 
cases who had past untreated or inadequately treated 
tuberculosis were also included this figure would be 
27%. Even more cases may have been prevented if all 
those screened had received TST, and if prophylaxis 
were recommended for older contacts. There is evi-
dence, however, that missed opportunities are not a 
problem unique to Australia: McAnulty et al. de-
scribed missed opportunities for prevention in 59% 
of 153 cases of active TB in Oregon, USA, but used 
a broader definition of missed opportunity than our 
study.14 Soresso et al. reported in Tennessee, USA, 
that only 30% of infected contacts deserving isoni-
azid preventive treatment actually received it.15 
The proportion of notified TB cases who are for-
eign born has increased steadily over the past two de-
cades, 6 such that the majority of new cases in Vic-
toria now occur in foreign-born persons. This group 
is an important target for TB control measures, par-
ticularly in the light of the fact that new cases are 
nearly seven times more likely to have had past post-
migration screening for TB than Australian-born cases. 
As such, the screening process should be seen as an 
important point of intervention, and opportunities 
for prevention should be seized. Furthermore, the 
highest risk for foreign-born persons seems to be with-
in the first three years after arrival in Australia, with 
24% diagnosed in the first year of arrival. This again 
emphasizes the opportunity for prevention at the time 
of screening, both pre- and post-migration, particti-
larly for those on a TBU. A study of the follow-up of 
migrants entering Australia on TBUs found that only 
58% complied with the health undertaking, but that 
89% of those who made contact with health author-
ities complied with the TBU.16 This indicates that 
further improvement in prevention of TB can be made 
·by improving compliance with TBUs. 
The reasons why the system appears to be failing 
to prevent cases of TB in those who have previously 
been screened cannot be answered by this study. How-
ever, contributing factors may include unclear or out-
dated guidelines for screening and prevention; prob-
lems with follow up (indicated by the fact that 15% 
of active cases of TB were lost to follow up); problems 
of following up TBUs, which are not legally enforce-
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able; and continuing hesitancy to use isoniazid pro-
phylaaically on the part of clinicians. These issues 
need to be studied in more detail-if we are to improw: 
our screening efforts. 
Patterns of drug treatment of active TB can inftu-
cncc the cycle of transmission, and are therefore rele-
vant aspectS of pn:venrion. This study shows some 
haphazardness in the treatment of active TB, with 
seven culture-positive cases treated with only one or 
two drugs, and a further seven cases having a single 
drug added to continuing treatment. Both these treat-
ment options arc known to increase the risk of drug 
resistance.17 In addition, in 15% of cases, frank non-
compliance was documented in the case notes, a 
figure which probably underestimates the true preva-
lence of non-compliance, since only the extreme end 
of the spectrum of non-compliant behaviour is likely 
to be recorded. Non-compliance and poor drug regi-
mens (particularly monotherapy or addition of a sin-
gle drug to a failing regimen) are the most important 
predictors of drug resistance.17,ll Multi-drug resis-
tance is an emerging problem in the USA and other 
de\'Cloping countries, 18,111 but has yet to be a major 
threat in Australia. The prevalence of multi-drug re-
sistant strains was less than 3% in Victoria in 1991,6 
but this is no reason for complacency. An important 
preventive strategy advocated by many is the use of 
DOf,17 which was prescribed for only 2.6% of cases. 
Our study is subject to certain limitations. We may 
not have ascertained all cases of TB; however the stat-
utory notification system is likely to include the major-
ity of cases that occur in Victoria. Tuberculosis is 
less likely than other notifiable diseases to be under-
noti6ed, particularly since notification is necessary in 
order to obtain anti-tuberculosis drugs for treatment 
in the public sector. 20 Missing screening data (such 
as for screening carried out in other states or in the 
private sector) may have led to an underestimate of 
prew:ntable cases. 
The present study indicates that tuberculosis con-
trol measUies can be improved in Victoria by maxi-
mising opportunities for prevention at the time of 
screening. The Victoria Tubetculosis programme, as 
a result of this review, changed their screening guide-
lines by adopting a more sensitive screening cut-off 
point. In addition, other aspects of the screening pro-
grammes are being reviewed, and efforts have been 
made at a national level to improve physician educa-
tion in this area. Revised recommendations by the Vic-
toria TB Programme in mid 1992 suggest that a reac-
tion of 10 mm or more in the absence of BCG, or 15 
mm or more regardless of BCG, or documented con-
version from negative to positive or of 10 mm or more 
within the test period is sutlicient to indicate infec-
tion. We conclude that even in industrialized coun-
tries such as Australia, with low rates of TB, there are 
substantial opportunities to improve TB control. 
However, these opportunities cannot be maximi~d 
without adequate resources. 
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~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~RESUME 
CADRE: Etat de Victoria en Australie. 
OBJECTIF: Preciser lcs occasions manquees de preven-
tion cha. touccs les personnes dCclaries ca 1991 au rc-
gisttc de fCtat cOm.mc tubcrculosc (TB) active, ct exa-
miner Jes aspects de la prise en charge preventive de ces 
cas •. 
SCHitMA: Etudc descriptive. Les dossiers de 231/236 
cas de tubcrculosc dCclarie dans l'Etat de Victoria en 
1991 oat &C ICYllS. Unc documentation sur un depistagc 
anterieur pour la TB, unc th&apic preventive, un traite-
mcnt de maladic active ct un suivi ont etc RChcn:hCs 
pour tous lcs cas. Un dCpistagc antCricur est defini 
commc un depistagc antericur des contacts, un depistagc 
des . immigrants. UD dcpistagc chez lcs refugies ct des 
intcnmtions de santc pour la TB. · 
RitSULTATS: Fanni lcs 231 cas dCclarCs, 13 voicnt lcur 
TB n0n confimaie. Des 218 cas rcstants. 78% sont nes 
U'etrangcr ct panni ccux-ci pres de la moitie sont diag-
nostiques dans lcs trois ans faisant suite a lcur arrivcc 
ca Australic. Pres de la moitie de tous lcs cas (97 /218) 
oat subi antmeurcment une forme ou l'autrc de depistagc 
de TB. Le type le plus courant de dCpistagc est le depist-
age des rffugies et des immigrants (45/218, soit 21%) 
suivi par des actions de sante Cll manm de tubcrculose 
(25/218, soit 12%) et par le depistagc des contacts 
(lS/218, soit 7%). Panni ccux ayant cu un depistagc 
antericur, 70% (68/97) avaient cu a l'epoquc un resultat 
positif du depisrage (infection ou maladic tuberculeusc). 
Panni ccux-c:i, le premier episode de depistagc a entraine 
un diagnostic de TB active chez 5/68 et d'infcction tu-
berculeusc chez 63/68. Dans cc dcmier groupc, 5% 
seulcment (3/63) ont ~u UDc chimiotherapic prCventive. 
CONCLUSION: On observe de nombrcuscs occasions 
manquies de prevention dans l'Etat de Victoria, particu-
lmmcnt daas lcs cas nes a Petrangcr, qui ont subi UD 
dCpistagc a Penttie dans le pays. Si l'on wut quc le dCpist-
agc soit unc action valablc, ii faut utiliscr la chimiothe-
rapic prCvcntive lorsqu'cllc est medicalcmcnt indiquec. 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-RESUMEN 
MARCO DE REFERENCIA: Victoria, Australia. 
OBJETIVO: Dctcrminar las oportunidadcs no aprovc-
chadas de prcvenci6n en todas las pcrsonas norificadas 
en 1991 al rcgisrro cstatal como casos de tuberculosis 
(TB) activa y analizar los aspcctos dd mancjo de casos 
con rcspccto a la prcvcnci6n. 
MitTODO: Estudio dcscriptivo. Sc rcvisaron las fichas 
clinicas de 231/236 casos de TB notificados en 1991 CD 
cl cstado de Victoria. Par.a todos los casos sc busc6 an-
tcccdcntcs de dctcccion de TB, tcrapia prcvcntiva, tra-
tamicntn de la cnfcnncdad activa o scguimiCDtn. El an-
tcccdcntc de dctccci6n sc dcfinio como la busqucda 
anterior de contactos, la pcsquisa en immigrantcs y rc-
fugiados y las accioncs de salud tendicntcs a dctcctar 
la TB. 
RES UL TAD os : Del total de 231 casos, 13 DO tcnian una 
confinnacion de la TB. De los 218 casos rcstantcs, d 
789k cran pcrsonas nacidas en paiscs cxtranjeros y de 
estos, ccra de la mitad habian sido diagnosticados den-
tro de los trcs aios dcspues de la llcgada a Australia. 
Alrcdedor de la mitad de los casos (97 /218) tcnian alglin 
antcccdcntc de dctccci6n de TB. El ripo mas comun de 
dctccciOn era la pcsquisa en tanto quc rcfugiados c in-
migrantcs ( 45 / 218, 21 % ), scguida de las accioncs de sa-
lud tcndicntcs a dctcctar la tuberculosis (25/218, 12"!.) 
y la busqucda de contactos (15/218, 7%). En los sujctos 
con antcccdcntcs de detccci6a, cl 70% (68/97) habian 
tcnido, a la epoca, un rcsultado posirivo de la dctccci6n. 
De estos cl primer antcccdcntc de dctccci6n habia dado 
como rcsultado cl diagn6stico de una TB activa en 5168 
casos y UDa infcccion tubcrculosa en 63/68 casos. End 
Ultimo. grupo, s61o cl 5% (3163) habia rccibido una tc-
rapia prcvcnriva. 
CONCLUSION: Sc pudo constatar quc, CD Victoria, en' 
forma significativa, no sc aprovccharon bicn las oportu-
nidadcs de prncnci6n de la TB, en particular en las pcr-
soaas nacidas en cl cxtranjcro quc habian sido somcri-
das a un proccdimicnto de dctcccion en cl momenta de 
cntrar al pais. Para quc la dctccci6n consrituya una ac-
ci6n provcchosa, dcbc USIP'SC la tcrapia prcvcnriva 
cuando csta indicada. 
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Impact of Tuberculosis Control Measures and Crowding on the Incidence of 
Tuberculous Infection in Maryland Prisons 
C. Raina Maclatyre, Newtea Kendig, Leslie Kammer, 
Susaa Bira:o, aad Neil M. H. Grallam 
FroM 17ae National Centre for Epidemiology and Population Health, 
AUJttralian Nolional University, Callberra, AUJttralia; tlie Deportment of 
Epidemiology (Sc/fo!JI of HygieM and Public Health). Johns Hop/tins 
University; and the Department of Public Safety, Mary/llnd DMsion of 
CorrectiOli, BaltiMore. Maryland 
Our aim was to determine the incidence of tuberculin skin test (TST) conversion in the Maryland 
state cornctional system. We conducted a historical longitudinal cohort study. A sample of 1,289 
inmates, incarcerated in 16"of 23 prisons, who bad a negative TST and a second test within 24 
months was selected. The incidcDce of recent conversion was 6.3 per 100 person-years. Risk facfool 
for conversion included high prison-population density (relative risk (RR.] = 2.4; 9S'I> confidence 
interval [CI], 1.5-3.8) and iocan:eration in a higher-security institution (RR = 2.4; 95'1> Cl, 
1.4-4.3). Incarceration in an institution with higher levels of i-uazicl prophylaxis (>65'1> of TST 
positives) reduced the risk of infection by 50'1> (RR = 0.5; 95'1> CI, 0.3-0.7). Crowding was strongly · 
correlated with risk of conversion (r = 0.83; P < .001), while rates of isoniazid prophylaxis initiation 
were Inversely correlated with risk of infection (r = -0.82; P < .001). In stepwise regression, higher 
prison-population density was the strongest predictor of illcreased infeqion. In a final model, 
inclusion of the rate of isooiazid prophylaxis initiation n:duced the risk associated with crowding 
(Rll = 1.4; P = .4). Annual llCRelling programs for prisons can identify rec:cnt conveniom that 
-Y not othenrise be detected. 
Jn the United States the annual incidence of tuberculosis rose 
by 20% between 198S and 1992 and has since declined by 8.7"'°' 
[l, 2). Outbreaks of tuberculosis in prisons have been well docu-
mented (3, 4), making these sites impol1ant targets for tuberculosis 
control Screening of and prophylaxis for individuals at high risk is 
recommended by the Centets for Disease Control and Pn:vention 
(CDC) as a priority method oftubm:ulosis c:ontrol [SJ. 
Chemoprophylaxis with isoniazid has been shown to be up 
to 90% effective in preventing tuberculosis in both HIV-posi-
tive and HIV-negative persons with tuberculous infection, as 
long as they are compliant with therapy, and offers long-lasting 
benefits [6-9). Although isoniazid has been associated with a 
risk of hepatitis in l %-2% of cases, the risk is negligll>le in 
those aged .e;;JS years [10, 11). Risk-benefit studies ofisoniazid 
prophylaxis have shown that-particularly if a patient is aged 
<3S years, and in many instances even in elderly patients-
the benefits of isoniazid outweigh the risks [12). 
The preva1cnce of tuberculo1u infection varies demognpbically 
in the United States. Studies have shown a point prevalence of 
2S% tubc:n:u1in skin test (TST) i:cactivily among U.S. Navyn:auits 
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in 1990, vacying 1i"om 26% among Asian reauits to 5.2% among 
Afiican..American recruits and 0.8% in white n:auits [13). The 
prevalence of tuberculous infection in prisons is higher than in the 
general population. Prevalmc.e rates of up to 2S% have been de-
scnlled in correctiooal institutions (14-18). Jn mv seronegative 
iolravcnous ckug users in Baltimore the )RVlllence was is-...o [19). 
Infectious tuberculosis in prison inmates can be spread back 
into the community [14), as well as within the prisons, and 
should be an important target for tuberculosis control. The 
factors associated with the transmission of tuberculosis in pris-
ons in the United States include the high prevalence of infection 
in the source population, lilV infection, oven:nlwding, and 
systematic rotation of prisoners. Stead [14) described conver-
sion ftom negative to positive TST status among 12% of prison-
ers exposed to infectious tuberculosis. 
While contact tracing around discrete outbreaks of tubereulo-
sis in prisons has been well described and point prevalence of 
tuberculous infection in prisoners is easily studied, there are 
few data on the background incidence of new infection acquired 
within correctional facilities. The Maryland correctional system 
in March 1992 instituted systematic annual retesting of all 
inmates whose initial test was negati'Ve. This provides a unique 
opportUnity to study the overall incidence of tuberculous infec-
tion, associated risk factors, and impact of control measures. 
Metlaodll 
Study Populatiea 
The study population consisted of male inmates of the Maey-
land Division of Correction (MD<>c): MDOC is a state prison 
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system encompassing 23 prisons contained in four regions of 
Maryland, with an average daily population of 20,247 in 1994. 
Only one prison is solely for women, who comprise 5% of the 
MD0C inmate population. The study population was selected 
from Baltimore (region 1) and Jessup (region 2), the two re-
gions that house 46% (9,308) of the MDOC population. 
The demographic features of inmates do not vary signifi-
• cantly between the four regions. In the entire population, 77% 
. ,: of inmates are African-American and 22% are white. The mean 
. ,.age of inmates is 33 years, the mean duration of incarceration 
is 74 months, and the mean turnover is 21%. 
All 16 prisons in regions 1 and 2 were included. The facilities 
studied included the intake facility; a home detention unit; S 
prerelease units; 3 minimum, 2 medium, and 2 maximum secu-
rity units; 1 combined medium and maximum security unit; 
and a solitary confinement unit 
Between 1991 and 1993 the MDOC tuberculosis program 
restructured its activities to include administration of isoniazid 
prophylaxis under direct observation, construction of tubercu-
losis isolation units, and mandatory annual skin testing for all 
inmates. Contact tracing is conducted for all cases of tuberculo-
sis, in coordination with state and local health departments. 
MDOC defines infection as a TST reaction of ;a.S mm. In-
mates with an initial TST reaction of ;;a.S mm are recommended 
for preventive therapy with isoniazid for 6 months if they are 
aged <35 years. Inmates with documented TST conversion or 
who are TST-positive and are known to have been exposed to 
infectious tuberculosis, to have HIV infection, to have used 
intravenous drugs in the past year, or to have medical condi-
tions predisposing to tuberculosis are recommended for isonia-
zid therapy, regardless of age. All inmates are offered HIV 
testing, which is voluntary. Speciai efforts are made to ensure 
that tuberculin-positive inmates agree to HIV testing. 
Stlldy Desip 
A historical cohort study of incidence of new infection ac-
quired within the prison system was performed. Inmates ·un-
dergo a TST on entry into the prison system, and since March 
1992 annual retesting has been done for negative reactors dur-
ing their birth month. Therefore, the interval between the first 
and second test may vary, which we accounted for by measur-
ing person-years of incidence. If, however, an individual's 
birthday falls within 3 months of the initial test, retesting is 
postponed until the following year. Complete .2-year foll(!w-
up data were available for inmates whose most recent birthday 
fell between August and December 1994 (inclusive). 
A systematic sample consisting of all inmates born between 
I August and 31 December (inclusive) of any year, regardless 
of when they entered the pri8on system, was selected. All 
inmates undergo annual screening or review for tuberculosis 
during their birth month; therefore, the inmates in our sample 
(n = 2,606) were due for review between 1 August and 31 
December 1994. Those with a previously negative~ un-
dergo retesting, and those with a previously positive TST are 
screened by clinical examination and chest radiography. 
Prevalence of infection was calculated only for those 
(n = 1,977) who underwent an initial test between 1990 and 
1994. A positive reaction was defined as one ;a.IO mm. If 
HIV infection was present, a reaction of ;a.S 111"1 warranted 
consideration for preventive therapy. A cohort of 1,289 individ-
uals within this sample who had a negative initial skin test and 
a second test within 24 months was studied to detennine the 
incidence of recent TST conversion. 
The dates of retesting for this cohort ranged from February 
1993 to December 1994, and all inmates had the initial and 
second test perfoimed in the same institution, while serving 
the same sentence. The following factors were used to define 
newiy acquired tuberculous infection: (l) an initial negative 
TST reaction ( <S mm) and no previously documented positive 
reactions and (2) a reaction with an increase in size (;;a. l 0 mm) 
to a second TST perfonned within 24 months of the initial test 
(a reaction of ;a.S mm in HIV-infected individuals wananted 
consideration for preventive therapy). 
Tllllereulhl Testiag Pncedure 
All inmates undergo tuberculin testing on admission to 
Maryland prisons, unless documented prior positive test results 
(most commonly from previous admissions) are available: Test-
ing is performed and read by licensed nurses by means of the 
Mantoux method, with use ofO.l mL of tuberculin containing 
5 TU (Tubersol; Connaught Lab, Swiftwater; PA). 
Data SellJ'ces ud Colledien 
Tuberculin testing data were collected from MDOC testing 
logs. These data were merged with additional infonnation from 
the correctional system database. If tuberculin testing data were 
incomplete, medical records were reviewed. Medical records 
were also reviewed for inmates with a positive TST or docu-
mented conversion. HIV testing results were matched to our 
database from the MOOC HIV testing records, and unique 
identifiers were then delinked. HIV testing is voluntary iu the 
MDOC. 
Estimates of population densities in each prison were made 
on the basis of total popul;ation and area of the prison. Estimates 
of population turnover for each prison were based on monthly 
a.chajssions, discharges, and resident populations for the time 
period studied. Three binary variables were created, and 0-1 
values were assigned to individuals according to which prison 
they were in. The cutoff points were selected as the median 
values for the variables being studied: isoniazid prophylaxis 
rates for infected individuals, >65% per prison; prison popula-
tion turnover, >30"A.; and prison population density, >9 
I, 
"I' 
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inmates per 1,000 square feet. The results of screening at the 
intake institution were significandy diffm:nt from those at the 
other institutions, so screening data for all of 1994 at this 
institution were reviewed. 
Data Aulysis 
Univariate analysis was performed with Epi-Info version 5 
(CDC) [20], with use of .,C, Taylor series 95% confidence 
intervals (Cls) for relative risks, and Cornfield 95% Cls for 
odds ratios. Multiple regression was performed with EGRET 
software [21]. Poisson regressi0n was used to analyze risk 
factors for TST conversion. The most significant increases in 
likelihood were used to select the best multivariate models. 
We computed Pearson's moment correlation coefficients 
(r values). We excluded the intake' institution in the correlation 
studies because of the unusually high conversion rates therein. 
We also excluded the solitary confinement unit, in which no 
inmate-intermingling occurs and, therefore, degree of crowding 
is not a relevant factor. 
A sensitivity analysis for incidence of TST conversion was 
performed to allow for the boosting effect, assuming a maxi-
mum of 30"/o of all positive reactions in recent converters were 
due to boosting. This figure was based on the highest incidence 
of boosting noted in the literature [22]. 
lutibltioaal Approval 
The study was approved by the Committee for Human Re-
search of the School of Hygiene and Public Health at Johns 
Hopkins University (Baltimore). This committee includes a 
prisoner advocate. 
Result• 
Demegrapltics ••d 1ilberculelis Case Rates 
In 1992, the incidence of active tuberculosis in Maryland 
prisons was 58 cases per 100,000 inmates, >5-fold the inci-
dence rate in the state of Maryland. Howevec, the annual num-
ber of cases in the MDOC has decreased from 11 . in 1992 to 
4 (20 per 100,000) in 1994. 
The sample comprised 2S-/o of the inmates of the two regions 
studied (2,606 of 9,308) and 13% of the total MDOC inmate 
population (2,606 of 20,247). The total number of inmates 
eligible for screening between August and December 1994 was 
2,606. Of these, 82% (2,143 of 2,606) had at least one TST 
done. The remainder (%3, or 18%) were excluded because no 
TST was done. The reasons for this were transfer to another 
institution (347 of %3; 75%), release or leave (107 of %3; 
23%), and refusal (9 of %3; 2%). Over 90"/o (1,977 of 2,143) 
were tested after 1990, and only 1.S% (32 of2,143) were tested 
before 1980. 
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Figure 1. Proportion of Maryland prison inmates who were tuber-
culin skin test (TST)-positive, according to duration of incan:eration 
(P < .0001). 
Within this sample of 2,143, 1,708 had a negative initial 
TST. Of these, 86% (l,466 of 1,708) underwent a second test, 
and 1,289 of these l,~6 (88%) had the second TST performed 
within 24 months. The remainder were transfcrrc4 to other 
prisons or discharged, and they were excluded. 
Of the 2,143 inmates, 72% (1,532) were housed in region 2 
and 28% (6ll) in region 1. The mean age of inmates was 33 
years (median, 32 years), and the mean duration of incarcera-
tion was 72 months (median, 42 months; nmge, <l month to 
437 months); most (77%; 1,651) were African-American, and 
22% (473) were white. Most inmates (99.5%; 2,134) were born 
in the United States, and 70% (1,492) were bom in the state 
of Maryland. Most inmates (l,393; 65%) resided in Baltimore 
before incarceration. The remainder included 7.'79/o (164) from 
Prince Georges County, Maryland; 3.9"/o (83) from Baltimore 
County; 16.S-/o (361) from other counties ii} Maryland; and 
6.6% (142) from other states. 
Prevaleace er l•fedi .. 
The prevalence of infection was 18% (358 of 1,977). There 
was no significant difference in prevalence of infection between 
region 1 (17.5%; 104 of594) and region 2 (18%; 254 ofl,383) 
(P = . 7). There was a higher prevalence of infection in inmates 
aged >3S years (33%; 212 of 651) than in those aged <35 
years (11%; l~ of 1,326) (OR= 3.9; 95% Cl, 3.0-S.O). The 
strongest risk factor associated with prevalence was an age 
> 3S years. Prevalence was also associated with a duration of 
incarceration > 10 years (OR = 2.0; 95% CI, 1.6-2.6). 
Prevalence increased significantly with duration of incarcera-
tion, from 13% for inmates incarcerated for ,.;;;12 months to 
31% for those incarcerated >10 years (P < .001) (figure I). 
Prison population density and rate of isoniazid prophylaxis 
were not associated with prevalence. Among African-American 
inmates the prevalence was 18.8% (287of1,523), and among 
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Table 1. Incidence of recent tuberculin skin test (TST) conversion 
per institution type in Maryland. 
No. of ccnvenions 
No.of No.of No.of per 100 
Type of unit units ccnvenions pcrson-yean person-years 
Home delmlion I 0 7.3 0 
Pmelease s I 19S o.s 
Minimum security 3 9 131 6.9 
Medium security 2 28 319 8.8 
·. Mediumand 
maximum 
security 9 139 6.S 
Maximum sccurify 2 18 276 6.S· 
Solitary confinement I 0 44 0 
. llltake s 9.4 53 
Total 16 70 1,119 6.3 
white inmates it was 15.6% (71 of 454) (OR = 1.3; 95% CI, 
. 0.9-1.7). 
lllddellee of Ceavenioa 
For 70 of l,289 inmates, the TST converted from positive 
to negative within 24 months. The incidence of recent conver-
sion was 6.3 per 100 person-years. To be certain that boosting 
did not significantly influence the estimated incidence of TST 
conversion, we perfonned a sensitivity analysis, ass!JD1ing that 
30-At of positive reactions in recent converters were due to 
boosting, Even with adjustment for this high hypothetical rate 
of boosting, the rate of conversion was 5.0 per 100 person-
years. 
The mean reaction size among recent converters was 15 mm. 
There were significant differences in conversion rates between 
regions and between prisons. Region 1 had a significantly 
higher conversion rate (8.5 per 100 person-years) than did 
region 2 (5.4 per 100 person-years) (RR = 1.6; 95% CI, 
1.1-2.5). Six prison facilities had no conversions; these were 
the solitary confinement unit, the home detention unit, and four 
prerelease units. The remaining prerelease unit had only one 
conversion. 
Table 1 shows the wide variation in rates of recent conver-
sion by institution type. Because of the extremely high rate of 
conversion in the intake facility, we reviewed screening data 
for all of 1994 for that institution to detenniDe if we had 
inadvertently sampled a period of unusually high incidence. In 
fact, all the conversions in the intake facility for 1994 occurred 
in just l month (September 1994), yielding unusually high 
rates in our sample. These conversions were all associated with 
exposure to a single infectious case of tuberculosis in the intake 
institution. The incidence of conversion at the intake institution 
for all of 1994 was nine per I 00 person-years, which was not 
significantly higher than the overall rate (RR = 2.0; 95% CI, 
0.9-4.8). 
Table 2 shows risk factors for conversion, determined in 
univariate analysis. In stepwise Poisson regression using all 
variables in table 2, prison population density was the .most 
significant variable (RR= 2.22; P < .001), followed by a rate 
of isoniazid prophylaxis initiation of >65% (RR = 0.44; 
P = .001), medium and maximum.security level (RR= 2.35; 
P = .01), and race (RR = 2.15; P = .03). In all multivariate 
Poisson regression models tested, rate of isoniazid prophylaxis 
initiation and population density were consisten~y the most 
significant variables when only one or the other was included. 
However, when these two variables were included together, 
rate of isoniazid prophylaxis reduced the risk associated with 
crowding. 
Table 3 shows three multivariate models (A, B, and C) ll:t-
cluding variables that were significant in stepwise testing and 
illustrates the effect of isoniazid prophylaxis initiation rates on 
crowding. In model A, prison population density is the most 
significant variable, and in model B rate of isoniazid prophy-
laxis is the most significant variable. When both were included 
in model C, both ceased to be significant, while race and secu-
rity level remained significant 
Impact ef Isolliazid Propllyluis aad Crowdiag ea Tllberculeus 
lafectioa 
Prison population density and rates of isoniazid prophylaxis 
were strongly associated with risk of tuben:ulous infection and 
varied between institutions. These variables were examined 
further to determine if tuberculous infection rates in eacll insti-
tution were conelated with the level of crowding and the level 
of isoniazid prophylaxis initiation per institution. These data 
are shown in figures 2 and 3, where each point on the graph 
represents an individual institution. 
Figure 2 shows that prison population density was strongly 
correlated with conversion rates per institution (r = 0.83; 95% 
Cl, 0.56-0.94; P < .001): conversion rates increased as popu-
lation density increased. There was also a significant iJiverse 
correlation between isoniazid prophylaxis initiation rates and 
recent TST conversion rates per institution. As isoniazid rates 
increased, conversion rates decreased (r = -0.82; 95% CI, 
-0.94 to -0.54; p < .01). 
mv Iafectio• 
Overall, 36% (774) of .the 2,143 analyzed inmates were 
tested for HIV. The prevalence of infection was 9% (70 of 
774). The prevalence of HIV infection in those aged <35 years 
was 7%, and in those aged >3S years, 12% (OR= 0.55; 95~ 
CI, 0.32-0.92; P = .02). The mean age of HIV-positive in-
mates was 36 years, and that of HIV-negative inmates was 33 
years (P < .001). In the cohort tested for recent conversion, 
398 of the 1,289 underwent an HIV test, of whom 38 (9.5%) 
tested positive. · 
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Table 2. IAcidence of recent TST conversion in Maryland prisons: univariate analysis. 
No. of Incidence per 100 
Variable conversions Person-years person-years RR 9S%CI Pvalue 
A&ican-Amcric:an race 61 858 7.1 2.1 1.1-4.1 <.OS• 
Age <35 y 44 804 5.S 0.7 0.4-1.I .08 
Pri-. population density >911,000 sq ft 40 399 10.0 2.4 l.S-3.8 <.001* 
lsoaiazid >65%' 22 S61 3.9 O.S 0.3-0.7 <.Ot• 
Region I facility 27 316 8.S 1.6 1.0-2.S <.OS* 
Prerdcase unit I 19S o.s 0.1 0.01-0.S <.OOJ• 
Medium uul maximlm security level S6 704 8.0 2.4 1.4-4.3 <.01* 
Duration of incarceration > I 0 y 10 178 S.6 0.9 O.S-1.1 .7 
Turnover > 30".4 14 213 6.6 I.I 0.6-2.0 .68 
Total 70 1,119 6.3 
• Statistically signifH:ut 
t Residence in a prisoa where ;a.65% of infected inmates arc tn:atcd with isoniazid. 
Two of the 38 in the HIV-positive group converted (5.7 per 
100 person-years) vs. 48 of the 360 in the HIV-negative group 
(14.0 per 100 person-years). This difference was large but did 
not reach statistical significance (RR = 0.41; 95% CI, 
0.1-1.60; Yates-corrected P = .26). The TST reaction sizes 
of the two HIV-positive individuals who converted increased 
from zero to 12 mm and 16 mm, respectively. The mean TST 
reaction size in converters was not significantly different be-
tween HIV-positive persons (14 mm) and HIV-negative per-
sons (14.3 mm) (P = .6). 
Discussioa 
It has been shown that the rate of active tuberculosis in 
prisons is nearly 4 times higher than in the general comrmmity 
Table 3. Incidence of recent TST conversion in Maryiand prisons: 
multivariate analysis by Poisson regression. · 
Multivariate model RR 95%CI P value 
Model A 
Race, Aliican-American 2.1 1.1-4.3 .04* 
Prison population dmsity >911,000 sq ft 2.2 1.4-3.6 <.01* 
Medium/maximum aecurity 1.9 1.1-J.S .04• 
Age <3S y 0.6 0.4-1.1 .06 
ModclB 
Race, Aftican..Americall 2.2 1.1-4.3 .OJ* 
laoniazid pmphyluis iaitiatioa ....... >65% 0.4 0.3-0.7 .001• 
Medilimlmuimwn sccwity 2.4 1.3-4.2 .03* 
Age >JS y 0.6 0.4-1.0 .OS 
ModclC 
Race, Afiican-American 2.1 1.1-4.3 .04* 
lsoniazid propllyluis Wtiation tale >6S% 0.6 0.3-1.4 .20 
Medilimlmaximwn security 2.1 1.1-4.0 .02• 
Age >3Sy 0.6 0.4-1.0 .OSl 
Prison populalion density >911,000 sq ft 1.4 0.6-3.2 .43 
• Statistically significanl 
[23]. Braun et al. showed by phage typing that intramural 
transmission of tuberculosis in prisons does occur (16], and 
Stead (14] showed that active tuberculosis may go undetected 
in prison. A study of New York state prisons identified 171 
cases of active tuberculosis between 1990 and 1991 [24]. The 
occurrence of significant transmission of tuberculosis in prisons 
is also supported by the sttong association we found between 
duration of incarceration and prevalence, with rates as high as 
31 % after I 0 years. The relationship of active tuberculosis to 
number of admissions and increasing duration of incarceration 
has been described previously [15]. 
With this background, high conversion rates would be ex-
pected in prisons. Our study found a TST conversion rate of 
6.3 per 100 person-years. A contact study in a correctional 
facility in California demonstrated a conversion rate in exposed 
employees of 6.4 per 100 person-years [4]. Another study re-
ported an initial TST positivity rate of 23%, with a 71% rate 
of subsequent conversion in initially negative reactors, among 
107 inmates residing in the same tier as an infectious inmate 
No. uf prlsooeis per 1,000 square teet 
Figure 2. Pearson's moment com:lation between prison population 
density and TST conversion rates per institution in Maryland 
(r = 0.83; 95% Cl, 0.56-0.94; P < .001). Each point represents one 
institution. 
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Figure 3. Pearsoa's moment c:oaelation between rates of isoniazid 
prophylaxis initiation for eligible inmates and TST conversion rates 
pe:r institution in Maryland (r = -0.82; 95% CI, -0.94 to -0.54; 
P < .0 I). Each point represents one institution. 
[25). In the same study, new inmates admitted to the same tier 
after the exposure period had a significantly lower rate of initial 
test positivity (13%) [25). This rate is similar to the 13% preva-
lence we have descnDed in inmates incarcerated for <12 
months, a figure which probably approximates the preincarcera-
tion prevalence. 
Crowding of prisons and rates of isoniazid administration 
were the strongest predictors ofTST conversion, but the effect 
of crowding is reduced significantly by rates of isoniazid ad-
ministration. This finding has important public health implica-
tions. The direct relationship between TST conversion and pop-
ulation density is not surprising and indicates that crowded 
conditions facilitate tuberoulosis transmission. The relationship 
of prison crowding to the transmission of pneumococcal disease 
was descnDed by Hoge et al., who found significantly higher 
attack rates in more crowded prison units [26). 
The biological plausibility of our findings is supported by 
the fact that the solitary confinement unit (where no prisoner 
iriteraction takes place) and the home detention unit (where 
inmates have access to the community and live in less crowded 
conditions) had no conversions. In addition, the prerelease units 
(where conditions are less crowded) had minimal TST conver-
sion. 
Institutions at greater risk: for tuberculosis transmission in-
cluded the intake institution and the maximum and medium 
security institutions, which have crowded conditions, daily 
prisoner intermingling, and no community access. The intake 
institution had the highest case rate of active tuberculosis and 
the highest staff TST conversion rates, and it was the only 
facility in which a staff member developed active tuberoulosis 
(unpublished data, N. Kendig). Inmates with active tuberculosis 
diagnosed in the intake institution are likely to have acquired 
their disease outside the prison system. but uninfected inmates 
in the same institution are still at high risk: of exposure during 
the initial holding perjod. 
The association of conversion with institution type, indepen-
dent of levels of crowding and preventive therapy, may reflect 
a different inmate mix in different institutions. The independent 
association of race is consistent with the findings of Stead' et 
al. [27]. 
The inverse correlation between use of isoniazid prophylaxis 
and incidence of tuberculous infection in institutions could 
indicate that a prison with high prophylaxis rates is more likely 
to have a more disciplined and systematic approach to tubercu-
losis control and, therefore, fewer conversions. The wide varia-
tion in isoniazid prophylaxis rates between prisons may indicate 
underutilization in some institutions. A study of preventive 
therapy in older contacts of infectious tuberculosis found that 
only 30"A. of infected contacts who were deserving of preven-
tive therapy actually received it [28). 
Another study found that for 59% of all patients with tuber· 
culosis reported to the Oregon health division, previous op-
portunities for prevention had been missed [29). Mehta et al. 
found a decline in the rate of preventive therapy for infected 
contacts in Tennessee, ~ping from 67% in 1979 to 37% 
in 1985 [30). With regard to tuberculosis screening, when 
effective intervention is available, it is essential that adequate 
resources are made available to the correctional system to 
ensure uniformly high initiation and completion of isoniazid 
prophylaxis. 
The incidence of TST conversion in our study is subject to 
certain caveats. For example, transient anergy or observer error 
may have contnl>uted to the occurrence of false-negative TST 
reactions on initial testing. We compared the groups with prev-
alent and incident infection to test the hypothesis that if anergy 
at the time of entry into the prison system and test failure were 
largely responsible for "conversions" (that is, the inmates who 
converted from negative to positive were actually infected but 
anergic at the time of the first test), then the demographics and 
risk: factors for the two groups would be similar. 
In contrast with those with prevalent infection, there was no 
significant difference in the incidence of infection by age group, 
implying that the risk: of negative reactors acquiring infection 
remains uniformly high, regardless of age. In addition, conver-
sion rates were significantly higher in prisons in region I than 
in those in region 2, but prevalence of infection was the same. 
Duration of incarceration was associated with prevalence (as 
expected), but not with incidence. 
This makes intuitive sense, since the risk: of an uninfected 
inmate acquiring tuberculous infection would not depend on 
duration of incarceration but on the risk: of exposure at any 
given time. Furthermore, risk: factors such as rate of isoniazid 
prophylaxis initiation and population density were associated 
with incidence but not prevalence. This suggests that anergy 
and test failure probably made only a minimal contnl>ution to 
the results. 
Boosting cannot be. excluded, since two-step testing was 
not used, but several factors suggest its contnl>ution was also 
minimal. Boosting is associated with larger initial TST reac-
tions, previous BCG vaccination, birth in a foreign country, 
and older age [31]. Our group had initially negative (0 mm) 
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TST reactions. a mean age of 33 years, and minimal prior 
vaccination with BCG, since >99".4 wen: born in the United 
States. In largely unvaccinated North American populations 
with and without mv infection, no more than 3%-5% of 
reactions of >10 mm can be attributed to boosting (31, 32). 
Boosting is also associated with past exposure to atypical 
mycobacteria, and Thompson et al. showed that residents of 
Pennsylvania had significantly lower rates of boosting than did 
residents of southeastern and western states (33]. Maryland, 
which is adjacent to Pennsylvania, is not known to have a high 
prevalence of environmental mycobacterial exposure (personal 
communication, G. Comstock). 
Higher rates of boosting (up to 30".4) in Southeast Asian 
refugees, who have a higher level of BCG vaccination and 
exposure to environmental mycobacteria [22], have been de-
scribed, but there are very few Southeast Asian refugees in 
Maryland prisons. Nevertheless, if we assumed 30% of positive 
reactions in recent converters were due to boosting, the adjusted 
conversion rate would still be 5.0 per 100 person-years, so it 
is unlikely to have had a major impact on the estimated inci-
dence in this study. 
The fact that lower conversion rates were described for mv-
positive inmates than for IIlV-negative inmates may suggest 
that the cutoff point used is not sensitive enough to detect all 
cases of tuberculous infection in the IIlV-positive group. One 
study found a significantly lower rate of TST reactions of > 5 
mm in IIlV-positive inmates than in IIlV-negative inmates of 
correctional and drug treatment facilities (34). In the MDOC, 
where HIV testing is voluntary, only 30".4-40% consent to 
testing, and mv seroprevalence is higher among inmates who 
initially refuse testing [35). 
Anonymous serosurveys conducted in the MDOC since 1985 
show a '79.4-8.5% mv seroprevalence among male inmates 
(JS). This is lower than the 21% HIV seroprevalence reported 
in a survey of prisons in 25 states [34). Studies have described 
HIV seroprevalence of 49".4-56% in prison inmates with active 
tuberculosis (16, 34). For this reason, the MDOC uses a 
S-mm cutoff point for all inmates, to define infection and guide 
decisions to treat. The rationale for this is that the potential 
sequelae of missing a diagnosis of tuberculous infection in an 
HIV-positive inmate because of a higher cutoff point are more 
serious than those of increasing the false-positivity rate in non~ 
IIlV-infected inmates. 
The annual screening program at the MDOC identified and 
treated individuals with infection that might otherwise have 
gone undetected. The occurrence of undetected transmission 
of tuberculosis in prisons has been described before (14, 17] 
and may be due to high rates of population turnover in prisons. 
For this reason, contact screening alone, in response to discrete 
outbreaks, may not be adequate for control of tuberculosis. 
Increasing incarceration rates and longer inmate senten-
ces mean that crowding in prisons is not readily amenable 
to change. Instead, a practical approach would be to main-
tain annual screening and to target the most crowded insti-
tutions for increased support and resources in tuberculosis 
control. 
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SETTING: ContaclS oftuberculosis (TB) cases are at risk 
for TB. If contact SCReDing and intervention are dfec:tive, · 
one -uld expect a reduced incidence of TB in colitaCIS 
who have been screened. 
OBJECTIVE: To measure the incidence of TB in contacts 
during a 2-year follow up. and to estimate: the prevent-
ability of incident cases. 
M ETHODSl A retro5pc:ctiw: cohort study of 783 contacis' 
screened in Victoria, Australia, in 1991. ContaclS wen: 
matched with the TB registry for the following 2 years. 
Screening records - reviewed. · 
RESULTS: The rate of TB in contaclS was 511/100000 
population/year for the first 2 years. In Poisson Rgrc:s-
sion ntodds the cmly significant variable predicting dis-
ease was skin test reaction size. Six of eight incident cases · 
were potmtiaUy preventable, with a lowest achievable in-
cidence rate of 128/100 000/year. 
CONTACTS of infectious tuberculosis are known to 
be at high risk for acquiring infection and developing 
disease. I The risk of acquiring tubettulous infection 
.inCRases with increasing closeness of contact2.l and 
with .increasing 1n7Cctiviti Of the-indei'"case,-as mea-
sured by sputum smear. 4 The aim of tuberculosis (TB) 
screening program~es is to change the natural his-
tory of the TB disease cycle by identifying infected in-
dividuals and preventing the development of disease 
in these individuals. The contact screening guidelines 
of the time state that the aims of the Victorian TB pro-
gramme in 1991 were case finding and identification 
of asymptomatic infection. In practice, however, more 
importance was placed on case finding. Regardless of 
the aim, such screening programmes utilize signifi-
cant resources. Screening and surveillance should only 
be carried out if the disease under surveillance is of 
sufficient public health importance, and if some inter-
vention and change of outcome is possible and prob-
able. S Quality control and evaluation of programme 
CONCLUSION: Contacts who underwent screening for 
TB through a state icncning proaram111e had a high in· 
cidence of TB during the 2 year follow up. Published 
rates of TB of 425-670/100 000 in untreated contaclS 
suggests that the Victorian screening programme had 
minimal impact oli the natural history of disease progres-
sion. Intrinsic programme facton such as the appropri-
ateness of the guidelines, adhettnce to guidelines and 
rates of prnentive therapy need to be evaluated. The de-
volution of the TB programme in the :t980s also reduced 
ilS dficacy. Systematic assessment of screening pro." 
grammes for efficacy and outcome is part of good public 
. health practice. · 
KEY WORDS: tuben:ulosis; screening; ·prnention;· con-
tacts; in~dence. · 
effectiw:ness is therefore an imponant aspect of screen-
ing. One possible means of cltimating the eHective· 
ness of a screening programme is to· measure the 
degree of prevention achie\led as reflected by the inci-
dence of disease in the screened population. We had 
the opponunity to study this in a cohort of contacts 
screened in Victoria, the second most populated state 
in Australia. · 
Aims 
To calculate the incidence in the first two ,.ears after 
exposure to tuberculosis (TB) in contacts of notified 
cases of TB, and to determine whether preventive mea-
sures were successful. 
METHODS 
TB is a notifiable disease in Victoria, where doctors 
and laboratories have a statutory obligation to notify 
cases of active disease to the Department of Human 
Com:spondence to: Dr C Raina Madotyre, Victorian Infectious Diseases Service, 9th Floor, Royal Melbourne Hospital, 
Parkville, Victoria, Australia 3052. Tel: (H) ( + 61 3) 9434 3423, (W) ( + 61 J) 9342 7212. Fax: (W) 61 3 9342 7277. 
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Services (DHS). Once a case is notified to the DHS, 
. nurses from a dedicated TB programme within the 
DHS initiate contact tracing and screening. 
Identified contacts of all cases notified in 1991 were 
studied in a retrospective cohort analysis. The year 
1991 was chosen because the highest incidence of ac-
tive TB within contacts is in the first 2 years after ex-
posiue, and this aJlowed for analysis within 2 recent 
years (1992 and· 1993 ). Records for contacts were 
available from both the index case notes, and from in-
dividual contact records, both of which contain con-
tact demographic details, investigations, results of in-
vestigations,. intervention and follow-up details. 
The c0ntact database was then matched with no-
tifications of aC:rive tB for the years 1991-1993, for 
24 months following the notification of each case, 
and incident cases were identified. Univariate analysis 
was. performed in Epilnfo 6,' and multivariate ·analy-
sis in Egret. 7 Poisson regression was u$ed to test like-
lihood for deveiopment of TB in contacts. The data 
in the regre5sion 01odels induded all contacts iden-
tified, regardless of the results of screening,. arld re-
gardless of whether or not they Were infected. 
UniverSal bacille Calmette-Guerin (BCG) va~­
tion of school leavers was practised in Victoria until 
1985, thus the majo.rity of the adult population have 
'been BCG-vaccinated. In Victoria skin tests utilise 10 
TU of purified protein derivative (PPD), and are per· 
formed by i:he Mantoux method. We defined infec-
tion is a skin test ieaction of 10 mm or moie in the . 
absence of past BCG· vaccination, or 15 mm or more 
with past BCG vaccination; or conversion from a neg-
ative to a positive skin test of at least 10 mm within 
3 months; or chest radiograph (OCR) evidence of in· 
active TB. These criteria are iecommended by the 
Victoria guidelines of 1994. In 1991, however, the Vic-
toria screening guidelines defined infection as a skin 
test reaction of 5 mm or greater in the absence of pre-
vious BCG vaccination, or 20 mm or more with a his-
tory of past BCG. The guidelines also recommended 
skin test screening and isoniazid prophylaxis only for 
contacts aged under 35 years. Contacts aged over 35 
years were recommended for CXR only. The ratio-
nale for this was that interpretation of the skin te5t in 
the face of a largely BCG-vaccinated adult population 
was thought to be too difficult. The guidelines also rec-
ommended screening for contacts of all notified cases 
of TB, including non~infectious (exti'a-pulmonuy) 
TB. Infectious TB was defined as pulmonary or laryn-
geal TB, and non-infectious TB as all other (extra· 
pulmonary) forms of TB.. 
We estlinateci the pieventabiiity of each case as as-
sessed. by a ntimber of factors listed below: 
'1 Tiine from notification of the index case to initia-
tion of contact tracing-if this was significantly de-
la~d, the case was a~sed as potentially pRYent-
able had contact tracing been timely. 
2 Whether a skin teSt; was done. If not, the case may 
have been preventable. 
3 Skin test rea~ion size. If the reaction was 5 Dim or 
greater, we considetcd the case potentially pievent-
able, had the guidelines of the time considered this 
an appropriate level to define infection in teceilt 
contacts. 
4 Whether a CXR was done. If not, the case may 
have been preventable (for ex'ample if a OCR had 
shown inactive TB and the case could have been 
given pieventive therapy on that basis). 
5 Whether the diagnosis of TB was made at the time 
of first screening. If so, the case was considered not 
preventable, unless there was a significant delay 
(defined as >4 weeks) in initiating screening. 
6 Whether preventive therapy was given. 
We evaluated actual practice retrospectively and 
proposed a hypothetical 'best case scenario' where an 
conditions for prevention •re maximal. For' exam-
ple, the screening guidelines could have been more 
evidence-based and suggested skin testing for all con-
tacts (regardless of age), thereby increasing prevent· 
ability by increasing identification of infected per-
sons. The screening guidelines would also have used 
Tablet Estimation of preventability of incident cases of TB 
Screened within TB 
Case 1 month diagnosed (age in of notification Skin test Reaction O<R at first INH 
years) of index case done >S nim done screening given 
' (2) y y y y y NA 
2 (42) N x NA y y NA 
(7 months) 
3 (49) N y y y y NA 
(5 weeks) 
4 (29) y y y y N N 
5 (17) y y y y N N 
6 (45) y y y y N Y* 
7 (25) y y y y y NA 
8 (20) y y y y N N 
*It was known at the time that the index caR had ~ tubemdosis resistant to lsonlazicl. 
O<R = chost radiograph;· INH c isonlazid; NA • the variable was not applicable for that c-. 
Potentially 
preventable 
N 
y 
y 
y 
y 
y 
N 
y 
Table 2 The risk of actM! TB by skin test reaction size 
in contacts 
Skin test Rate of TB 
reaction Past8CG Incident per 100 
size (mm) n (%)_ cases (n) contacts 
0-4 233 0 0 
5-9 52 72 1 1.9 
10-14 69 72 1 ·1.4 
15-19 71 73 3 4.2 
>19 29 70 2 6.9 
• BCG status documented in only 15% of nogotive reactors. 
5 mm (rather than 20 mm, as was used in 1991) as 
the cut-off point for determining infection with TB in 
recent contacts, thereby increasing the sensitivity of 
. the se«ening test. We also assumed that ideally all 
contacts would be screened in a timely manner, and · 
receive a CXR if indicated, and cominence and com-
plete preventive therapy· if indicated. 
RESULTS 
There \Wre 231 cases of TB notified in 1991, resulting · 
in 1142 contacts being identified that Jear. Of the 
notified cases, 55% (1271231) had pulmonary TB. 
Of these, 82% 104/127 were culture positive, and 
60% (76/127) were sputum smear positive. Of the 
1142 contacts sci'ecned, 68% (78311142) were ex-
posed to an infectious case, 28% (31511142) to a non-
infectious case and 4% (44/1142) to a case of un-
known infectivity. 
The majority of contacts (62%, 710/1142) were 
aged 35 years or under; 32% (365/1142) were over 35 
years and in 6% (67/1142) age was not documented. 
Fortr five percent (517 /1142) of contacts were born in 
Asia, 29% (325/1142) in Australia, 5% (5311142) 
in Europe and 4% (46/1142) in other regions. In 17% 
(20111142.) the region of birth was unknown. The 
majority (55%, 626/1142) were household contacts, 
36% (407/1142) were social contacts, 6% (63/1142) 
were school contacts and 4"/o (42/1142) were work 
contacts. The type of contact was not documented for 
411142. 
In only 42% (484/1142) of contacts could presence 
or absence of infection be determined after screening. 
In the remainder, presence of infection could not be 
determined because the CXR was clear and a skin test 
was not done. Of the 484 screened appropriately, 
42% (206/484) were infected as determined by skin 
test and/or CXR criteria. .. 
During the i-year follow-up of contacts there were 
eight incident cases of TB. All eight of the incident 
cases were exposed to an infectious index case. The 
incidence of active TB for rontacts of an infectious in-
dex case was 511/100 000 population/year for the 
first 2 years. There was no a_ssociation with age 
group-the incidence of active disease was not sig-
nificantly different in the age groups <20 years 
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(361/100000/year) and ;;;i.20 years (403/100000/ 
year, P = 0.8), or <35 years (4231100000/year) and 
;;;i.35 years (274/100 000/yeai', P = OS). Six of the 
eight cases were Asian-born. The incidence of active 
disease for Asi_an-bom contacts was 561/100,000/ 
year, and non-Asian born contacts, 1671100 000/year, 
but this difference \vas not statistically significant in 
univariate analysis (risk ratio [RR) 3.4, 95% confi-
dence Interval [Clj 0.62-24.3, P = 0.2). . · 
The incidence of disease among infected contacts 
only was i460/100 000/year. Table 1 desc;ribes ·the 
preventability of each case as assessed by a number of · 
factors, such as time &om notification of the. index 
case to initiation of contact tracing, whether a skin· 
test and CXR were done, whether the diagnosis of TB 
was made at the time of first SC11:eniilg, and whether 
preventive therapy \vas gi\ien. It shows that t-wO cases . 
were definitely not preventable, and that the remain-
ing six 'W'Cre potentially p~ntable. H_all six had been 
prevented, the lowest possible incidence rate that could 
have been achieved is 128/100 000/year for contact5 
of infectious cases. 
Skin test reactiorl size and risk of TB 
The risk of developing TB increased with increasing 
size of the reaction, as shown in Table 2. The relative 
risk of disease if the reaction size was 15 mni or more 
was 8.9 (95% CI 1.7-45). The largest increase in risk 
of disease was berwten the Categories 10-14 irun and 
15-19 mm, from 1.4% to 4.:Z%_of contacts respec-
tively. No case5 developed in contacts with reactions 
of 0-4 mm. Age, region of birth, type of contact, 
BCG status; past prophylaxis and three different skin 
test reaction size categories (>IO, 15 and 20 mm) 
were tested in stepwise regression as predictors of de-
. veloping active TB for all contacts. Only skin test re-
. action size of 15 mm or more was significant. Table 3 
shows the best Poision regression modd for ptedic-
tors of development of TB. The relative risk of infec-
tivity of the index ease was incalculable, due tO the 
zero incidence of disease in contacts exposed to a non-
infectious index case. 
DISCUSSION 
The incidence of disease in the first 2 years was 511/ 
100 000/year for rontacts of pulmonary TB, compared 
Table 3 l'oisson regression model for de\lelopment 
of actilll! TB in contacts 
Variable 
Age <35 years 
Asian born 
Household contact 
BCG vaccination 
Skin test reaction > 15 mm 
lsoniazid prophylaxis 
RR 
0.68 
0.9 
2.7 
0.6 
8.1 
1.7 
95'11. a Pvalue 
0.07-6.5 0.74 
0.15-5.5 0.91 
0.31-24.4 0.37 
0.1-3.3 0.53 
1.2-55.0 0.03 
0.24-11.8 0.68 
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to a rate of about 6/100 000 in the general Victoria 
population and 100/100 000 in Asian bom Victo-
rians. 8 The first two years after exposure to TB are 
associated with the highest incidence of disease in in-
fected contacts. There are some data in the literature 
which suggest expected rates of disease in untreated 
contacts. Exposure to a case of pulmonary TB in a US 
schoola:sulted in six secondary cases in 900 untreated 
contacts, a rate of 6671100 000/year in the first year. 9 
An outbreak in the UK describes· one case of TB re-
sulting in 16 seeondary cases in 3674 exposed, un-
treated children, a rate of 435/100 000/year in the 
lint ,ear.10 Another study compared various dura-
tions ofisoniazid prophylaxis with placebo in persons 
with inactive TB on CJCR.11 Subjects in this study, 
picked at random . times from the onset of infection, 
and followed up for five years, are not directly com-
parable with recent contacts, and would be expected 
to have a lower rate of disease. However; the study 
found a rate of 2861100 000/year in the placebo group 
during the five year follow-up, 11 a figure much lower 
than the rate of 14601100000/year described in in-
feCted contacts in our study. These and the other data, 
in the literatu1e suggest that the rate of disease in 
the Victoria contacts is dose to the rate in untreated 
groups. 
We found that 6/8 cases were potentially prevent-
able. If all six we.re prevented, the lowest possible in-
cidence rate achievable was 1281100 000/year for con-
tacts of infectious cases, a figure which may be closer 
to that expected fro!D a contact screening programme .. 
The high rate. of disease described suggests that 
screening and pICventive measures may be sub-optimal 
in Victoria. This can be attributed to two general 
factors-influences external to the TB programme, 
and intrinsic programme factors. The 1945 Tuber-
culosis Act, which resulted in a national campaign for 
tuberculosis control, was enfon:ed in Australia until 
1976. During those 30 years the Commonwealth gov-
ernment provided states with funding for TB con-
troJ.12 The Victorian tuberculosis campaign con-
tinued until 1976, after which there was a gradual 
devolution of the programme, corresponding with 
the declining incidence of TB in the country. Reduced 
funding for TB control activities in the 1970s and 
1980s resulted Di gradual devolution and decentralisa-
tion of the State-run chest clinics which were a dedi-
cated TB service, along with a reduction in their medi-
cal and nursing staff. During the preceding decade, 
we saw a change in patient mix, from a predominantly 
Australian-born patient population in the 1970s to a 
predominantly foreign-born patient population by 
1992. 8 Despite this, the programme was left with out-
dated guidelines in use since the 1960s, written for a 
different patient mix and with an emphasis on mass 
CJCR screening and case finding, and which did not 
take into account the changing medical evidence. 
Factors intrinsic to the programme can be deter-
mined only by doser study of the screening process. 
Areas for study include the guidelines for sctcening 
and prevention, how Well the guidelines are foll~, 
and rates of cominencement and completion of pre-
ventive therapy. Sorresso et al. reported in Tennessee, 
USA, that only 30% of infected contacts meriting iso-
niazid p~tive therapy actually received it. U An-
other study found that 59% of all TB patients no-
tified to the Oregon health division had previous 
missed opportunities for.prevention.H Mehta et al. 
found a decline in the rate of preventive therapy for 
infected contacts in Tennessee, falling from 67% in 
1979 to 37% jn 1985.JS We have demonstrated •ig-
nificant missed opportilnities for prevention of TB in 
a previous study, which showed that nearly half of no~ 
tified cases of TB in Victoria haYC been previously 
screened for TB.16 
Our models for risk of disease suggest that BCG 
status should not be considered when interpreting the 
risk of disease and potential benefits of preventive 
therapy in recent contacts. Studies suggest that BCG 
may not prevent iiifectiori, therefore preventiile ther-
apy may be beneficial for vaccinated, infeaed dose 
contacrs.17,18 Our results also suggest i:hat the use of 
a 20 mm cut-off point to define infection in those who 
haw had past BCG is not sensitive enough, and ex-
dudes the majority of contacts at risk. A 15 mm cut-
off point, regardless of BCG vaccination, may be ap-
propriate fur recent contacts, but not necessarily for 
other forms of population screening. A 15 mm ·cur-off 
may still exclude some at-risk contacts and may in-
clude some people who are not at risk. The process 
of choosing a· definition of inEection always involves . 
a trade off between sensitivity and specificity, and 
the appropriate cut-off point varies depending on the 
population being screened.19 Our finding of inCICas-
ing risk of disease with increasing skin test size re-
flects the higher prevalence of true infection with 
Mycobacterium tuberculosis in per5ons with larger 
skin test reactions. 
In our study isoniazid prophylaxis did not signifi-
cantly predict risk .of disease. A possible reason for 
this is the law number of individuals who receiYCd pro-
phylaxis. Our study also suggests that screening all 
contacts of non-infectious cases may not be the best 
use of resources, since all the incident cases were ex-
posed to infectious TB. In Victoria nearly one third 
of resources were expended in tracing and screening 
contacts of non-infectious cases of TB. The use of an 
age cut-off of 35 years, along with region of birth, 
whilst associated with infection rates, did not predict 
the ·risk of disease in recent contacts in our study. We 
did not examine the effect of age by more specific age 
groups, but the risk of active TB has been shown to 
be higher in YCry young children.20 
New TB programme management_ in 1994 led to 
significant changes in the Victorian contact screening 
guidelines in that year, and the data presented in this 
study ~re used to support these changes. These in-
cluded adoption of more sensitive skin test criteria for 
defining infection, skin testing for all contacts regard-
less of age, and recommendation of preventive ther-
apy for all infected recent contacts, regardless of age. 
The i:onsideraMe resources expended in tubercuio-
sis screening programmes, and the changing epidemi-
ology of tuberculosis, makes periodic programme eval-
uation imperative. This study provides some useful 
data to contribute to decision making, but programme 
performance cannot be systematically improved with-
out detailed data on each level of programme opera-
tion. These data will be presented in a subsequent 
study. In addition, it is vital to consider the impact of 
political and structural changes on programme perfor-
mance and efficacy. 
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cas nouveaux sur buit auraient pu eR prevenus, d'ou un 
taux d'incidence minimum accessible de 128/100 000/an. 
CONCLUSION: Chez les sujets-contac:t soumis .a un 
dcpistage de la tuberculose dans le cadre d'un pro-
gramme gouvcmemental, l'incidtna: de la tuberculose 
fut Bevec pendant un suivi de dcux ans. Les taux publics 
de tuben:ulose (elltre 425 ct 670/100 000 cbez les con-
tacts non trait&) suggerent que le programme de dCpis-
tage de l'ctat de Victoria n'a eu qu'un impact minime sur 
l'histoire naturclle de progression de la maladie.. Des fac-
teurs intrinsequcs du programme, comme d'ad~quation 
des directives et le taux de traitement preventifs, doivent 
eue evalu&. Les restrictions du programme antitubcr-
culcux pendant Jes annees 80 ont cgalement uduit son 
cflicacit~. I!'cvaluation systanatique des programmes de 
dq,istage en a: qui conccme leur eflicience et leurs usul-
tats font partie d'unc bonne pratique de santc publique.. 
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~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-RESUMEN 
MAllCO DE REFEllENCIA: Los contactos de tubc:rculosis 
corRD d riesgo de pRSCDtar una tuberculosis (TB). Si 
la detcccion de los cnntactos y las intervenciones son 
efecdvas, poda11os espcnar reducir la iJJcidenda de la TB 
en los contactos que han sido deiectados. 
OIJETIVOS: Medir la iJJcidencia de la TB en los contac-
tos durante llll seguimiento de dos aiios y estimar la po-
sibilidad de evirar la aparicioa de casos entre dlos. 
MCTODO: Un estudio de cohorte rctrospectivo de 783 
contactos cletectados en Victoria, Australia ea 1991. Los 
coatactos fueron confrontados con el rcgistro de TB por 
los siguientcs dos a~os. Se rcvisaron los RgistlOs de 
detecciOn. 
RESULTADOS: La tasa de TB en. los contactos fue de 
511/100 000/aiio para los primems dos aiios. En los mo-
delos de regresi6n de Poisson la sola variable significa-
tiva de pn:dicci6n de enfermedad fue d tamaiio de la 
rcaccion dd test cutaneo. Seis de los ocho casos de inci-
deacia eran evitables potencialmente, lo que da una tasa 
de incidencia minima alcaazable de 128/100 000/aiio. 
CONCLUSION: las contactos somcddos a detecci6n de 
TB a trav& de un programa de detecci6n esratal tuvieron 
una incidencia de TB alta durante d seguimiento de dos 
aiios. La tasas publicadas de TB de 425 a 670/100 000 
en los contactos no tratados sugierm que el programam 
de detecci6n de Victoria tuvo no minimo impacto sobre 
la historia natural de la progresi6n de la enfermedad. Se 
deberin evaluar factora intrinsecos tales como nonnas 
adecuadas, la adhesion a las mismas y las tasas de te-
rapia prcventiva. El desatrollo rctr6grado del programa 
de TB en los aios 80 redujo tambiin la eficacia del pro-
grama. La sistematica evaluac:Wn de los programas de 
detecci6n en cuanto a SU eficada y n:sultados SOD parte 
de una buena practica de la salud pubHca. 
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Missed opportunities for prevention of 
tuberculosis in Victoria 
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Introduction: Despite a low incidence of tuberculosis (IB) in 
Australla. there are opportunities to Improve and enhance 
screening, surveillance and prevention. If current screening 
programs are successful, we would expect a low incidence of TB 
In those who have undergone screening. The aim of this study 
was to assess missed opportunities for prevention in people 
notified with active TB. 
Methods: A descriptive study of all cases of TB notified to the 
Victorian Health Department in 1991. Records were reviewed to 
ascertain past screening for TB in Victoria. specifically. contact 
refugee and migrant screening, and follow up for tuberculosis 
health undertakings (IBUS). Infection with TB was defined as a 
PPD skin test result of lOmm or greater without a past history of 
BCG, or 15mm or greater with past 8CG vaccination. Results: We 
reviewed the records of 218/228 cases notified in 1991. The 
majority of cases (171/218, 78%) were foreign oorn. Nearly half 
were diagnosed with TB within three years of arrival In Australia. 
OVer 44% (97 /218) had past screening for TB - 21 % (45/218) had 
post-migration refugee screening, 11.5% (25/218) had been 
followed up for a mu. 7% (15/218) had past contact screening 
and 5.5% (12/218) had other types of screening for TB. Of those 
screened in the past 70% (68/97) had a positive screening result 
at the time. either with CXR. PPD test or both. Of those with a 
n'egatlve screening result only 8/15 had a PPD test Indicating 
potentially preventable cases had they been skin tested. When a 
positive screening result was present only 7% (5/68) received 
preventive therapy. and over half of those not treated were aged 
under 35 years at the time. OVer half (59%,40/68) of those with a 
past positive screening results presented with active TB unrelated 
to any follow up by the Health Department and 41 % (28/68) were 
Improving Aboriginal and Torres Strai 
Islander childhood immunisation 
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Adequate Immunisation coverage is a public healt 
endeavour that will impact on the still unacceptab 
high morbidity and mortality rates of Aboriginal a1 
Torres Strait Islander children. 
Diversity in national Immunisation law. policy and 
practice. and historical precedents for the deliVery 
Immunisation services, has resulted in a system 
without co-ordination of immunisation services 
delivery. 
Prevalence of adequate immunlsatton within 
Aboriginal and Torres Strait Islander communlttes 
varies dramatically. both between and within stat4 
Some rural and remote communities have achieve 
nearly 100% coverage. other rural, remote and 
urban locations have very low rates The challenge 
to Identify successful strategies and to Incorporate 
these into the delivery of immunisation services to 
Aboriginal and Torres.Strait Islander people. 
Funded by the National Childhood Immunisation 
Program (NCIP), the Department of Public Health 
and Tropical Medicine (DPHTM), James Cook 
University: 
• undertook a national audit of the training 
opportunities for health workers providing 
Immunisation services to Aboriginal and 
Torres Strait Islander children, and 
identified with active TB during follow up procedures. Perceived • determined current practice. Including the 
Impact of State law and policy on the delM 
of immunisation services to Aboriginal and 
Torres Strait Islander children. 
level of compliance with treatment of active disease was 
documented In 68% (149/218). Among these. non-compliance 
was recorded In 1Z5% (26n49). OVer 8% (18/218) had 
incompletely treated or untreated TB In the past Overall, only 51 
218 cases received directly observed therapy. and 33/218 cases 
were lost to follow up. This study raises Important Issues: 
• of improving accesstblltty to immunisation Conclusions: Substantial opportunities for prevention of TB are 
missed in Victoria. Nearly half of notified cases are specifically 
screened for TB prior to presenting with active disease. Screening • 
and follow up were instrumental In identifying some cases of. 
acttve TB. but appear to have failed to prevent them. For · 
screening to be successful Intervention must follow in the form of • 
preventive therapy - this ts an area which can be improved In 
Victoria Guidelines for and practice of screening and prevention • 
need to be reassessed If preventive opportunities are to be 
maximised. 
services; 
the role of Aboriginal and Torres Strait 
Islander Health WOrkers In Immunisation 
practice; 
mechanisms for accredltatton of immunisat 
training, and 
The co-ordination of lmmunlsatton services 
EXPOSt/RE TO INRCTIOOS TUBERCULOSIS IN PPD SKIN TEST 
COl'IVEllTER.S IN MARYLAND PRISONS. 
"'n'n'nCR (mjjsN J LBjpmS GgbwNJ 1JGhnsHopkinsUnivcnity, 
'Motyt.ndi>¢of~· 
We havullreody described *ia lat canvasion of6.lll00 pers9-years ill Moryllncl ~ 
inmates. We aimed lo detaminc wliether lhese inmall:s bid idallifioble exposun lo 1B 
wilhin die prison system. There were 70/1,289 imnales whose skin latcanvalcd within 24 
months, beCwcen 1992·94; All cases of.infectious 1B in inm11es dilpoaed beCwcen 3191 
and 12194 w..., idcnti6ed. A!l inmafle movemeals widlin die c:onectimalsystem.were used 
lo asccnain wbcdaer con~ were exposed. to ~· at any time !Je!ween die. lint and 
second P!'D lest. !lxposun - •!&ssified. probable; possible and unlikely. 111,onler to lat 
die hypadiesis that inadveitPt-issiOnot.TBocc:un due lo bighimmllo-. we 
matdlcd all"""*" disc:blrged 6-die ~system after JaDuary 1992 (1!'!34,331} wilh 
all ~ of1B notified"! die ~iancl ~of ffe!l\!h .t: ~ Hyp TB 
~.iBJ~.(n-;3'3).~w..., 13~11f~TBwithin\l!Oprisons,idealijiecl 
during the stu4y peJiocL Of~ 6113 o~ in. !he .... instill\!iOll, :The~ ~idi 
oa:umd ill ihii .. ~were all diagDosed widiin 2 llllllllhs Of~ilig !lf!iaittcd. 'Jhe 
Relati.w ~(or~.·'ljl ii\dle~ ir.stilutioa-9.89,(9S%CI3JJ.29:J6).p<O.OOQL .. 
For· .· 'conWrim,~' · · W.S,._._.ilialJ%, · 'ible~'lnlo%iiDcf' un~~ili~a=S%~-=ld'*.be~vh 
identi6ed 4 • cl$es !If~ m llOlified 1o die .S!llC in· 199,4; m lnmatOs distliargcd. 
after 1992 (12/i00,000).'ThOse indMduals weie DOI bowillo bavetubcmllosis wbilst 
incareeraied; and al 1eut """ was Jikefy lo have beea infedicius prior'to disdWge &om 
prisoa'.'ForlbiliiajorityofRCeiitskin test Cc!nvenm. ~to u.c.caausTB ccluld not 
be icleillified. 11Us may ~ that ltansmission ·~ Undetected due to high prison 
populatiOii'lllmOYer. This is sUppon=I by the finding of c:ases of iafeetiOU$ TB which were• 
undiaposc4 during incarceqtio!'-
lhio --• -"" 
CUlllCALAllBllAilloclt.\rmc nasi!HtA,._ WrLBUllAL Tll-=tlUllllfi 
A.a--. 0 •. Cm6; ll ~. A. Floies. 1. IJaca, 1. o-Jlc:z. Helpilll Yai...atario "fl<. 
1.E.~,UANL,-..,Y,Ni..~ · •..• ,. .. 
PleuDI  (PT!J) is .. _ -...--.c~ ~· 
(111}.' our · - IO da<ril>e tiac diaical ~ .cllii9 ..._,;,, ..... 'Witll a liiah 
...ma-i::'rii""w.a.: tUt is .... Ol'lbc ladiog ....... lif pkuni ...... All aftlle induded 
pdiellb Jiod ~ • a ,..,...,biopsy, ~'llilt.' o.;y iBut 1im· citliior a posili.C 
.;... (AFB) or ..... Car M. ........., .... ~with....._ -
Clinical doott, filei'eiod .-X.ftywaeim&Wodin....Y-. DSllLTS: 
S4 -·-.. - (moJo.34.Q.!1%. -211137.1''). A- 11pwu 42;S yean 
(millilllum-17, ..-.00). 27 cases. 50%, llad a lllMledyiq ..iitiaa; akalool obuse woos 
die-- 21 --- illillal .,.._. - ...... plin(ll/46.3%) ud 
cough (121222'6). 'Ille·-~ wu 74...,. (-4-lfiS). Syinplamt iqata!Jli•no: 
....,. {'lsn4.1%). °"""' (42f17:7"). r1iest p.u. (42177.7"). .-;. <~·!"l. '!"'igllt 1oss 
(40f74.1%), aight - .~1.9%), .. ~ (27~), ....- (Ill.~). hanoplylis 
(ill.~). llionx~,liadiooP-~llles wiilipi.iiiol dliolioa ia.47117". CloatX~ 
ny liadiop: 11111% of .. ._. - pleuial ellluiiooi; rigid 1!1153.7"; left' 23142.5%, 
liiJali:nl 2/l.8" Size ofdoeCftlulioa....,. _ 10 to 100%, (a-33%j. Pleural thicJaieSs 
wu-...iia24/'46%;.-;,, 14117" and ea~;,, 1/1.!1%. no. ftoiid wumi CKudatc 
in 50f9l.6%. JI wu llaelloioonhaci ioo l/S.S% ..d puruleat in 111.11%. L~ 
............... in 14162.11%. Flllid-lilr AFB,... poaitm: ia .417.4"; - was positive ia 
llll0.4%., .13124.1% a{ ,lbc ~ w.... ..,... ar Cllllon ar - ... """"" positive. 
Gnmul-. _,, tilomd in.aU - caseatiag in 39172.3% ..d-ca-ainc m IS/27.7". AFB 
wm: .....r... in.12122.2%.Cdie biaplic:s. la l cues, S.S%, gnmulamu - - in a 
...ii.I tikunl bipply. PleWBl .binpsy Was lll1leni!I in 25146.3% of die ,cues· 111 tlui. lime aC 
detec:lilos die plelirlol effillicioL' CONCLUSIQNS: 'hiac "!118 a 1111>popdation of paliqils with 
Pm - did DOI fill die CJUika1 fimliags 8C llml . ....,.__ .MycolJodcriolog ~
woi doaeinjust oboUt a quidi< ollbc cua. Fiadinjj or........., in a plelnl loioply seems ID 
..tf.~-~·""""diapooisorPlB .. 
RAmOGRAPHrc. FINDINGS JN PAllENTS wrrn TllBl!RCULOSIS (1B) AND 
D1ABBTES Ml!Ll.rrUS (DM) .· • 
A a-_ '1.Villepl, J_...,__ ll Medina, Hmpital Uniwasituio "I)<. J. E. Goazolh:z", 
UANL.~.NL.- . ' 
111e ollje<ti,...at: lliil 11uo1y - 1o dosail!e lbc ndiop1ojolli< liadiap or m in ..-wilh 
-.clbc--~~DM.Baides~"'1.tbcpolicubo,we 
lbolied ..... c+> ...... lilr ..,;.1-r..t-... (AFB) .. a(+) - filr.M. ~ ' 
- (+), culbnw: (-) polimU ""'"'1cl .... ~ wiU. 1B - .... be illlcluded. 
Chai X.ny liadiap ,,_ ~ u  ;rt11ey:,~ iBfi"'- Allll catilies in 
upper Jabos (• or .._). CJlhawiae, Ibey - eJaail!ed u "atypic:al". RESULTS: A , 
-i.cs1cues...n.induilod.(saale· .. WS0.!1%.-·W4U%J.A-•-.so.s 
yean <-.2' ... 79){Malt·-·_.... . ....., ....... ~re.or 37nl.S% .... 
..apt- 31m.S%. ·~ - obecneo! in 11/35.2%.AFB --m ,...._ 
-·Jia 35.'lil.6"; .._ IS/29.4%.,11"4 ~ W., 1n.m. 
Typical lilldiDp "IJI ~ X.ny. - - .in <mly, 11/ll.S%.. tlppo!:. leloes -... 
................. 3<of11!,5%, ..._,Jabos ~- isolaW ........ binllioa with- lobes 
lesioa, _.......,..24147". Bilalsnllai-....n......,.a.WQ:7".~­
dallified • ~ ._, 33164.7". ~ 21/4'1.1%, a1...iar, 411171.s, ~~. 
7n3.7",-~ 11/ll.5". Sod!ocleP!c af~)llio .......... 21141.1%. 
CavilicO _,j fi...t. 4J/ll0.3% and ......... 11/ll.5%. .......... Dool;,, 7n3.7%.~;.?v!'\1n~~~~10ll9.:i%,,A~of.m..lliDdm,. 
- aDl<d m 36n0.~ CONCLUSIONS:. Atypi<al lindiap aC 1B iR wsy - - . 
.,m- JOiU. DM. Ja' .. pip nlied, 31.3% ..oded ~ ID be tliij:aooi:il. We. 
\ .......... that TB .iiaald be....,..... m Oil patiaols with I>Mlil!d.., ...... lilldiilg •' 
the .-x.ny. A(·).,- smear lilr AFB - DOI rule out 1B .Ud u;..,. ..... -" 
invui"' ............. ~~maybe •-till diopollic biol. . . . . 
--·-· 
SAFETY OF INTRA VENOUS STR.El'TOMYCJN IN TREATING T1 
M. Narit.a. JJ. S!amhe""' D. A"""i- E.S. HoJlcad<r. A.E. Pitclpjl 
TB Hoepital; VA Medial Caller.Miami; Div. of Nm and CritC 
Millllli. 
Su"'*""ycia (SM) is afint-liae druc for the - el blhcrculo 
admiaillndi ... is requiml to olllaia daenpetnic ..-trJlli.., tJi lhe 
JIOOI" abscllplioa 1i1G doc GI llaCI. lllilial operiaM:e widldllo illln.ven 
dnq: WU ..,_;ated with facial Ruem..,, ~ a!"f liawca, 
Udnimmc:lllar(IM) roulc --· wH PU Ouoci..i wilhinjc< 
111811, ud tbc ~ et11qilic ~may aU limit~.­
improved~- el the tis. anev•~ al the toaicit)' et .r 
•arranteil A.G .. Holley Staie TB Hmpilal hal !lied IV SM in patie 
The IV· SM prolOCol iacluo!Cd iiaamitoriq Of aym..-,, 1esw1 
BUN/~ • ...t&lidiopml. Mvene evcall during or afW ad 
were rellGopcclivdy analyzed u ...U u tcml -1 aliditory func:tj.., i 
received SM bctwem 1995 aml · 1996. 
(toialdoap bcfoni"-cat aft.rlmllillalt . 
or SM . BUN Cialinime BUN o.aiinine~ 
10:2±0.7 o:93±0.03 12.2±1.0 0.?4±11.03 
9.5±0.9 0.M±0.06 9.B±J.ci 0.82±0.03 
* tbc number ia'exp;;-d iat ~SEM" 
Noataliltical diff--aiiled Ulliilguajiaued Half cir BUN/cieati: 
total e1asage, •No facial tludoiJl&, lieadache, or - """ noted. II: 
appears ID be safe ud dfcclive, ud tbe complic:atiOD1 mad di•com 
iajecti- may be )IRYOliled. 
----.... 
PULMONARYDISEASES IN·DIABETIC PATIENTS 
S. Fifuloyi<!. V. ~Odrk!, A. ZchaVlrovic!; S. Savi<!•, N1 Gatic 
Instilllte of Pu!~~ ~d TB, Uc~·' Clinicill Cc 
Iosti1111e ro.. MicmmolOii,y,•• SCbool i;>fMedicioe, Belgra<\e, 
The ·fact is diat chroiiic metabolic disbalanae in · diabe 
characterized by an increased riak of a different type 
Themore, we were in-fed in analyzing whlch kind 
diseases are .thci. most ci>inmoo in. diabetics, and tlieir corre 
same clinical characteriatica. The study included. 74 di 
hospilalized at a department of the Insti11111e of Pulmonary D 
in Belgrade during 1996. Thirty two plll were female and 42 
mean age 62 (range 28-73 yn). PulmOiwy TB was tlie 
disease in 24 pis (32,4%), with TB pleural ~Oil 4 pts(S 
by poeqmooia.aod broochopacumooia in 16:(21 ;6%), lung c 
( l 8,9"Ai), chronic obstraclive pulmonary. diseases in II pll 
sarcoidosis in 8 pis (10,So-'>· Fifty two pis (70,3%)-were m 
bypoglycemic agents but 22, pis (29,7%) were OD insulin 
cases (27"Ai) diabelea was non regulated. The clinical COUI' 
the treatments of resPitatory infections ( TB and ooupecif 
were longer ( 1-2 months) tlian in non .diabetic patjonts. 111 c 
the most comln<in pulmonary disease in diabetic J*ients. · 
----.... 
VALIDATION OF MiJLTIPR.IMEll l'CR. SYSTEM IN TH 
OF M: . TU•ERCULOSIS IN SPUTUM SAMPLE; 
PR.l!;l.lll1U~AllY llESllL.TS. 
MA...E&z. ,i fbprco-Leyj 1 M Mmtfn-Cqmeo.r ~ LJl!. 
Unital de Ri<arca Respirotinia i Ambiental. Serv<i de Pneurr1• 
Microbiologfa. Htnpilal del Mar-IMIM. Univeni!r>t A"'°""'"" de IJQ 
Catalonia. Spam. ··" . . · .. . . 
The polymense chain reaction (PCR) is a quick technique· fo..Cletectio 
DNA It has high sens.ibility .and j/;. fow in co.st. Most of the ·methoc 
amp~ifi\:aUon of~ fi1lm diem_, scqueno:e, especiallyfS6ll 
specific seq- for M. ~n:Nhµis &ad as a result ire-IS several SJ 
in the diagnO&i& of tiatoen:ukiiis. M.ULTl/>R/MER l'CR SYSTEM (ll 
Micmbiol 1996,14:124) has heaf~tly propoMxl f• iJl!provini .the 
in detecting M. IVIH!n:uloiis;' discrimlaaling it lioon Giber mycoliiCteri 
validate the MULTIPRIMER />CJI SYSTEM .ill the·~ of. A 
sput1fm SIJ!IPles. )l(et).o4s:.T1>te,MQLTl/>RIMER.P<;R SYSTU( inc 
of pn~ aa the~~-~.:~ ~amplifies a ~t !>f 605. b 
kDa protem commm f• all micob1i:fieria. die SCICOlld a fragma11 of 91 
IS6J/O inliert'sequeaa: specific to lhliM:taben:olosu ~··and tho 
396 bp ("pt") of MTB40 speciea'iipe<:ific protein for M. IUben:ulo.ris (! 
MicrobiOl 1991,29:2163). To dole, a total of S4 sputum samples.h 
simpJe.blind a>ndition .. (dl ~wen: simul--.sly s-.;u~1ho ~ aoaiY,sis .... lft ··~ or DNA protocol .that illcludecl 
phenOi-chl.rotonn.'Tb6'exuaciioR "'°"""' - Used for the PC1t rca 
negalive ciJlllrols _., iiicludod ill die ptoceSs. 1he ~·pro 
agarose' gel tJ;S~). stained·· Wilb ethidium bromide' :ind am 
transilluminatiod. llesalts: MULTIPRJMER PCR S.YSTEM was p 
I I sputum samples with;- positive for M. · Tubei-crdosis and i• 
negll\i.>!e c..i11!R- C-"'""""': In this~. MULTl/>RIMER .. />CR 
this liloiDeill, a ~vity or 82.,. ud I\ SpC.i~ or 98~ in de!CCtii 
;.:=~:ritedbj FIS 9MJ02B-02: . . . .. , .. 
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